0001214659-11-003916.txt : 20111114 0001214659-11-003916.hdr.sgml : 20111111 20111114134954 ACCESSION NUMBER: 0001214659-11-003916 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111114 DATE AS OF CHANGE: 20111114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BROADCAST INTERNATIONAL INC CENTRAL INDEX KEY: 0000740726 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 870395567 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13316 FILM NUMBER: 111200668 BUSINESS ADDRESS: STREET 1: 7050 UNION PARK AVENUE, #600 CITY: SALT LAKE CITY STATE: UT ZIP: 84047 BUSINESS PHONE: 801-562-2252 MAIL ADDRESS: STREET 1: 7050 UNION PARK AVENUE #600 CITY: SALT LAKE CITY STATE: UT ZIP: 84047 FORMER COMPANY: FORMER CONFORMED NAME: LASER CORP DATE OF NAME CHANGE: 19920703 10-Q 1 j111011110q.htm FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 j111011110q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 10-Q

S           Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2011

OR

£           Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________ to ________

Commission File No.0-13316
BROADCAST INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)

Utah
 
87-0395567
(State or other jurisdiction of
 
(IRS Employer
incorporation or organization)
 
Identification No.)

7050 Union Park Ave. #600, Salt Lake City, Utah 84047
(Address of principal executive offices and zip code)

(801) 562-2252
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  S     No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to post such files). Yes S  No £

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
£ Large accelerated filer
£ Accelerated filer
£ Non-accelerated filer
S  Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)  Yes   £    No   S

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date:
 
Class
Outstanding as of October 31, 2011
Common Stock, $.05 par value
75,975,656 shares
 


 
1

 
 
Broadcast International, Inc.
Form 10-Q

Table of Contents

PART I - FINANCIAL INFORMATION
Page
Item 1.   Financial Statements
3
Item 2.   Management’s Discussion and Analysis of Financial Condition
 
                          and Results of Operations
22
Item 3.   Quantitative and Qualitative Disclosures about Market Risk
31
Item 4.   Controls and Procedures
31
PART II -OTHER INFORMATION
 
Item 1.   Legal Proceedings
32
Item 1A. Risk Factors
32
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds
32
Item 3.   Defaults Upon Senior Securities
33
Item 4.   [REMOVED AND RESERVED]
33
Item 5.   Other Information “Not Applicable”
33
Item 6.   Exhibits
33
Signatures
35
 
 
 
 

 
 
2

 
 
PART I.   FINANCIAL INFORMATION

Item 1. Financial Statements
BROADCAST INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

   
December 31, 2010
   
September 30, 2011
 
         
(Unaudited)
 
ASSETS:
           
     Current Assets
           
Cash and cash equivalents
  $ 6,129,632     $ 414,472  
Trade accounts receivable, net
    1,125,055       1,192,248  
Inventory
    52,175       106,574  
Prepaid expenses
    190,877       238,043  
Total current assets
    7,497,739       1,951,337  
     Property and equipment, net
    2,419,891       1,732,177  
     Other Assets, non current
               
Patents, net
    167,410       159,797  
Deposits and other assets
    624,598       476,156  
Total other assets, non current
    792,008       635,953  
                 
     Total assets
  $ 10,709,638     $ 4,319,467  
                 
LIABILITIES AND STOCKHOLDERS DEFICIT:
               
 
               
     Current Liabilities
               
Accounts payable
  $ 1,552,006     $ 1,073,967  
Payroll and related expenses
    341,255       433,169  
Other accrued expenses
    381,015       78,526  
Unearned revenue
    139,437       35,808  
Current notes payable
    775,000       171,875  
Other current obligations
    1,426,834       1,443,044  
Derivative valuation
    14,759,300       3,095,900  
Total current liabilities
    19,374,847       6,332,289  
     Long-term Liabilities
               
Long-term portion of notes payable (net of discount of $992,832
and $742,830, respectively
    6,187,984       6,266,111  
Other long-term obligations
    1,067,649       --  
Total long-term liabilities
    7,255,633       6,266,111  
     Total liabilities
    26,630,480       12,598,400  
     Commitments and contingencies
               
     STOCKHOLDERS’ DEFICIT:
               
Preferred stock, no par value, 20,000,000 shares authorized; none issued
    --       --  
Common stock, $.05 par value, 180,000,000 shares authorized;   
74,078,153 and 75,949,016 shares issued as of December 31,  
2010 and September 30, 2011, respectively
    3,703,908       3,797,451  
Additional paid-in capital
    92,867,561       96,686,414  
Accumulated deficit
    (112,492,311 )     (108,762,798 )
Total stockholders’ deficit
    (15,920,842 )     (8,278,933 )
                 
     Total liabilities and stockholders’ deficit
  $ 10,709,638     $ 4,319,467  

See accompanying notes to condensed consolidated financial statements.
 
 
3

 

 
BROADCAST INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

   
For the three months ended
   
For the nine months ended
 
   
September 30,
   
September 30,
 
   
2010
   
2011
   
2010
   
2011
 
                         
Net sales
  $ 1,885,600     $ 2,277,074     $ 5,359,907     $ 6,321,495  
Cost of sales
    1,257,954       1,518,310       3,847,716       4,414,402  
Gross profit
    627,646       758,764       1,512,191       1,907,093  
                                 
Operating expenses:
                               
     Administrative and general
    801,351       1,280,183       3,180,412       5,124,883  
     Selling and marketing
    55,007       401,826       197,276       824,771  
     Research and development
    588,147       570,197       2,090,212       1,793,596  
     Depreciation and amortization
    190,846       169,592       575,856       517,751  
     Total operating expenses
    1,635,351       2,421,798       6,043,756       8,261,001  
Total operating loss
    (1,007,705 )     (1,663,034 )     (4,531,565 )     (6,353,908 )
                                 
Other income (expense):
                               
     Interest income
    --       338       3,295       2,324  
     Interest expense
    (3,531,090 )     (176,047 )     (7,379,794 )     (745,925 )
     Gain (loss) on derivative valuation
    (1,044,993 )     5,851,300       240,100       12,257,500  
     Equity issuance costs related to warrants
    --       --       --       (476,234 )
     Loss on extinguishment of debt
    --       16,000       --       (954,033 )
     Loss on sale of securities
    --       --       (49,264 )     --  
     Loss on sale of assets
    --       --       --       (362 )
     Other income (expense), net
    59,121       5,597       67,870       151  
     Total other income (expense)
    (4,516,962 )     5,697,188       (7,117,793 )     10,083,421  
                                 
Profit (loss) before income taxes
    (5,524,667 )     4,034,154       (11,649,358 )     3,729,513  
Provision for income taxes
    --       --       --       --  
Net profit (loss)
  $ (5,524,667 )   $ 4,034,154     $ (11,649,358 )   $ 3,729,513  
                                 
Net profit (loss) per share – basic
  $ (0.13 )   $ 0.05     $ (0.28 )   $ 0.05  
Net profit (loss) per share – diluted
  $ (0.13 )   $ 0.05     $ (0.28 )   $ 0.05  
                                 
Weighted average shares – basic
    43,098,800       75,229,254       41,402,000       75,240,313  
Weighted average shares –diluted
    43,098,800       78,414,453       41,402,000       77,970,216  

See accompanying notes to condensed consolidated financial statements.
 
 
4

 
 
BROADCAST INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
   
Nine Months Ended
 
   
September 30,
 
   
2010
   
2011
 
Cash flows from operating activities:
           
     Net income (loss)
  $ (11,649,358 )   $ 3,729,513  
     Adjustments to reconcile net income (loss) to net cash used in operating activities:
               
         Depreciation and amortization
    1,179,380       1,117,703  
         Common stock issued for services
    399,466       --  
         Common stock issued for interest
    --       19,634  
         Common stock issued for research and development
    4,024       903  
         Non-cash interest upon conversion of convertible notes
    802,190       --  
         Accretion of discount on convertible notes payable
    3,251,360       250,002  
         Capitalized interest on convertible note
    1,131,836       --  
         Stock based compensation
    879,570       2,072,993  
         Loss on sale of assets
    --       362  
         Loss on extinguishment of Debt
    --       954,033  
         Gain on derivative liability valuation
    (240,100 )     (12,257,500 )
         Loss on sale of securities available for sale
    49,264       --  
         Warrants issued for interest
    --       157,400  
         Warrants issued for debt extinguishment costs
    --       404,000  
         Allowance for doubtful accounts
    (38,904 )     1,414  
     Changes in assets and liabilities:
               
         Decrease (increase) in accounts receivable
    279,020       (68,607 )
         Decrease (increase) in inventories
    42,295       (54,399 )
         Decrease in debt offering costs
    1,648,620       --  
         Decrease in prepaid and other assets
    20,393       126,704  
         Increase (decrease) in accounts payable and accrued expenses
    259,419       (485,735 )
         Decrease in deferred revenues
    (10,909 )     (103,629 )
                 
    Net cash used in operating activities
    (1,992,434 )     (4,135,209 )
                 
Cash flows from investing activities:
               
     Purchase of equipment
    (190,173 )     (422,978 )
     Proceeds from the sale of auction rate preferred securities
    225,000       --  
     Proceeds from the sale of assets
    --       240  
                 
    Net cash provided by investing activities
    34,827       (422,738 )
                 
Cash flows from financing activities:
               
     Proceeds from the sale of common stock
    1,335,000       --  
     Proceeds from the exercise of options and warrants
    --       18,304  
     Principal payments on debt
    (1,304,658 )     (1,151,439 )
     Equity issuance costs
    --       (24,078 )
     Proceeds from notes payable
    1,975,000       --  
                 
    Net cash provided (used) by financing activities
    2,005,342       (1,157,213 )
                 
Net increase (decrease) in cash and cash equivalents
    47,735       (5,715,160 )
Cash and cash equivalents, beginning of period
    263,492       6,129,632  
                 
Cash and cash equivalents, end of period
  $ 311,227     $ 414,472  
                 
Supplemental disclosure of cash flow information:
               
    Interest paid
  $ 369,591     $ 244,966  
    Income taxes paid
  $ --     $ --  
See accompanying notes to condensed consolidated financial statements.
 
 
5

 
 
BROADCAST INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
September 30, 2011

Note 1 – Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Broadcast International, Inc. (“we” or the “Company”) contain the adjustments, all of which are of a normal recurring nature, necessary to present fairly our financial position at December 31, 2010 and September 30, 2011 and the results of operations for the three and nine months ended September 30, 2010 and 2011, respectively, with the cash flows for each of the nine month periods ended September 30, 2010 and 2011, in conformity with U.S. generally accepted accounting principles.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2010.  Operating results for the three and nine months ended September 30, 2011 are not necessarily indicative of the results that may be expected for the year ended December 31, 2011.

Note 2 - Reclassifications

Certain 2010 financial statement amounts have been reclassified to conform to 2011 presentations.

Note 3 – Weighted Average Shares

Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.
 
The following table sets forth the computation of basic and diluted earnings per common share for the three and nine month periods ended September 30, 2011 and 2010:

   
For the three months ended
   
For the nine months ended
 
   
September 30,
   
September 30,
 
   
2010
   
2011
   
2010
   
2011
 
Numerator
                       
  Net income (loss)
  $ (5,524,667 )   $ 4,034,154     $ (11,649,358 )   $ 3,729,513  
Denominator
                               
  Basic weighted average shares outstanding
    43,098,800       75,844,526       41,402,000       75,240,313  
  Effect of dilutive securities:
                               
  Stock options and warrants
    --       19,927       --       179,903  
  Restricted stock units
    --       2,550,000       --       2,550,000  
Diluted weighted average shares outstanding
    43,098,800       78,414,453       41,402,000       77,970,216  
                                 
  Net income (loss) per common share
                               
    Basic
  $ (0.13 )   $ 0.05     $ (0.28 )   $ 0.05  
    Diluted
  $ (0.13 )   $ 0.05     $ (0.28 )   $ 0.05  

Potentially dilutive securities representing 25,193,934 and 24,723,934 shares of common stock were excluded from the computation of diluted earnings per common share for the three and nine months ended September 30, 2011, respectively, because their effect would have been anti-dilutive.
 
 
6

 
 
Note 4 – Stock-based Compensation

In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.

Stock Incentive Plans

Under the Broadcast International, Inc. 2004 Long-Term Incentive Plan (the “2004 Plan”), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company.  Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon the anniversary date of the grant.  Should an employee terminate before the vesting period is completed, the unvested portion of each grant is forfeited. We have used the Black-Scholes valuation model to estimate fair value of our stock-based awards, which requires various judgmental assumptions including estimated stock price volatility, forfeiture rates, and expected life.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The number of unissued stock options authorized under the 2004 Plan at September 30, 2011 was 2,024,400.

The Broadcast International, Inc. 2008 Equity Incentive Plan (the “2008 Plan”) has become our primary plan for providing stock-based incentive compensation to our eligible employees and non-employee directors and consultants of the company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. We continue to maintain and grant awards under our 2004 Plan which will remain in effect until it expires by its terms. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 1,165,000 at September 30, 2011.

Stock Options

We estimate the fair value of stock option awards granted beginning January 1, 2006 using the Black-Scholes option-pricing model. We then amortize the fair value of awards expected to vest on a straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and expected option term.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. The expected option term is derived from an analysis of historical experience of similar awards combined with expected future exercise patterns based on several factors including the strike price in relation to the current and expected stock price, the minimum vest period and the remaining contractual period.

The fair values for the options granted for the nine months ended September 30, 2011 and 2010 were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
 
   
Nine Months Ended
September 30, 2011
   
Nine Months Ended
September 30, 2010
 
Risk free interest rate
    1.96%       3.14%  
Expected life (in years)
    6.28       7.5  
Expected volatility
    81.03%       80.71%  
Expected dividend yield
    0.00%       0.00%  

The weighted average fair value of options granted during the nine months ended September 30, 2011 and 2010 was $0.63 and $0.80, respectively.

Warrants

We estimate the fair value of issued warrants on the date of issuance as determined using a Black-Scholes pricing model. We amortize the fair value of issued warrants using a vesting schedule based on the terms and conditions of each associated underlying contract, as earned. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and warrant expected exercise term.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the warrant was issued with a maturity equal to the expected term of the warrant.
 
 
7

 
 
The fair values for the warrants issued for the nine months ended September 30, 2011 and 2010 estimated at the date of issuance using the Black-Scholes option-pricing model with the following weighted average assumptions:
 
   
Nine Months Ended
September 30, 2011
   
Nine Months Ended
September 30, 2010
 
Risk free interest rate
    2.04%       1.34%  
Expected life (in years)
    5.00       2.98  
Expected volatility
    85.82%       88.65%  
Expected dividend yield
    0.00%       0.00%  

 
The weighted average fair value of warrants issued during the nine months ended September 30, 2011 and 2010 was $0.79 and $0.53, respectively.
 
Results of operations for the nine months ended September 30, 2011 and 2010 includes $2,072,993 and $879,570, respectively, of non-cash stock-based compensation expense. Restricted stock units and options issued to directors vest immediately. All other restricted stock units, options and warrants are subject to applicable vesting schedules. Expense is recognized proportionally as each award or grant vests.

Included in the $2,072,993 non-cash stock-based compensation expense for the nine months ended September 30, 2011 are (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, (iii) $263,572 for 600,000 options issued to one individual and one corporation for consulting services, (iv) $51,207 for 874,200 options granted to 38 employees, (v) $4,263 for 8,700 options granted to 15 of our non-employee installation technicians and (vi) $85,951 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2011.

Included in the $879,571 non-cash stock-based compensation expense for the nine months ended September 30, 2010 is (i) $80,000 for 100,000 options granted to one member of the board of directors, (ii) $93,000 for 150,000 warrants issued to three new members of our advisory board, (iii) $44,450 for 460,000 warrants issued to five individuals and two corporations for consulting services, (iv) $568,121 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2010 and (v) $94,000 for 100,000 restricted stock units issued to a member of the board of directors. Additionally, we issued (i) 183,824 warrants to a former member of the board of directors in exchange for the return and cancellation of 125,000 shares of our common stock, (ii) 2,295,075 warrants to investors of our Private Placement Memorandum Offering and (iii) 3,333,333 warrants with the July 2010 amendment to our 6.25% senior secured convertible note.

The impact on our results of operations for recording stock-based compensation for the three and nine months ended September 30, 2011 and 2010 is as follows:
 
   
For the three months ended
September 30,
   
For the nine months ended
September 30,
 
   
2010
   
2011
   
2010
   
2011
 
General and administrative
  $ 96,973     $ 234,185     $ 616,001     $ 1,915,969  
Research and development
    87,593       51,934       263,570       157,024  
                                 
Total
  $ 184,566     $ 286,119     $ 879,571     $ 2,072,993  
 
 
8

 

 
Due to unexercised options and warrants outstanding at September 30, 2011, we will recognize an additional aggregate total of $692,344 of compensation expense over the next four years based upon option and warrant award vesting parameters as shown below:

 
2011
  $ 174,037  
2012
    257,857  
2013
    178,090  
2014
    82,360  
Total
  $ 692,344  

The following unaudited tables summarize option and warrant activity during the nine months ended September 30, 2011.
 
   
Options
and
Warrants
Outstanding
   
Weighted
Average
Exercise
Price
 
             
Outstanding at December 31, 2010
    20,442,170     $ 1.13  
Options granted
    1,482,900       0.93  
Warrants issued
    1,275,334       0.68  
Expired
    (201,254 )     3.47  
Forfeited
    (2,319,981 )     1.25  
Exercised
    (455,098 )     0.08  
                 
Outstanding at September 30, 2011
    20,224,071     $ 1.10  

The following table summarizes information about stock options and warrants outstanding at September 30, 2011.
 
   
Outstanding
   
Exercisable
 
         
Weighted
Average
Remaining
   
Weighted
Average
         
Weighted
Average
 
Range of
Exercise Prices
 
Number
Outstanding
   
Contractual
Life (years)
   
Exercise
Price
   
Number
Exercisable
   
Exercise
Price
 
$0.05-0.95     1,901,336       5.12     $ 0.78       1,273,836     $ 0.71  
1.06-6.25
    18,321,135       4.25       1.13       17,916,991       1.13  
9.50-11.50
    1,600       0.42       10.50       1,600       10.50  
$0.05-11.50     20,224,071       4.33     $ 1.10       19,192,427     $ 1.10  

Restricted Stock Units

The value of restricted stock units is determined using the fair value of our common stock on the date of the award and compensation expense is recognized in accordance with the vesting schedule. During the nine months ended September 30, 2011 and 2010, 1,600,000 and 100,000 restricted stock units were awarded, respectively. During the nine months ended September 30, 2010, 35,000 restricted stock units were settled by two individuals through the issuance of 35,000 shares of our common stock.
 
 
9

 
 
The following is a summary of restricted stock unit activity for the nine months ended September 30, 2011.

   
Restricted
Stock Units
   
Weighted
Average
Grant
Date Fair
Value
 
             
Outstanding at December 31, 2010
    950,000     $ 1.63  
Awarded at fair value
    1,600,000       1.04  
Canceled/Forfeited
    --       --  
Settled by issuance of stock
    --       --  
Outstanding at September 30, 2011
    2,550,000     $ 1.25  
Vested at September 30, 2011
    2,550,000     $ 1.25  

Note 5 - Significant Accounting Policies

Cash and Cash Equivalents

We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At September 30, 2011 and December 31, 2010, we had bank balances of $104,367 and $5,879,632, respectively, in excess of amounts insured by the Federal Deposit Insurance Corporation. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.

Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions.  We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.

Accounts Receivable

Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when collected.

Included in our $1,192,248 and $1,125,055 net accounts receivable for the nine months ended September 30, 2011 and the year ended December 31, 2010, respectively, were (i) $1,150,276 and $1,031,795 for billed trade receivables, respectively; (ii) $86,716 and $143,542 of unbilled trade receivables (iii) $56 and $208 for employee travel advances and other receivables, respectively; less (iv) ($44,800) and ($50,490) for allowance for uncollectible accounts, respectively.

Inventories

Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.

Property and Equipment

Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years.  Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.
 
 
10

 
 
Patents and Intangibles

Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years.  We have filed several patents in the United States and foreign countries. As of September 30, 2011, the United States Patent and Trademark Office had approved four patents.  Additionally, eleven foreign countries had approved patent rights.  While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward.

Amortization expense recognized on all patents totaled $2,538 and $7,613 for the three and nine months ended September 30, 2011, respectively. Amortization expense recognized on all patents totaled $2,591 and $7,466 for the three and nine months and ended September 30, 2010, respectively.

Estimated amortization expense, if all patents were issued at the beginning of 2011, for each of the next five years is as follows:

Year ending
December 31:
     
2011
  $ 12,231  
2012
    11,763  
2013
    11,763  
2014
    11,763  
2015
    11,763  

Long-Lived Assets

We review our long-lived assets, including patents, annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.  Fair value is determined by using cash flow analyses and other market valuations.

Income Taxes

We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740.  Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.

Revenue Recognition

We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.

When we enter into a multi-year contract with a customer to provide installation, network management, satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold.  These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.
 
 
11

 
 
In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.

Research and Development

Research and development costs are expensed when incurred.  We expensed $570,197 and $1,793,596 of research and development costs for the three and nine months ended September 30, 2011, respectively. We expensed $588,147 and $2,090,212 of research and development costs for the three and nine months ended September 30, 2010, respectively.

Concentration of Credit Risk

Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management’s expectations.

For the nine months ended September 30, 2011 and 2010, we had one customer that individually constituted 91% and 87%, respectively of our total revenues.

Note 6 – Notes Payable

The recorded value of our notes payable (net of debt discount) for the nine months ended September 30, 2011 and year ended December 31, 2010 was as follows:

   
December 31, 2010
   
September 30, 2011
 
             
Amended and Restated Senior 6.25% Convertible Note
  $ 6,180,816     $ 6,180,816  
Unsecured Convertible Note
    7,168       257,170  
Pledged A/R Note Payable
    675,000       --  
Short Term Note Payable
    100,000       --  
Total
    6,962,984       6,437,986  
Less Current Portion
    (775,000 )     (171,875 )
Total Long-term
  $ 6,187,984     $ 6,266,111  

Amended and Restated Senior 6.25% Convertible Note

On December 24, 2007, we entered into a securities purchase agreement in which we raised $15,000,000 (less $937,000 of prepaid interest).  We used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes.  Pursuant to the financing, we issued a senior secured convertible note in the principal amount of $15,000,000.  The senior secured convertible note bore interest at 6.25% per annum if paid in cash.  Interest for the first year was prepaid at closing.  Interest-only payments thereafter in the amount of $234,375 were due quarterly and commenced in April 2009.  The original principal of the note was convertible into 2,752,294 shares of our common stock at a conversion price of $5.45 per share, convertible any time during the term of the note.  We granted a first priority security interest in all of our property and assets and of our subsidiaries to secure our obligations under the note and related transaction agreements.

In connection with the 2007 financing, the senior secured convertible note holder received warrants to acquire 1,875,000 shares of our common stock exercisable at $5.00 per share.  We also issued to the convertible note holder 1,000,000 shares of our common stock valued at $3,750,000 and incurred an additional $1,377,000 for commissions, finders fees and other transaction expenses, including the grant of a three-year warrant to purchase 112,500 shares of our common stock to a third party at an exercise price of $3.75 per share, valued at $252,000.  A total of $1,377,000 was included in debt offering costs and was amortized over the term of the note.
 
From March 26, 2010 through October 29, 2010, we entered into a series of amendments to the senior secured convertible note under which we issued to the holder of the senior secured convertible note an additional 3,000,000 shares of our common stock, increased the number of warrants by 3,333,333 shares, and reduced the warrant exercise price to $1.80 per share for all warrants, all as consideration for the amendments.
 
 
12

 
 
On December 24, 2010, we closed on the Debt Restructuring (as defined below).  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into a Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest. The Debt Restructuring was considered a troubled-debt restructuring and a gain on debt restructuring of $3,062,457 was recorded during the year ended December 31, 2010, which was the difference between the adjusted carrying value of the original note and the carrying value of the Amended and Restated Note.
 
The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of $350,434 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.

The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company’s securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.

As of September 30, 2011 and 2010, we recorded an aggregate derivative liability of $203,700 and $1,000,500 respectively, related to the conversion features of the Amended and Restated Note and the conversion feature and warrants related to the Original Note.  A derivative valuation gain of $2,403,700 and loss of $235,200 was recorded during the nine months ended September 30, 2011 and 2010, to reflect the change in value of the aggregate derivative liability since December 31, 2010 and 2009, respectively. The aggregate derivative liability of $203,700 for the Amended and Restated Note conversion feature was calculated at September 30, 2011 using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate of 0.25%, (ii) expected life (in years) of 2.2; (iii) expected volatility of 68.80% for the conversion feature, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.

During the nine months ended September 30, 2010, the principal value of the 6.25% senior secured convertible note was increased by $1,131,836 to $17,528,086 (convertible into 9,737,826 common shares), for interest capitalized rather than making a payment in cash.

The original principal value of the note was being accreted over the term of the obligation, for which $1,047,825 and $3,143,475 was included in interest expense for the three and nine months ended September 30, 2010. The note now bears a 6.25% annual interest rate payable quarterly and for the nine months ended September 30, 2010, $27,388 was accrued and included as interest expense.  For the nine months ended September 30, 2010, $1,106,217 ($1,131,836 offset by $25,619 note interest accrued in 2009) was included in interest expense for capitalized interest.

The $6,180,816 value of the note at September 30, 2011 consists of $5,500,000 for the principal due of the note plus $1,031,250 for aggregate future interest less $350,434 for interest withheld at closing for interest due from the initial date of the debt restructuring transaction until December 31, 2011.

Unsecured Convertible Note

On September 29, 2006, we entered into a letter of understanding with Triage Capital Management, or Triage, dated as of September 25, 2006.  The letter of understanding provided that Triage loan $1,000,000 to us in exchange for us entering into, on or prior to October 30, 2006, a convertible note securities agreement.  It was intended that the funding provided by Triage be replaced by a convertible note and accompanying warrants, as described below.  Effective November 2, 2006, we entered into securities a purchase agreement, a 5% convertible note, a registration rights agreement, and four classes of warrants to purchase our common stock, all of which were with an individual note holder, the controlling owner of Triage, who caused our agreement with Triage to be assigned to him, which satisfied our agreement with Triage.
 
 
13

 
 
Pursuant to the securities purchase agreement, (i) we sold to the convertible note holder a three-year convertible note in the principal amount of $1,000,000 representing the funding received by us on September 29, 2006; (ii) the convertible note bore an annual interest rate of 5%, payable semi-annually in cash or shares of our common stock; (iii) the convertible note was convertible into shares of our common stock at a conversion price of $1.50 per share subject to full-ratchet anti-dilution price protection provisions ; and (iv) we issued to the convertible note holder four classes of warrants (A Warrants, B Warrants, C Warrants and D Warrants), which give the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock as described below.  The A and B Warrants originally expired one year after the effective date of a registration statement filed under the Securities Act of 1933, as amended (the “Securities Act”), to register the subsequent sale of shares received from exercise of the A and B Warrants. The C Warrants and D Warrants originally expired eighteen months and twenty four months, respectively, after the effective date of a registration statement to be filed under the Securities Act.  The A Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.60 per share, the B Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.75 per share, the C Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $2.10 per share, and the D Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $3.00 per share.

During the year ended December 31, 2007, the convertible note holder exercised 454,000 A Warrants. We entered into an exchange agreement dated October 31, 2007 in which the convertible note holder received 650,000 shares of our common stock in exchange for cancellation of the C and the D Warrants.  The expiration date of the A Warrants and the B Warrants was extended from January 11, 2008 to December 3, 2008. During the year ended December 31, 2008, the convertible note holder exercised 64,400 A Warrants. On December 3, 2008, the remaining 231,600 A Warrants and 750,000 B Warrants expired.

On December 23, 2009 we entered into an amendment with the holder of this unsecured convertible note, which (i) extended the note maturity date to December 22, 2010 and (ii) increased the annual rate of interest from 5% to 8% commencing October 16, 2009. All other terms and conditions of the note remained unchanged.

On December 24, 2010 we closed on a Debt Restructuring as mentioned above. In connection with that Debt Restructuring the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We issued 150,000 shares to the holder of this note as consideration to extend the term of the note.

During March 2011, we issued 135,369 shares of common stock to the holder of our unsecured convertible note in satisfaction of $81,221 of accrued interest on the unsecured convertible note.  Also in connection with the satisfaction of the accrued interest we granted to the holder a warrant to acquire up to 221,758 additional shares of our common stock at an exercise price of $0.96 per share.  The warrant is exercisable at any time for a five-year period. For the nine months ended September 30, 2011, the $157,400 value of the warrant was included in interest expense.
 
At September 30, 2011 and 2010 we recorded an aggregate derivative liability of $256,700 and $2,800, respectively, related to the conversion feature of the note. A derivative valuation gain of $1,145,200 and $197,200, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2010 and December 31, 2009, respectively.  The aggregate derivative liability of $256,700 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.25%, (ii) expected life (in years) of 2.3; (iii) expected volatility of 73.43%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.

In connection with the amendment mentioned above, the principal value of the note will be accreted due to the difference in the value of the conversion feature before and after the amendment.  The accretion for the three and nine months ended September 30, 2011, was $83,334 and $250,002, respectively and was included in interest expense. The note currently bears an 8% annual interest rate payable semi-annually, and for each of the three and nine month periods ended September 30, 2011 and 2010, $20,000 and $60,000, respectively was included in interest expense.
 
 
14

 
 
Accounts Receivable Purchase Agreements

During the year ended December 31, 2010 we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. In these agreements, we pledged certain outstanding accounts receivable in exchange for advanced payment and a commitment to remit to the purchaser the amount advanced upon collection from our customer. Terms of the first agreement under which we were advanced $175,000 include a 3% discount with a 3% interest fee for every 30 days the advances remain outstanding. Terms of the second agreement under which we were advanced $500,000 include a 10% discount with a 0.5% interest fee for every 30 days the advances remain outstanding.

During the three months ended March 31, 2011 we converted the remaining $675,000 of principal along with $109,292 of accrued and unpaid interest into 1,307,153 shares of our common stock and warrants to purchase an additional 653,576 shares of our common stock. The warrants contain anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than $1.00 per share.

At September 30, 2011 we recorded an aggregate derivative liability of $135,500 related to the warrant reset provision. A derivative valuation gain of $314,600 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued.  The aggregate derivative liability of $135,500 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.83%, (ii) expected life (in years) of 4.5; (iii) expected volatility of 81.42%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.

Short Term Note Payable

During the three months ended March 31, 2011 we remitted $100,000 of the principal balance and accrued interest of $8,360 to a company pursuant to a short term note. The note had originated in June 2010 and bore an annual interest rate of 12%. Of the $8,360 of interest paid, $2,327 was related to and included in interest expense for the nine months ended September 30, 2011.

Note 7 – Equity Financing and the Debt Restructuring
 
On December 24, 2010, we closed on an equity financing (the “Equity Financing”) as well as a restructuring of our outstanding convertible indebtedness (the “Debt Restructuring”).  The Equity Financing and the Debt Restructuring are described as follows.

We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation (“PBC”), pursuant to which PBC agreed to act as the exclusive agent of the Company on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company’s securities, subject to a minimum gross consideration of $10,000,000.  The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock.  The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering.  The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.

Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and an exercise price of $1.00 per share.

Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder is being used for working capital.
 
 
15

 
 
On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.

In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants.  The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.

On December 24, 2010, we also closed on the Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.

The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of $350,434 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.

The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company’s securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.

During the three months ended March 31, 2011, we issued Castlerigg 400,000 warrants pursuant to a waiver agreement dated March 10, 2011 allowing the issuance of shares and warrants for the conversion of the AR Note Payable without adjusting the conversion price of the Amended and Restated Senior 6.25% Convertible Note.  These warrants contain full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. During the three and nine months ended September 30, 2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock. A valuation gain of $144,000 was recorded to reflect the change in value of the aggregate derivative from the time of issue to the date of conversion.

In connection with the Debt Restructuring, the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We also issued 150,000 shares to the holder of this note as consideration to extend the term of the note.

Investor warrants totaling 12,499,980 issued under the Placement Agency Agreement contain price protection adjustments in the event we issue new common stock or common stock equivalents in certain transactions at a price less than $1.00 per share and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model.

At September 30, 2011, we recorded an aggregate derivative liability of $2,500,000 related to these warrants and valuation gain of $8,250,000 for the nine months ended September 30, 2011 to reflect the change in value of the aggregate derivative from December 31, 2010. The aggregate derivative liability of $2,500,000 was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate of 0.83%, (ii) expected life (in years) of 4.2; (iii) expected volatility of 81.51%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.
 
 
16

 
 
Note 8 – Fair Value Measurements

The Company has certain financial instruments that are measured at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-tier fair value hierarchy has been established which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).  These tiers include:

 
·
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
 
·
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
·
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2011:
               
Significant
       
         
Quoted Prices in
   
Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets
                       
Treasury cash reserves
  $ 414,472     $ 414,472     $ --     $ --  
Total assets measured at fair value
  $ 414,472     $ 414,472     $ --     $ --  
                                 
Liabilities
                               
Derivative valuation (1)
  $ 3,095,900     $ --     $ --     $ 3,095,900  
Total liabilities measured at fair value
  $ 3,095,900     $ --     $ --     $ 3,095,900  
                                 
(1) See Note 6 for additional discussion.
 
 
 
17

 
 
The table below presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at September 30, 2011.  We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model.

   
Derivative
 
   
Valuation
 
   
Liability
 
Balance at December 31, 2010
  $ (14,759,300 )
Total gains or losses (realized and unrealized)
       
Included in net loss
    12,257,500  
Valuation adjustment
    --  
Purchases, issuances, and settlements, net
    (594,100 )
Transfers to Level 3
    --  
Balance at September 30, 2011
  $ (3,095,900 )

Money Market Funds and Treasury Securities

The money market funds and treasury cash reserve securities balances are classified as cash and cash equivalents on our condensed consolidated balance sheet.

Fair Value of Other Financial Instruments

The carrying amounts of our accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their immediate or short-term maturities.  The aggregate carrying amount of the notes payable approximates fair value as the individual notes bear interest at market interest rates and there has not been a significant change in our operations and risk profile.

Note 9 – Equipment Financing

On August 27, 2009, we completed an equipment lease financing transaction with a financial institution.  Pursuant to the financing, we entered into various material agreements with the financial institution. These agreements are identified and summarized below.

We entered into a Master Lease Agreement dated as of July 28, 2009 with the financial institution pursuant to which we sold to the financing institution certain telecommunications equipment to be installed at 1,981 (subsequent additional locations have increased the customer’s network to an aggregate of approximately 2,100 locations) of our customer’s retail locations in exchange for a one time payment of $4,100,670 by the financial institution. We will pay to the financial institution 36 monthly lease payments and at the expiration of the equipment lease will pay the greater of the then in place fair market value of the equipment or 10% of the original purchase price.

We also entered into a security agreement with the financial institution pursuant to which we granted a first priority security interest in the equipment, whether now owned or hereafter acquired, and in our customer service agreement and service payments thereunder during the term of the equipment lease. We received a waiver from our 6.25% convertible note holder releasing its security interest in the equipment purchased under our sale lease back financing. See Note 6.

The sale leaseback financing arrangement with the financial institution related to the purchase and deployment of certain digital signage equipment for a new customer.  As a result of this financing, we incurred an obligation to make 36 monthly payments of approximately $144,000 plus applicable sales taxes. The proceeds of the financing are being used to purchase and install the digital signage equipment for our customer and for general working capital purposes.  We have the right to terminate the lease after making 33 payments for a termination fee of approximately $451,000 after which time we would own all of the equipment.  We have accounted for this arrangement as a capital lease.

During the three and nine months ended September 30, 2011, we made lease payments totaling approximately $422,096 and $1,266,287 of which $361,966 and $1,048,491 was applied toward the outstanding lease with $60,130 and $217,796, respectively, included in interest expense.
 
 
18

 
 
During the three and nine months ended September 30, 2010, we made lease payments totaling approximately $422,096 and $1,266,287 of which $314,080 and $909,781 was applied toward the outstanding lease with $108,016 and $356,506, respectively, included in interest expense.

Additionally, we recognized amortization of the lease acquisition fee of $12,567 and $37,701 which was included in interest expense for the three and nine months ended September 30, 2011 and 2010, respectively.

Note 10 – Interact Devices Inc. (IDI)

We began investing in and advancing monies to IDI in 2001. IDI was developing technology which became CodecSys.
 
On October 23, 2003, IDI filed for Chapter 11 Federal Bankruptcy protection. We desired that the underlying patent process proceed and that the development of CodecSys technology continue. Therefore, we participated in IDI’s plan of reorganization, whereby we would satisfy the debts of the creditors and obtained certain licensing rights.  On May 18, 2004, the debtor-in-possession’s plan of reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation, we issued to the creditors of IDI approximately 111,800 shares of our common stock, and cash of approximately $312,768 in exchange for approximately 50,127,218 shares of the common stock of IDI, which increased our aggregate common share equivalents in IDI to approximately 51,426,719 shares.
 
During the nine months ended September 30, 2011, we acquired 14,571 IDI common share equivalents in exchange for 971 shares of our common stock valued at $903.
 
Since May 18, 2004, we have acquired an aggregate of 4,070,849 additional common share equivalents IDI. As of September 30, 2011, we owned approximately 55,497,568 IDI common share equivalents, representing approximately 94% of the total outstanding IDI share equivalents
 
Since May 18, 2004, we have advanced additional cash to IDI for the payment of operating expenses, which continues development and marketing of the CodecSys technology. As of September 30, 2011 we have advanced an aggregate amount of $3,057,605 pursuant to a promissory note that is secured by assets and technology of IDI.
 
Note 11 – Recent Accounting Pronouncements

In September 2011, the FASB issued ASU 2011-08, Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment. The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value.  The more likely than not threshold is defined as having a likelihood of more than 50%.  The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued.  The Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012 and will also determine if it wants to adopt the Update early and utilize the option for its goodwill impairment test.

In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220) – Presentation of Comprehensive Income. This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income).  Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements.  This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This will impact how items for Other Comprehensive Income are presented and the Company will plan on following the guidance in the Update as of January 1, 2012.
 
 
19

 
 
In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) – Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRS. The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs.  The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A few of the more significant changes are; 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specification that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, and 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity’s use of a nonfinancial asset in a way that differs from the asset’s highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011.  The Company does not expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.

The following update was issued in 2010 and became effective on or after January 1, 2011.  Only significant updates that may impact the Company are included herein.

In August 2010, the FASB issued ASU No 2010-22, Accounting for Various Topics. Technical Corrections to SEC Paragraphs- An announcement made by the staff of US Securities and Exchange Commission. This Update makes changes to several of the SEC guidance literature within the Codification.  Some of the changes relate to (1) Oil and Gas Exchange Offers, (2) Accounting for Divestiture of a Subsidiary or Other Business Operations, (3) Replaces “Push Down” basis accounting references with “New” basis of accounting to be used in the acquired companies financial statements, (4) Fees paid to an investment banker in connection with an acquisition or asset purchase, when the investment banker is also providing interim financing or underwriting services must be allocated between the related service and debt issue costs. The amendments in this Update are effective immediately.  The Company does not expect this guidance to have a significant impact on its financials since there are no changes to accounting that were not already being applied by the Company.

Note 12 – Supplemental Cash Flow Information

2011

During the nine months ended September 30, 2011, we granted options to acquire up to 600,000 shares of our common stock valued at $389,000 to two consultants in consideration of consulting services to be rendered by the consultants over a one year period pursuant to a written consulting agreement. The value of options is being recognized over the contract period and for the nine months ended September 30, 2011, $263,572 was included in stock based compensation.

On March 21, 2011, the Company, converted $784,292 of its short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, the Company issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. The Company’s objective for converting the short-term debt into equity is to conserve cash for further market development.

In March 2011, we granted to the holder of our senior unsecured convertible note a warrant to acquire 400,000 shares of our common stock at an exercise price of $.05 per share in consideration of a waiver of the holder’s reset provision that allowed us to convert certain short terms loans to equity without causing an adjustment in the conversion price of our senior note.  The warrants had a 5 - year life from the date of grant, contained full-ratchet anti-dilution price protection provisions and were valued $404,000 using a Black Scholes pricing model on the date of grant. During the three and nine months ended September 30, 2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock.
 
 
20

 
 
For the nine months ended September 30, 2011 an aggregate non-cash expense of $250,002 was recorded for the accretion of the unsecured convertible note.

For the nine months ended September 30, 2011, we recognized $1,117,703 in depreciation and amortization expense from the following: (i) $599,952 related to cost of sales for equipment used directly by or for customers, (ii) $510,138 related to other property and equipment, and (iii) $7,613 for patent amortization.

2010

During the nine months ended September 30, 2010, we issued 406,927 shares of our common stock valued in aggregate at $399,466 to three companies and three individuals for consulting services rendered, the expense of which is included in our general and administrative expense.

During the nine months ended September 30, 2010 we issued 200,000 shares our common stock valued at $216,000 to a corporation for the purchase of a H.264 codec software license to be used in our CodecSys product development. We have included it as an asset on our balance sheet and will amortize it as part of cost of sales.

During the nine months ended September 30, 2010, we issued 3,000,000 shares our common stock valued at $3,290,000 to our senior secured 6.25% convertible note holder as part of amendment and extension agreements. We included it as an asset on our balance sheet as additional note acquisition costs and will amortize it over the remaining term of the note.

For the nine months ended September 30, 2010, an aggregate non-cash expense of $3,251,360 was recorded for the accretion of our convertible notes as follows, (i) $3,143,475 for the senior secured 6.25% convertible note and (ii) $107,885 for our unsecured 3% convertible notes.

For the nine months ended September 30, 2010, we recognized $1,179,380 in depreciation and amortization expense from the following: (i) $603,524 related to cost of sales for equipment used directly by or for customers, (ii) $568,390 related to other property and equipment, and (iii) $7,466 for patent amortization.

During the nine months ended September 30, 2010, the conversion to common stock of all of our unsecured 3% convertible notes and the conversion of $50,000 to common stock of our unsecured short term notes resulted in an $802,190 extinguishment of debt primarily due to unrealized note discounts and accrued interest.

Note 13 – Subsequent Events

During October 2011 we issued 26,640 shares of our common stock to one individual in exchange for 399,601 Interact Device Inc. (IDI) share equivalents.

During October 2011 we issued an aggregate of 77,500 options to one member of our Advisory Board and two employees.
 
During October and November 2011 we entered into an Equipment Sales Agreement under the terms of which a company purchased installation services and equipment to be installed, used and sold to our customers.  The company granted us ninety (90) day terms, which should allow us time to install the equipment, bill our customers, and receive payment to satisfy the outstanding payable to the financing company.  This accommodation will increase the cost of our equipment by approximately 10% if it is paid on time.  The total amount of equipment funding aggregated to $700,000.
 
We evaluated subsequent events pursuant to ASC Topic 855 and have determined that there are no additional events that need to be reported.
 
 
21

 
 
Item 2.     MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Note Regarding Forward-Looking Statements
 
This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended, and Rule 3b-6 promulgated thereunder, that involve inherent risk and uncertainties.  Any statements about our expectations, beliefs, plans, objectives, strategies or future events or performance constitute forward-looking statements.  These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend” and similar words or phrases.  Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied therein.  All forward-looking statements are qualified in their entirety by reference to the factors discussed in this report and to the following risk factors discussed more fully in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010:
 
 
·
dependence on commercialization of our CodecSys technology;
 
 
·
our need and ability to raise sufficient additional capital;
 
 
·
uncertainty about our ability to repay our outstanding convertible notes;
 
 
·
our continued losses;
 
 
·
delays in adoption of our CodecSys technoloty;
 
 
·
concerns of OEMs and customers relating to our financial uncertainty;
 
 
·
restrictions contained in our outstanding convertible notes;
 
 
·
general economic and market conditions;
 
 
·
ineffective internal operational and financial control systems;
 
 
·
rapid technological change;
 
 
·
intense competitive factors;
 
 
·
our ability to hire and retain specialized and key personnel;
 
 
·
dependence on the sales efforts of others;
 
 
·
dependence on significant customers;
 
 
·
uncertainty of intellectual property protection;
 
 
·
potential infringement on the intellectual property rights of others;
 
 
·
factors affecting our common stock as a “penny stock”;
 
 
·
extreme price fluctuations in our common stock;
 
 
·
price decreases due to future sales of our common stock;
 
 
·
future shareholder dilution; and
 
 
·
absence of dividends.
 
Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed or implied in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statement.  Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of future events or developments.  New factors emerge from time to time, and it is not possible for us to predict which factors will arise.  In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
 
 
22

 
 
Section 27A(b)(1)(C) of the Securities Act of 1933, as amended and Section 21E(b)(1)(C) of the Securities Exchange Act of 1934, as amended state that the safe harbor for forward-looking statements does not apply to statements made by companies that issue penny stock.  Because our common stock is “penny stock,” the safe harbor for forward-looking statements does not apply to us.
 
Critical Accounting Policies
 
The preparation of financial statements in conformity with U.S. GAAP requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our assumptions and estimates, including those related to recognition of revenue, valuation of investments, valuation of inventory, valuation of intangible assets, valuation of derivatives, measurement of stock-based compensation expense and litigation. We base our estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We discuss our critical accounting policies in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2010. There have been no other significant changes in our critical accounting policies or estimates since those reported in our Annual Report.
 
Executive Overview
 
The current recession and market conditions have had substantial impacts on the global and national economies and financial markets.  These factors, together with soft credit markets, have slowed business growth and generally made potential funding sources more difficult to access.  We continue to be affected by prevailing economic and market conditions, which present considerable risks and challenges to us.

On July 1, 2010, we released CodecSys 2.0, which has been installed in over 30 large telecoms and labs for evaluation by potential customers.  We continue to make sales presentations and respond to requests for proposals at other large telecoms, cable companies and broadcasting companies.  These presentations have been made with our technology partners which are suppliers of hardware and software for video transmission applications in media room environments such as IBM, HP, Fujitsu and Microsoft. In September 2011, we entered into a sales agreement with a small cable company in Mexico for the installation of our CodecSys software running on a Fujitsu hardware platform.  The sale included a three year license of CodecSys with license fees payable monthly.  The initial installation includes 20 standard definition channels with potential for expansion.  The installation has been made and will be on line in November 2011.  This represents the first of our installations of CodecSys in an operating environment.  Although license revenue from the CodecSys technology has been minimal to date, we believe we have made significant progress and continue to believe that our CodecSys technology holds substantial revenue opportunities for our business.

On July 31, 2009, we entered into a $10.1 million, three-year contract with a Fortune 10 financial institution customer to provide technology and digital signage services to approximately 2,100 of the customer’s more than 6,000 retail and administrative locations throughout North America.  The customer is expanding its network to additional retail and administrative locations.  In addition, the customer selected us to be its vendor for certain additional audio visual services.  A factor in securing this contract was the benefits of the CodecSys technology delivering our services to be utilized in our services.

During 2010 we sold 1,601,666 shares of our common stock to 19 separate investors at a purchase price of $1.00 per share together with a warrant to purchase additional shares of our stock for $1.50 per share. The warrant expires at the end of three years. The net proceeds from the sale of these shares were used for general working capital purposes.  Each of the investors was given the right to adjust their purchase in the event we sold additional equity at a price and on terms different from the terms on which their equity was purchased.  Upon completion of the Equity Financing described below, each of the investors converted their purchase to the terms contained in the Equity Financing.  This resulted in the issuance of an additional 956,659 shares of common stock and the cancellation of 2,295,075 warrants with an exercise price of $1.50 and the issuance of 2,079,222 warrants with an exercise price of $1.00 and an expiration date of five years from the conversion.
 
 
23

 
 
On December 24, 2010, we closed on an equity financing (the “Equity Financing”) as well as a restructuring of our outstanding convertible indebtedness (the “Debt Restructuring”).  The Equity Financing and the Debt Restructuring are described as follows:

We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation (“PBC”), pursuant to which PBC agreed to act as the exclusive agent of the Company on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company’s securities, subject to a minimum gross consideration of $10,000,000.  The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock.  The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering.  The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.

Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and an exercise price of $1.00 per share.

Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder is being used for working capital.

On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.

In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants.  The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.

On December 24, 2010, we also closed on the Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the “Amended and Restated Note”) to Castlerigg Master Investment Ltd. (“Castlerigg”), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the “Loan Restructuring Agreement”), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.

The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of $350,434 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.

The Investor Rights Agreement contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.
 
 
24

 
 
In connection with the Debt Restructuring, the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We also issued 150,000 shares to the holder of this note as consideration to extend the term of the note.

Results of Operations for the Nine Months ended September 30, 2011 and September 30, 2010

Revenues

We generated $6,321,495 in revenue during the nine months ended September 30, 2011.  During the same nine-month period in 2010, we generated revenue of $5,359,907.  The increase in revenue of $961,588 was due primarily to continued increases in revenue from our digital signage contract with our largest customer, a financial services company, which accounted for approximately 91% of our revenues for the nine months ending September 30, 2011. License fees decreased by $354,571, but system sales and installation revenues increased by $1,417,355 in the nine months ended September 30, 2011, almost all of which increase was due to our major digital signage customer.  Satellite transmission fees decreased by $114,621, which resulted primarily from changing the delivery platform of one customer from a satellite delivered service to delivering its content via the Internet.

Sales revenues from our largest customer accounted for approximately 91% and 87% of total revenues for the nine months ended September 30, 2011 and 2010, respectively. Revenues from all of our customers, except our largest customer, decreased by $156,030 in the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010.

Cost of Revenues

Cost of revenues increased by approximately $566,686 to $4,414,402 for the nine months ended September 30, 2011 from $3,847,716 for the nine months ended September 30, 2010.  Costs of equipment and installation services increased by $579,761 primarily due to the installation of new equipment used in the continued expansion of our largest customer’s digital signage network.  Installation services for all other customers combined increased by approximately $35,266.  In addition, depreciation decreased by $58,105 due to certain equipment being fully depreciated.
 
Expenses

General and administrative expenses for the nine months ended September 30, 2011 were $5,124,883 compared to $3,180,412 for the nine months ended September 30, 2010.  The increase of $1,944,471 resulted primarily from an increase of approximately $1,299,967 in the amount charged for the issuance of options and warrants.  In addition, employee and related costs increased by $239,635, temporary help increased by $215,895, and travel, lodging and meals expense increased by $177,752.  These and other miscellaneous increases in costs were partially offset by a decrease of $161,880 in consulting fees and a decrease of $60,000 in finance fees.

Research and development in process decreased by $296,616 for the nine months ended September 30, 2011 to $1,793,596 from $2,090,212 for the nine months ended September 30, 2010.  The decrease resulted primarily from a decrease of $463,133 in employee related expenses and a decrease of $106,545 in option related expenses, which were partially offset by an increase of $207,569 in temporary help expense.

Sales and marketing expenses increased $627,495 to $824,771 for the nine months ending September 30, 2011 from $197,276 for the nine months ended September 30, 2010.  The increase reflects an increase in employee and related costs of $336,051, an increase of $214,021 in general operating costs including travel and tradeshow expenses and an increase in other professional services and consulting fees of $ 57,148.  The increases in sales and marketing expenses primarily reflects increased staff and activity in marketing the CodecSys technology subsequent to its readiness for implementation.

Interest Expense

For the nine months ended September 30, 2011, we incurred interest expense of $745,925 compared to interest expense for the nine months ended September 30, 2010 of $7,379,794.  The decrease of $6,633,869 resulted primarily from the negotiation and execution of the Loan Restructuring Agreement with Castlerigg Master Investments, Ltd. paying, extending and reducing the principal of our 6.25% senior convertible note in December, 2010. The principal balance of the 6.25% senior convertible note was reduced from approximately $17,500,000 to $5,500,000, which resulted in the decrease in interest expense. Of the total interest expense recorded for the nine months ended September 30, 2011, $467,402 was the amount incurred on the $1,000,000 of principal outstanding on our 8.0% unsecured convertible note, $217,796 was incurred on our equipment lease financing and $60,727 on all of our other indebtedness.  The amount of interest on our 6.25% senior convertible note was accounted for as accretion to the principal amount of the note resulting from the restructuring of that note.
 
 
25

 

Net Income

We realized net income for the nine months ended September 30, 2011 of $3,729,513 compared with a net loss for the nine months ended September 30, 2010 of $11,649,358. The change from a net loss to net income of $15,378,871 is primarily due to an increased gain related to our derivative valuation calculation of warrants and convertible notes of $12,017,400 and the decrease in interest expense of $6,633,869 discussed above. The increase was partially offset by an unrealized loss on securities of $1,381,003 resulting from the restructuring of our 6.25% senior convertible note.

Results of Operations for the Three Months ended September 30, 2011 and September 30, 2010

Revenues

We generated $2,277,074 in revenue during the three months ended September 30, 2011.  During the same three-month period in 2010, we generated revenue of $1,885,600.  The increase in revenue of $391,474 was due primarily to an increase of $450,873 in system sales and installation and service work primarily completed for the digital signage network of our largest customer.  The increase was partially offset by a decrease in satellite fees of $28,263 reflecting the change of one of our customers from a satellite delivered platform to an Internet delivered platform.

Our largest customer’s sales revenues accounted for approximately 92% and 83% of total revenues for the quarters ended September 30, 2011 and 2010, respectively.  Any material reduction in revenues generated from our largest customer could cause a substantial deterioration in our results of operations, financial condition and liquidity.

Cost of Revenues

Costs of revenues increased by approximately $260,356 to $1,518,310 for the three months ended September 30, 2011 from $1,257,954 for the three months ended September 30, 2010.  The increase was due primarily to an increase of $260,698 in cost of equipment sales and services because our largest customer’s digital signage network continued to expand and we perform additional services for it.

Expenses

General and administrative expenses for the three months ended September 30, 2011 were $1,280,183 compared to $801,351 for the three months ended September 30, 2010.  The increase of approximately $478,832 resulted primarily from an increase of $137,212 in option and warrant expenses, and increase in temporary help of $103,520, an increase of $72,707 in employee and related costs and an increase of $50,211 in bad debt expenses.

Research and development in process decreased by $17,950 for the three months ended September 30, 2011 to $570,197 from $588,147 for the three months ended September 30, 2010.  This decrease resulted primarily from decreased employee and related costs of $156,860, partially offset by an increase of $79,151 in temporary help and increased consulting and professional services of $77,335.
 
Sales and marketing expenses increased $346,819 for the three months ended September 30, 2011 to $401,826 from $55,007 for the three months September 30, 2010.  The increase was due primarily to increased employee and related expenses of $187,113 and increased travel and tradeshow expenses, including lodging and food of $108,187 reflecting increased marketing and sales activity in selling the CodecSys encoding system.

Interest Expense

For the three months ended September 30, 2011, we incurred interest expense of $176,047 compared to interest expense for the three months ended September 30, 2010 of $3,531,090.  The decrease of $3,355,043 resulted primarily from a decrease in interest expense due to the restructuring and payment of approximately $12,000,000 of our 6.25% senior convertible note in December, 2010.  The $176,047 of interest expense recorded  consisted of $103,334 recorded to account for the accretion of note liability on our balance sheet and accrued interest on our 8.0% unsecured convertible note and $60,130 of interest related to equipment financing for our largest customer.
 
 
26

 
 
Net Income

We realized net income for the three months ended September 30, 2011 of $4,034,154 compared to a net loss of $5,524,667 for the three months ended September 30, 2010. The difference between our net income in 2011 compared to our net loss in 2010 of $9,558,821 was primarily the result of recording a gain related to our derivative valuation of warrants and convertible notes for the three months ended September 30, 2011 of $6,896,293 and decreased interest expense recorded of $3,355,043 as explained above. The increase in our total income was partially offset by an increase in loss from operations of $655,329 resulting from increased operating expenses as explained above.

Liquidity and Capital Resources

At September 30, 2011, we had cash of $414,472, total current assets of $1,951,337, total current liabilities of $6,332,289 and total stockholders' deficit of $8,278,933.  Included in current liabilities is $3,095,900, which relates to the value of the embedded derivatives for the 6.25% senior convertible note and related warrants and the 8.0% unsecured convertible note and $1,443,044 related to the current portion of debt obligations for equipment financing.

We experienced negative cash flow used in operations during the nine months ending September 30, 2011 of $4,135,209 compared to negative cash flow used in operations for the nine months ended September 30, 2010 of $1,992,434.  The negative cash flow was met by cash reserves from the completion of our Equity Financing in December of 2010.  We expect to continue to experience negative operating cash flow as long as we continue our current expenditures related primarily to bringing our CodecSys products to market, continue our development of CodecSys or until we begin to receive licensing revenue from sales of our CodecSys proprietary software or increase sales in our network division by adding new customers.

On December 24, 2010, we also closed on the Debt Restructuring.  In connection therewith, we (i) issued the Amended and Restated Note in the principal amount of $5.5 million to Castlerigg, (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement with Castlerigg dated December 23, 2010 pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the Loan Restructuring Agreement, and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.

The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year’s interest of $350,434 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.

The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company’s securities held by Castlerigg, including the right to include 2,500,000 of its shares in the registration statement filed.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The registration statement was declared effective June 16, 2011 and therefore all of the registration deadlines were satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.

In connection with the Debt Restructuring, the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We also issued 150,000 shares of common stock to the holder of this note as consideration to extend the term of the note.
 
 
27

 
 
We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation (“PBC”), pursuant to which PBC agreed to act as the exclusive agent of the Company on a “best efforts” basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company’s securities, subject to a minimum gross consideration of $10,000,000.  The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering.  The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and simultaneous Debt Restructuring.

Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and an exercise price of $1.00 per share.

Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the Equity Financing to pay down our senior debt, brought our accounts payable current and the remainder is being used for working capital.

On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.

In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the Warrants.  If the Company had failed to file the registration statement within 60 days or to have the registration statement declared effective within 120 days following the date of the filing of the registration statement, the Company would have been obligated to issue additional warrants to the investors to purchase an additional 1,250,000 shares for each 30-day period after the deadlines.  However, since the registration statement was declared effective on June 16, 2011, all deadlines were satisfied.

During March 2010 through October 2010, we raised approximately $2,485,000 through the sale of common stock and the issuance of convertible notes to purchasers at an investment or conversion price of $1.00 per share. The financing included the sale of 1,535,000 shares of our common stock and the issuance of convertible notes in the aggregate principal amount of $950,000. We also issued to these purchasers warrants to acquire shares of our common stock at an exercise price of $1.50 per share, which are exercisable anytime during a three year period.  At the time of these sales, we agreed to certain price protection provisions whereby if we were to sell equity at a price lower than $1.00 per share before December 31, 2010, the purchasers would be able to elect to exchange and receive equity on the same financial terms and conditions as the new investors.

All holders of the convertible notes converted the notes and aggregate accrued interest of $10,075 into 960,075 shares of our common stock at a conversion price of $1.00 per share.  In addition, the holders received warrants to acquire up to 960,075 shares our common stock at an exercise price of $1.50 per share.  The shares issued upon conversion of the notes, together with the 1,535,000 shares issued to the purchasers of the common stock, total 2,495,075 shares of our common stock.  In addition, warrants to purchase an aggregate of 2,495,075 shares at an exercise price of $1.50 were held by the purchasers in this financing.  The warrants could be exercised any time for a period of three years.

Upon completion of the Equity Financing, each of the investors in these sales elected to treat their purchases according to the terms contained in the Equity Financing.  This resulted in the issuance of an additional 2,083,374 shares of common stock and the cancellation of 2,495,075 warrants with an exercise price of $1.50 and the issuance of 2,079,222 warrants with an exercise price of $1.00 and an expiration date of five years from the conversion.

During 2010, we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $675,000. In these agreements, we pledged certain outstanding accounts receivable in exchange for an advance payment and a commitment to remit to the purchaser the amount advanced upon collection from our customer. Terms of the first agreement under which we were advanced $175,000 include a 3% discount with a 3% interest fee for every 30 days the advances remain outstanding. Terms of the second agreement under which were advanced $500,000 include a 10% discount with a 0.5% interest fee for every 30 days the advances remain outstanding.
 
 
28

 
 
During 2010, we entered into a $500,000 line of credit for equipment financing to purchase equipment for our largest customer’s digital signage network.  The terms of the line of credit include a 3% interest fee for every 30 days the advances on the line of credit remain outstanding.  We received total advances on the line of credit of $500,000 and subsequent to the completion of the Equity Financing repaid the line of credit.  We used the proceeds to purchase and install the equipment at our customer’s locations.

In August 2009, we entered into a sale and leaseback agreement which financed the purchase and installation of equipment to retrofit our new customer’s approximately 2,100 retail sites with our digital signage product offering.  We received approximately $4,100,000 from the sale of the equipment in exchange for making lease payments over a 36 month period of $144,000 per month plus applicable sales taxes.

On December 24, 2007, we entered into a securities purchase agreement in connection with our senior secured convertible note financing in which we raised $15,000,000 (less $937,000 of prepaid interest).  We have used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes.  The senior secured convertible note has been restructured as described herein.  During 2010, we capitalized interest of $1,491,161 related to the senior secured convertible note.
 
The Loan Restructuring Agreement we entered into as part of the Debt Restructuring contains, among other things, covenants that may restrict our ability to obtain additional capital, to declare or pay a dividend or to engage in other business activities.  A breach of any of these covenants could result in a default under our Amended and Restated Note, in which event the holder of the note could elect to declare all amounts outstanding to be immediately due and payable, which would require us to secure additional debt or equity financing to repay the indebtedness or to seek bankruptcy protection or liquidation.  The Loan Restructuring Agreement provides that we cannot do any of the following without the prior written consent of the holder:
 
·
directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, our common stock;
 
 
·
incur or guarantee any indebtedness other than indebtedness evidenced by the Amended and Restated Note and other permitted indebtedness as defined in the Amended and Restated Note;
 
 
·
repay any indebtedness which is junior to the Amended and Restated Note;
 
 
·
issue any additional notes or issue any other securities that would cause a breach or default under the Amended and Restated Note;
 
 
·
issue or sell any rights, warrants or options to subscribe for or purchase common stock or directly or indirectly convertible into or exchangeable or exercisable for common stock at a price which varies or may vary with the market price of the common stock, including by way of one or more reset(s) to any fixed price unless the conversion, exchange or exercise price of any such security cannot be less than the then applicable conversion price with respect to the common stock into which any note is convertible or the then applicable exercise price with respect to the common stock into which any warrant is exercisable;
 
 
·
enter into or effect any dilutive issuance (as defined in the note) if the effect of such dilutive issuance is to cause us to be required to issue upon conversion of any note or exercise of any warrant any shares of common stock in excess of that number of shares of common stock which we may issue upon conversion of the note and exercise of the warrants without breaching our obligations under the rules or regulations of the principal market or any applicable eligible market;
 
 
·
liquidate, wind up or dissolve (or suffer any liquidation or dissolution);
 
 
·
convey, sell, lease, license, assign, transfer or otherwise dispose of all or any substantial portion of our properties or assets, other than transactions in the ordinary course of business consistent with past practices, and transactions by non-material subsidiaries, if any and;
 
 
29

 
 
 
·
cause, permit or suffer, directly or indirectly, any change in control transaction as defined in the Amended and Restated Note.
 
On November 2, 2006, we closed on a convertible note securities agreement dated October 28, 2006 with an individual that provided we issue to the convertible note holder (i) an unsecured convertible note in the principal amount of $1,000,000 representing the funding received by us from an affiliate of the convertible note holder on September 29, 2006, and (ii) four classes of warrants (A warrants, B warrants, C warrants and D warrants) which gave the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock.  The holder of the note no longer has any warrants to purchase any of our stock.  The unsecured convertible note was due October 16, 2009 and was extended to December 22, 2010 and the annual interest rate was increased to 8%, payable semi-annually in cash or in shares of our common stock if certain conditions are satisfied The unsecured convertible note is convertible into shares of our common stock at a conversion price of $1.50 per share, convertible any time during the term of the note, and is subject to standard anti-dilution rights.  The term of the convertible note has been extended and now is due December 31, 2013.  In connection with the extension of the note, we issued to the holder of the note 150,000 shares of common stock to extend the term of the note.  In addition, we committed to pay accrued interest due on the convertible note through the issuance of common stock and warrants on the same terms as the Equity Financing.

The conversion feature and the prepayment provision of our $5.5 million Amended and Restated Note and our $1.0 million unsecured convertible note have been accounted for as embedded derivatives and valued on the respective transaction dates using a Black-Scholes pricing model.  The warrants related to the $1.0 million unsecured convertible notes have been accounted for as derivatives and were valued on the respective transaction dates using a Black-Scholes pricing model as well.  At the end of each quarterly reporting date, the values of the embedded derivatives and the warrants are evaluated and adjusted to current market value.  The conversion features of the convertible notes and the warrants may be exercised at any time and, therefore, have been reported as current liabilities.  Prepayment provisions contained in the convertible notes limit our ability to prepay the notes in certain circumstances.  For all periods since the issuance of the senior secured convertible note and the unsecured convertible note, the derivative values of the respective prepayment provisions have been nominal and have not had any offsetting effect on the valuation of the conversion features of the notes.  For a description of the accounting treatment of the senior secured convertible note financing, see Note 7 to the Notes to Condensed Consolidated Financial Statements (Unaudited) included elsewhere herein.

On March 21, 2011, we converted $784,292 of our short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Company’s recent equity raise in December 2010. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, we issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. Our objective for converting the short-term debt into equity was to conserve cash for future market development.

Our monthly operating expenses, including our CodecSys technology research and development expenses, exceeded our monthly net sales by approximately $400,000 per month during the nine months ended September 30, 2011.  At our current rate of expenditures, including debt service, over expected revenues, we do not have sufficient capital to maintain operations at their current level. It will be necessary to raise additional equity or debt capital to enable us to maintain our operations at the current level or we will be required to curtail operations which may affect our relationships with our customers and affect are ability to market our products and services.  The foregoing estimates, expectations and forward-looking statements are subject to change as we make strategic operating decisions from time to time and as our expenses and sales fluctuate from period to period

The amount of our operating deficit could decrease or increase significantly depending on strategic and other operating decisions, thereby affecting our need for additional capital.  We expect our operating expenses will continue to outpace our net sales until we are able to generate additional revenue.  Our business model contemplates that sources of additional revenue include (i) sales from our private communication network services, (ii) sales resulting from new customer contracts, and (iii) sales, licensing fees and/or royalties related to commercial applications of our CodecSys technology, including sales resulting from marketing efforts by companies such as IBM, HP, Fujitsu  and Microsoft.

Our long-term liquidity is dependent upon execution of our business model and the realization of additional revenue and working capital as described above, and upon capital needed for continued commercialization and development of the CodecSys technology.  Commercialization and future applications of the CodecSys technology are expected to require additional capital estimated to be approximately $2.0 million annually for the foreseeable future.  This estimate will increase or decrease depending on specific opportunities and available funding.
 
 
30

 
 
To date, we have met our working capital needs primarily through funds received from sales of our common stock and from convertible debt financings.  Until our operations become profitable, we will continue to rely on proceeds received from external funding.  We expect additional investment capital, if needed, may come from (i) the exercise of outstanding warrants to purchase our capital stock currently held by existing warrant holders; (ii) additional private placements of our common stock with existing and new investors; and (iii) the private placement of other securities with institutional investors similar to those institutions that have provided funding in the past.  We have no arrangements for any such additional external financings, whether debt or equity, and are not certain whether any new external financing would be available on acceptable terms or at all. Any new debt financing would require the cooperation and agreement of existing note holders, of which there is no assurance.

Off-Balance Sheet Arrangements
 
We have no off-balance sheet arrangements.

Item 3.  Quantitative and Qualitative Disclosures about Market Risk
 
Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates.  We do not issue financial instruments for trading purposes.  As discussed above, however, the embedded conversion feature and prepayment option of our senior secured convertible notes and our related warrants are deemed to be derivatives and are subject to quarterly “mark-to-market” valuations.

Our cash and cash equivalents are also exposed to market risk.  However, because of the short-term maturities of our cash and cash equivalents, we do not believe that an increase in market rates would have any significant impact on the realized value of our cash and cash equivalent investments.  We currently do not hedge interest rate exposure and are not exposed to the impact of foreign currency fluctuations.

Item 4.  Controls and Procedures

Disclosure Controls and Procedures
 
Our management is responsible for establishing and maintaining effective disclosure controls and procedures, as defined under Rules 13a-15(e) and 15d-15(e) of the Exchange Act.  As of September 30, 2011, an evaluation was performed, under the supervision and with the participation of management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures.  Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures, as of September 30, 2011, were effective in ensuring that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and in ensuring that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
 
Management’s Annual Report on Internal Control Over Financial Reporting
 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our system of internal control over financial reporting within the meaning of Rules 13a-15(f) and 15d-15(f) of the Exchange Act is designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of our published financial statements in accordance with U.S. generally accepted accounting principles.
 
Our management, including the chief executive officer and the chief financial officer, assessed the effectiveness of our system of internal control over financial reporting as of September 30, 2011.  In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework.  Based on our assessment, we believe that, as of September 30, 2011, our system of internal control over financial reporting was effective to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with U.S. generally accepted accounting principles.
 
 
31

 
 
Changes in Internal Control Over Financial Reporting
 
There were no changes in our internal control over financial reporting for the quarter ended September 30, 2011 that have materially affected, or are reasonably likely to materially affect, such control.
 
Limitations on Controls and Procedures
 
The effectiveness of our disclosure controls and procedures and our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud.  Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time.  Because of these limitations, any system of disclosure controls and procedures or internal control over financial reporting may not be successful in preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.
 
The foregoing limitations do not qualify the conclusions set forth above by our chief executive officer and our chief financial officer regarding the effectiveness of our disclosure controls and procedures and our internal control over financial reporting as of September 30, 2011.
 
Part II – Other Information

Item 1.  Legal Proceedings

The Company is a defendant in one lawsuit, the total amount in dispute in which is approximately $125,000.

Item 1A. Risk Factors
`
Except as indicated below, there have been no material changes in risk factors from those described in our Annual Report of Form 10-K for the year ended December 31, 2010. 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

In August, 2011, we granted options pursuant to our 2004 Equity Incentive Plan to purchase up to 100,000 shares of our common stock to one consultant in consideration of consulting services to be rendered by the consultants over a one year period pursuant to written consulting agreements.  The options are exercisable at $1.15 per share and have a ten year life.  The consultants are accredited investors and were fully informed regarding their investment.  In the transaction, we relied on the exemptions from registration under the Securities Act set forth in Section 4(2) and Section 4(6) thereof.

During July, August and September, 2011, we granted options pursuant to our 2004 Equity Incentive Plan to purchase 447,500 shares of our common stock to 7 of our employees.  The options are exercisable at prices of $0.54 to $.0.68 per share and have a 10 year life and vest ratably over a three year period. In the transaction, we relied on the exemption from registration under the Securities Act set forth in Section 4(2) thereof.
 
In August, 2011, the holder of our 6.25% convertible note exercised a warrant to acquire shares of our stock and we issued 372,272 shares to the holder.  The warrant was for 400,000 shares, but was exercised pursuant to cashless exercise provisions and we received no cash in exchange for the exercise. In the transaction, we relied on the exemption from registration under the Securities Act set forth in Sections 4(2) and 4(6) thereof.
 
In August we awarded 200,000 Restricted Stock Units (“RSU”) pursuant to our 2008 Equity Incentive Plan to one of our employees.  The RSUs are to be settled by the issuance of 200,000 shares of common stock at the time that the employee ceases to be employed by us. In the transaction, we relied on the exemption from registration under the Securities Act set forth in Section 4(2) thereof.
 
In October, 2011, we issued a total of 26,640 shares of our common stock to one individual in exchange for 399,600 shares of the common stock of our controlled subsidiary, Interactive Devices, Inc.  There were no proceeds from the transaction.  In the transaction, we relied on the exemption from registration under the Securities Act set forth in Section 4(2).
 
 
32

 
 
Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Submission of Matters to Vote of Security Holders.

None.

Item 5.  Other Information

(a) None.

(b) None.

Item 6.  Exhibits  Not Updated
Exhibit Index
 
(a)           Exhibits
Exhibit
Number
Description of Document
3.1
Amended and Restated Articles of Incorporation of Broadcast International.   (Incorporated by reference to Exhibit No. 3.1 of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 filed with the SEC on November 14, 2006.)
   
3.2
Amended and Restated Bylaws of Broadcast International.  (Incorporated by reference to Exhibit No. 3.2 of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 filed with the SEC on November 14, 2006.)
   
4.1
Specimen Stock Certificate of Common Stock of Broadcast International.  (Incorporated by reference to Exhibit No. 4.1 of the Company's Registration Statement on Form SB-2, filed under cover of Form S-3, pre-effective Amendment No. 3 filed with the SEC on October 11, 2005.)
   
10.1*
Employment Agreement of Rodney M. Tiede dated April 28, 2004.  (Incorporated by reference to Exhibit No. 10.1 of the Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2004 filed with the SEC on May 12, 2004.)
   
10.2*
Employment Agreement of James E Solomon dated September 19, 2008.  (Incorporated by reference to Exhibit No. 10.2 of the Company's Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on Mach 31, 2010.)
   
10.3*
Broadcast International 2004 Long-Term Incentive Plan.  (Incorporated by reference to Exhibit No. 10.4 of the Company's Annual Report on Form 10-KSB for the year ended December 31, 2003 filed with the SEC on March 30, 2004.)
   
10.4*
Broadcast International 2008 Long-Term Incentive Plan.  (Incorporated by reference to the Company’s  definitive Proxy Statement on Schedule 14A filed with the SEC on April 17, 2009)
   
10.5
Securities Purchase Agreement dated October 28, 2006 between Broadcast International and Leon Frenkel.  (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.6
5% Convertible Note dated October 16, 2006 issued by Broadcast International to Leon Frenkel.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
 
 
33

 
 
10.7
Registration Rights Agreement dated October 28, 2006 between Broadcast International and Leon Frenkel.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2006.)
   
10.8
Securities Purchase Agreement dated as of December 21, 2007, by and among Broadcast International and the investors listed on the Schedule of Buyers attached thereto. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.9
Registration Rights Agreement dated as of December 21, 2007, by and among Broadcast International and the buyers listed therein.  (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.10
6.25% Senior Secured Convertible Promissory Note dated December 21, 2007 issued to the holder listed therein.  (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.11
Warrant to Purchase Common Stock dated December 21, 2007 issued to the holder listed therein.  (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on December 26, 2007.)
   
10.12
Loan Restructuring Agreement between the Company and Castlerigg Master Investments Ltd., dated December 16, 2010 (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2010.)
   
10.13
Amendment to 8% Convertible Note Due 2010 between the Company and Leon Frenkel, dated December 22, 2010 (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2010.)
   
10.14
Placement Agency Agreement between the Company and Philadelphia Brokerage Corporation, dated December 17, 2010 (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.15
Form of Subscription Agreement (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.16
Form of Warrant (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.17
Amended and Restated Senior Convertible Note issued by the Company to Castlerigg master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.18
Investor Rights Agreement between the Company and Castlerigg Master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
10.19
Letter between the Company and Castlerigg Master Investments Ltd., dated December 23, 2010 (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2010.)
   
101.INS**
XBRL Instance Document
   
101.SCH**
XBRL Taxonomy Extension Schema Document
   
101.CAL**
XBRL Taxonomy Extension Calculation Linkbase Document
   
101.LAB**
XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE**
XBRL Taxonomy Extension Presentation Linkbase Document
* Management contract or compensatory plan or arrangement.
** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Act of 1934 and otherwise are not subject to liability.
 
 
34

 
 
SIGNATURES

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Broadcast International, Inc.
 
     
     
Date: November 14, 2011
/s/ Rodney M. Tiede
 
 
By:  Rodney M. Tiede
 
 
Its:  President and Chief Executive Officer (Principal Executive Officer)
     
     
Date: November 14, 2011
/s/ James E. Solomon
 
 
By:  James E. Solomon
 
 
Its: Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
 
 
 
 35

EX-31.1 2 ex31_1.htm EXHIBIT 31.1 ex31_1.htm
Exhibit 31.1
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Executive Officer
PURSUANT TO RULE 13a – 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rodney M. Tiede, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Broadcast International, Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepting accounting principles;

 
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2011
 
/s/ Rodney M. Tiede
Rodney M. Tiede
Chief Executive Officer
 
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2 ex31_2.htm

Exhibit 31.2
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Financial Officer
PURSUANT TO RULE 13a – 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James E. Solomon, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Broadcast International, Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepting accounting principles;

 
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: November 14, 2011
 
/s/ James E. Solomon
James E. Solomon Chief Financial Officer
 
 
 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1 ex32_1.htm
Exhibit 32.1
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Executive Officer
Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To
Section 906 Of The Sarbanes-Oxley Act Of 2002

In connection with the quarterly report of Broadcast International, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2011, as filed with the Securities and Exchange Commission on the date hereof, Rodney M. Tiede, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
Date: November 14, 2011
 
   
   
   
/s/ Rodney M. Tiede
 
Rodney M. Tiede
 
Chief Executive Officer
 
 
 
 
 
 
 

EX-32.2 5 ex32_2.htm EXHIBIT 32.1 ex32_2.htm

Exhibit 32.2
Broadcast International, Inc. & Subsidiaries
Certification Of Chief Financial Officer
Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To
Section 906 Of The Sarbanes-Oxley Act Of 2002

In connection with the quarterly report of Broadcast International, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2011, as filed with the Securities and Exchange Commission on the date hereof, James E. Solomon, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2011
 
   
   
   
/s/ James E. Solomon
 
James E. Solomon
 
Chief Financial Officer
 

 
 
 
 
 

EX-101.INS 6 bcst-20110930.xml EXHIBIT 101.INS <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 7 - Equity Financing and the Debt Restructuring</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On December 24, 2010, we closed on an equity financing (the "Equity Financing") as well as a restructuring of our outstanding convertible indebtedness (the "Debt Restructuring").&nbsp;&nbsp;The Equity Financing and the Debt Restructuring are described as follows.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation ("PBC"), pursuant to which PBC agreed to act as the exclusive agent of the Company on a "best efforts" basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company&#39;s securities, subject to a minimum gross consideration of $10,000,000.&nbsp;&nbsp;The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock.&nbsp;&nbsp;The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering.&nbsp;&nbsp;The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities.&nbsp;&nbsp;The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.&nbsp;&nbsp;The warrants have a term of five years and an exercise price of $1.00 per share.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.&nbsp;&nbsp;We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder is being used for working capital.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.&nbsp;&nbsp;Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants.&nbsp;&nbsp;The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On December 24, 2010, we also closed on the Debt Restructuring.&nbsp;&nbsp;In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.&nbsp;&nbsp;As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.&nbsp;&nbsp;We paid the first year&#39;s interest of $350,434 at the closing.&nbsp;&nbsp;The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.&nbsp;&nbsp;The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.&nbsp;&nbsp;The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.<font style="DISPLAY: inline">&nbsp;&nbsp;Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline">The Investor Rights Agreement</font> provides Castlerigg with certain registration rights with respect to the Company&#39;s securities held by Castlerigg.&nbsp;&nbsp;These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.&nbsp;&nbsp;The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three months ended March 31, 2011, we issued Castlerigg 400,000 warrants pursuant to a waiver agreement dated March 10, 2011 allowing the issuance of shares and warrants for the conversion of the AR Note Payable without adjusting the conversion price of the Amended and Restated Senior 6.25% Convertible Note.&nbsp;&nbsp;These warrants contain full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. During the three and nine months ended September 30, 2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock. A valuation gain of $144,000 was recorded to reflect the change in value of the aggregate derivative from the time of issue to the date of conversion.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In connection with the Debt Restructuring, the Company <font style="DISPLAY: inline">amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We also issued 150,000 shares to the holder of this note as consideration to extend the term of the note.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Investor warrants totaling 12,499,980 issued under the Placement Agency Agreement contain price protection adjustments in the event we issue new common stock or common stock equivalents in certain transactions at a price less than $1.00 per share and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> At September 30, 2011, we recorded an aggregate derivative liability of $2,500,000 related to these warrants and valuation gain of $8,250,000 for the nine months ended September 30, 2011 to reflect the change in value of the aggregate derivative from December 31, 2010. The aggregate derivative liability of $2,500,000 was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate of 0.83%, (ii) expected life (in years) of 4.2; (iii) expected volatility of 81.51%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.</div> <!--EndFragment--></div> </div> 1648620 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 2 - Reclassifications</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Certain 2010 financial statement amounts have been reclassified to conform to 2011 presentations.</div> <!--EndFragment--></div> </div> false --12-31 Q3 2011 2011-09-30 10-Q 0000740726 75975656 Smaller Reporting Company BROADCAST INTERNATIONAL INC 1552006 1073967 1125055 1192248 92867561 96686414 404000 250002 3251360 476234 802190 10709638 4319467 7497739 1951337 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 1 - Basis of Presentation</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt; text-align: left; TEXT-INDENT: 0pt"> In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Broadcast International, Inc. ("we" or the "Company") contain the adjustments, all of which are of a normal recurring nature, necessary to present fairly our financial position at December 31, 2010 and September 30, 2011 and the results of operations for the three and nine months ended September 30, 2010 and 2011, respectively, with the cash flows for each of the nine month periods ended September 30, 2010 and 2011, in conformity with U.S. generally accepted accounting principles.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt; text-align: left; TEXT-INDENT: 0pt"> These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2010.&nbsp;&nbsp;Operating results for the three and nine months ended September 30, 2011 are not necessarily indicative of the results that may be expected for the year ended December 31, 2011.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 9 - Equipment Financing</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On August 27, 2009, we completed an equipment lease financing transaction with a financial institution. &nbsp;Pursuant to the financing, we entered into various material agreements with the financial institution. These agreements are identified and summarized below.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We entered into a Master Lease Agreement dated as of July 28, 2009 with the financial institution pursuant to which we sold to the financing institution certain telecommunications equipment to be installed at 1,981 (subsequent additional locations have increased the customer&#39;s network to an aggregate of approximately 2,100 locations) of our customer&#39;s retail locations in exchange for a one time payment of $4,100,670 by the financial institution. We will pay to the financial institution 36 monthly lease payments and at the expiration of the equipment lease will pay the greater of the then in place fair market value of the equipment or 10% of the original purchase price.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We also entered into a security agreement with the financial institution pursuant to which we granted a first priority security interest in the equipment, whether now owned or hereafter acquired, and in our customer service agreement and service payments thereunder during the term of the equipment lease. We received a waiver from our 6.25% convertible note holder releasing its security interest in the equipment purchased under our sale lease back financing. See Note 6.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The sale leaseback financing arrangement with the financial institution related to the purchase and deployment of certain digital signage equipment for a new customer.&nbsp;&nbsp;As a result of this financing, we incurred an obligation to make 36 monthly payments of approximately $144,000 plus applicable sales taxes. The proceeds of the financing are being used to purchase and install the digital signage equipment for our customer and for general working capital purposes.&nbsp;&nbsp;We have the right to terminate the lease after making 33 payments for a termination fee of approximately $451,000 after which time we would own all of the equipment.&nbsp;&nbsp;We have accounted for this arrangement as a capital lease.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three and nine months ended September 30, 2011, we made lease payments totaling approximately $422,096 and $1,266,287 of which $361,966 and $1,048,491 was applied toward the outstanding lease with $60,130 and $217,796, respectively, included in interest expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three and nine months ended September 30, 2010, we made lease payments totaling approximately $422,096 and $1,266,287 of which $314,080 and $909,781 was applied toward the outstanding lease with $108,016 and $356,506, respectively, included in interest expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Additionally, we recognized amortization of the lease acquisition fee of $12,567 and $37,701 which was included in interest expense for the three and nine months ended September 30, 2011 and 2010, respectively.</div> <!--EndFragment--></div> </div> 6129632 311227 414472 263492 -5715160 47735 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 12 - Supplemental Cash Flow Information</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2011</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2011, we granted options to acquire up to 600,000 shares of our common stock valued at $389,000 to two consultants in consideration of consulting services to be rendered by the consultants over a one year period pursuant to a written consulting agreement. The value of options is being recognized over the contract period and for the nine months ended September 30, 2011, $263,572 was included in stock based compensation.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On March 21, 2011, the Company, converted $784,292 of its short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, the Company issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. The Company&#39;s objective for converting the short-term debt into equity is to conserve cash for further market development.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In March 2011, we granted to the holder of our senior unsecured convertible note a warrant to acquire 400,000 shares of our common stock at an exercise price of $.05 per share in consideration of a waiver of the holder&#39;s reset provision that allowed us to convert certain short terms loans to equity without causing an adjustment in the conversion price of our senior note.&nbsp;&nbsp;The warrants had a 5 - year life from the date of grant, contained full-ratchet anti-dilution price protection provisions and were valued $404,000 using a Black Scholes pricing model on the date of grant. During the three and nine months ended September 30, 2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the nine months ended September 30, 2011 an aggregate non-cash expense of $250,002 was recorded for the accretion of the unsecured convertible note.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the nine months ended September 30, 2011, we recognized $1,117,703 in depreciation and amortization expense from the following: (i) $599,952 related to cost of sales for equipment used directly by or for customers, (ii) $510,138 related to other property and equipment, and (iii) $7,613 for patent amortization.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2010</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2010, we issued 406,927 shares of our common stock valued in aggregate at $399,466 to three companies and three individuals for consulting services rendered, the expense of which is included in our general and administrative expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2010 we issued 200,000 shares our common stock valued at $216,000 to a corporation for the purchase of a H.264 codec software license to be used in our CodecSys product development. We have included it as an asset on our balance sheet and will amortize it as part of cost of sales.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2010, we issued 3,000,000 shares our common stock valued at $3,290,000 to our senior secured 6.25% convertible note holder as part of amendment and extension agreements. We included it as an asset on our balance sheet as additional note acquisition costs and will amortize it over the remaining term of the note.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the nine months ended September 30, 2010, an aggregate non-cash expense of $3,251,360 was recorded for the accretion of our convertible notes as follows, (i) $3,143,475 for the senior secured 6.25% convertible note and (ii) $107,885 for our unsecured 3% convertible notes.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the nine months ended September 30, 2010, we recognized $1,179,380 in depreciation and amortization expense from the following: (i) $603,524 related to cost of sales for equipment used directly by or for customers, (ii) $568,390 related to other property and equipment, and (iii) $7,466 for patent amortization.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2010, the conversion to common stock of all of our unsecured 3% convertible notes and the conversion of $50,000 to common stock of our unsecured short term notes resulted in an $802,190 extinguishment of debt primarily due to unrealized note discounts and accrued interest.</div> <!--EndFragment--></div> </div> 0.05 0.05 180000000 180000000 74078153 75949016 3703908 3797451 4414402 3847716 1257954 1518310 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 6 - Notes Payable</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The recorded value of our notes payable (net of debt discount) for the nine months ended September 30, 2011 and year ended December 31, 2010 was as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> December 31, 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> September 30, 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amended and Restated Senior 6.25% Convertible Note</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,180,816</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,180,816</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured Convertible Note</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,168</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">257,170</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pledged A/R Note Payable</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">675,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Short Term Note Payable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">100,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,962,984</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,437,986</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Less Current Portion</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(775,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(171,875</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total Long-term</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,187,984</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,266,111</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amended and Restated Senior 6.25% Convertible Note</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On December 24, 2007, we entered into a securities purchase agreement in which we raised $15,000,000 (less $937,000 of prepaid interest).&nbsp;&nbsp;We used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes.&nbsp;&nbsp;Pursuant to the financing, we issued a senior secured convertible note in the principal amount of $15,000,000.&nbsp;&nbsp;The senior secured convertible note bore interest at 6.25% per annum if paid in cash.&nbsp;&nbsp;Interest for the first year was prepaid at closing.&nbsp;&nbsp;Interest-only payments thereafter in the amount of $234,375 were due quarterly and commenced in April 2009.&nbsp;&nbsp;The original principal of the note was convertible into 2,752,294 shares of our common stock at a conversion price of $5.45 per share, convertible any time during the term of the note.&nbsp;&nbsp;We granted a first priority security interest in all of our property and assets and of our subsidiaries to secure our obligations under the note and related transaction agreements.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In connection with the 2007 financing, the senior secured convertible note holder received warrants to acquire 1,875,000 shares of our common stock exercisable at $5.00 per share.&nbsp;&nbsp;We also issued to the convertible note holder 1,000,000 shares of our common stock valued at $3,750,000 and incurred an additional $1,377,000 for commissions, finders fees and other transaction expenses, including the grant of a three-year warrant to purchase 112,500 shares of our common stock to a third party at an exercise price of $3.75 per share, valued at $252,000.&nbsp;&nbsp;A total of $1,377,000 was included in debt offering costs and was amortized over the term of the note.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> From March 26, 2010 through October 29, 2010, we entered into a series of amendments to the senior secured convertible note under which we issued to the holder of the senior secured convertible note an additional 3,000,000 shares of our common stock, increased the number of warrants by 3,333,333 shares, and reduced the warrant exercise price to $1.80 per share for all warrants, all as consideration for the amendments.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On December 24, 2010, we closed on the Debt Restructuring (as defined below).&nbsp;&nbsp;In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into a Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.&nbsp;&nbsp;As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest. The Debt Restructuring was considered a troubled-debt restructuring and a gain on debt restructuring of $3,062,457 was recorded during the year ended December 31, 2010, which was the difference between the adjusted carrying value of the original note and the carrying value of the Amended and Restated Note.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.&nbsp;&nbsp;We paid the first year&#39;s interest of $350,434 at the closing.&nbsp;&nbsp;The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.&nbsp;&nbsp;The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.&nbsp;&nbsp;The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.<font style="DISPLAY: inline">&nbsp;&nbsp;Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline">The Investor Rights Agreement</font> provides Castlerigg with certain registration rights with respect to the Company&#39;s securities held by Castlerigg.&nbsp;&nbsp;These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.&nbsp;&nbsp;The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> As of September 30, 2011 and 2010, we recorded an aggregate derivative liability of $203,700 and $1,000,500 respectively, related to the conversion features of the Amended and Restated Note and the conversion feature and warrants related to the Original Note.&nbsp;&nbsp;A derivative valuation gain of $2,403,700 and loss of $235,200 was recorded during the nine months ended September 30, 2011 and 2010, to reflect the change in value of the aggregate derivative liability since December 31, 2010 and 2009, respectively. The aggregate derivative liability of $203,700 for the Amended and Restated Note conversion feature was calculated at September 30, 2011 using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate of 0.25%, (ii) expected life (in years) of 2.2; (iii) expected volatility of 68.80% for the conversion feature, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2010, the principal value of the 6.25% senior secured convertible note was increased by $1,131,836 to $17,528,086 (convertible into 9,737,826 common shares), for interest capitalized rather than making a payment in cash.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The original principal value of the note was being accreted over the term of the obligation, for which $1,047,825 and $3,143,475 was included in interest expense for the three and nine months ended September 30, 2010. The note now bears a 6.25% annual interest rate payable quarterly and for the nine months ended September 30, 2010, $27,388 was accrued and included as interest expense.&nbsp;&nbsp;For the nine months ended September 30, 2010, $1,106,217 ($1,131,836 offset by $25,619 note interest accrued in 2009) was included in interest expense for capitalized interest.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The $6,180,816 value of the note at September 30, 2011 consists of $5,500,000 for the principal due of the note plus $1,031,250 for aggregate future interest less $350,434 for interest withheld at closing for interest due from the initial date of the debt restructuring transaction until December 31, 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured Convertible Note</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On September 29, 2006, we entered into a letter of understanding with Triage Capital Management, or Triage, dated as of September 25, 2006.&nbsp;&nbsp;The letter of understanding provided that Triage loan $1,000,000 to us in exchange for us entering into, on or prior to October 30, 2006, a convertible note securities agreement.&nbsp;&nbsp;It was intended that the funding provided by Triage be replaced by a convertible note and accompanying warrants, as described below.&nbsp;&nbsp;Effective November 2, 2006, we entered into securities a purchase agreement, a 5% convertible note, a registration rights agreement, and four classes of warrants to purchase our common stock, all of which were with an individual note holder, the controlling owner of Triage, who caused our agreement with Triage to be assigned to him, which satisfied our agreement with Triage.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pursuant to the securities purchase agreement, (i) we sold to the convertible note holder a three-year convertible note in the principal amount of $1,000,000 representing the funding received by us on September 29, 2006; (ii) the convertible note bore an annual interest rate of 5%, payable semi-annually in cash or shares of our common stock; (iii) the convertible note was convertible into shares of our common stock at a conversion price of $1.50 per share subject to full-ratchet anti-dilution price protection provisions ; and (iv) we issued to the convertible note holder four classes of warrants (A Warrants, B Warrants, C Warrants and D Warrants), which give the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock as described below.&nbsp;&nbsp;The A and B Warrants originally expired one year after the effective date of a registration statement filed under the Securities Act of 1933, as amended (the "Securities Act"), to register the subsequent sale of shares received from exercise of the A and B Warrants. The C Warrants and D Warrants originally expired eighteen months and twenty four months, respectively, after the effective date of a registration statement to be filed under the Securities Act.&nbsp;&nbsp;The A Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.60 per share, the B Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.75 per share, the C Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $2.10 per share, and the D Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $3.00 per share.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the year ended December 31, 2007, the convertible note holder exercised 454,000 A Warrants. We entered into an exchange agreement dated October 31, 2007 in which the convertible note holder received 650,000 shares of our common stock in exchange for cancellation of the C and the D Warrants.&nbsp;&nbsp;The expiration date of the A Warrants and the B Warrants was extended from January 11, 2008 to December 3, 2008. During the year ended December 31, 2008, the convertible note holder exercised 64,400 A Warrants. On December 3, 2008, the remaining 231,600 A Warrants and 750,000 B Warrants expired.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On December 23, 2009 we entered into an amendment with the holder of this unsecured convertible note, which (i) extended the note maturity date to December 22, 2010 and (ii) increased the annual rate of interest from 5% to 8% commencing October 16, 2009. All other terms and conditions of the note remained unchanged.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On December 24, 2010 we closed on a Debt Restructuring as mentioned above. In connection with that Debt Restructuring the Company <font style="DISPLAY: inline">amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.&nbsp;&nbsp;We issued 150,000 shares to the holder of this note as consideration to extend the term of the note.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During March 2011, we issued 135,369 shares of common stock to the holder of our unsecured convertible note in satisfaction of $81,221 of accrued interest on the unsecured convertible note.&nbsp;&nbsp;Also in connection with the satisfaction of the accrued interest we granted to the holder a warrant to acquire up to 221,758 additional shares of our common stock at an exercise price of $0.96 per share.&nbsp;&nbsp;The warrant is exercisable at any time for a five-year period. For the nine months ended September 30, 2011, the $157,400 value of the warrant was included in interest expense.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> At September 30, 2011 and 2010 we recorded an aggregate derivative liability of $256,700 and $2,800, respectively, related to the conversion feature of the note. A derivative valuation gain of $1,145,200 and $197,200, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2010 and December 31, 2009, respectively.&nbsp;&nbsp;The aggregate derivative liability of $256,700 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.25%, (ii) expected life (in years) of 2.3; (iii) expected volatility of 73.43%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In connection with the amendment mentioned above, the principal value of the note will be accreted due to the difference in the value of the conversion feature before and after the amendment.&nbsp;&nbsp;The accretion for the three and nine months ended September 30, 2011, was $83,334 and $250,002, respectively and was included in interest expense. The note currently bears an 8% annual interest rate payable semi-annually, and for each of the three and nine month periods ended September 30, 2011 and 2010, $20,000 and $60,000, respectively was included in interest expense.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accounts Receivable Purchase Agreements</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the year ended December 31, 2010 we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. In these agreements, we pledged certain outstanding accounts receivable in exchange for advanced payment and a commitment to remit to the purchaser the amount advanced upon collection from our customer. Terms of the first agreement under which we were advanced $175,000 include a 3% discount with a 3% interest fee for every 30 days the advances remain outstanding. Terms of the second agreement under which we were advanced $500,000 include a 10% discount with a 0.5% interest fee for every 30 days the advances remain outstanding.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three months ended March 31, 2011 we converted the remaining $675,000 of principal along with $109,292 of accrued and unpaid interest into 1,307,153 shares of our common stock and warrants to purchase an additional 653,576 shares of our common stock. The warrants contain anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than $1.00 per share.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> At September 30, 2011 we recorded an aggregate derivative liability of $135,500 related to the warrant reset provision. A derivative valuation gain of $314,600 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued.&nbsp;&nbsp;The aggregate derivative liability of $135,500 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.83%, (ii) expected life (in years) of 4.5; (iii) expected volatility of 81.42%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Short Term Note Payable</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three months ended March 31, 2011 we remitted $100,000 of the principal balance and accrued interest of $8,360 to a company pursuant to a short term note. The note had originated in June 2010 and bore an annual interest rate of 12%. Of the $8,360 of interest paid, $2,327 was related to and included in interest expense for the nine months ended September 30, 2011.</div> <!--EndFragment--></div> </div> 992832 742830 139437 35808 517751 575856 190846 169592 1117703 1179380 14759300 3095900 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 11 -</font> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Recent Accounting Pronouncements</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In September 2011, the FASB issued ASU 2011-08, <font style="FONT-STYLE: italic; DISPLAY: inline">Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment.</font> The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value.&nbsp;&nbsp;The more likely than not threshold is defined as having a likelihood of more than 50%.&nbsp;&nbsp;The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued.&nbsp;&nbsp;The Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012 and will also determine if it wants to adopt the Update early and utilize the option for its goodwill impairment test.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In June 2011, the FASB issued ASU 2011-05, <font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220) - Presentation of Comprehensive Income.</font> This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders&#39; equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders&#39; equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income).&nbsp;&nbsp;Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements.&nbsp;&nbsp;This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This will impact how items for Other Comprehensive Income are presented and the Company will plan on following the guidance in the Update as of January 1, 2012.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In May 2011, the FASB issued ASU 2011-04, <font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRS.</font> The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs.&nbsp;&nbsp;The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A few of the more significant changes are; 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specification that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, and 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity&#39;s use of a nonfinancial asset in a way that differs from the asset&#39;s highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011.&nbsp;&nbsp;The Company does not expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following update was issued in 2010 and became effective on or after January 1, 2011.&nbsp;&nbsp;Only significant updates that may impact the Company are included herein.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In August 2010, the FASB issued ASU No 2010-22, <font style="FONT-STYLE: italic; DISPLAY: inline">Accounting for Various Topics. Technical Corrections to SEC Paragraphs- An announcement made by the staff of US Securities and Exchange Commission.</font> This Update makes changes to several of the SEC guidance literature within the Codification.&nbsp;&nbsp;Some of the changes relate to (1) Oil and Gas Exchange Offers, (2) Accounting for Divestiture of a Subsidiary or Other Business Operations, (3) Replaces "Push Down" basis accounting references with "New" basis of accounting to be used in the acquired companies financial statements, (4) Fees paid to an investment banker in connection with an acquisition or asset purchase, when the investment banker is also providing interim financing or underwriting services must be allocated between the related service and debt issue costs. The amendments in this Update are effective immediately.&nbsp;&nbsp;The Company does not expect this guidance to have a significant impact on its financials since there are no changes to accounting that were not already being applied by the Company.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 4 - Stock-based Compensation</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock Incentive Plans</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline">Under the Broadcast International, Inc. 2004 Long-Term Incentive Plan (the "2004 Plan"), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company.&nbsp;&nbsp;</font> Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon the anniversary date of the grant.&nbsp;&nbsp;Should an employee terminate before the vesting period is completed, the unvested portion of each grant is forfeited. We have used the Black-Scholes valuation model to estimate fair value of our stock-based awards, which requires various judgmental assumptions including estimated stock price volatility, forfeiture rates, and expected life.&nbsp;&nbsp;Our computation of expected volatility is based on a combination of historical and market-based implied volatility.&nbsp;&nbsp;The number of unissued stock options authorized under the 2004 Plan at September 30, 2011 was 2,024,400.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Broadcast International, Inc. 2008 Equity Incentive Plan (the "2008 Plan") has become our primary plan for providing stock-based incentive compensation to our eligible employees and non-employee directors and consultants of the company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. We continue to maintain and grant awards under our 2004 Plan which will remain in effect until it expires by its terms. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 1,165,000 at September 30, 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Stock Options</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline">We estimate the fair value of stock option awards granted beginning January 1, 2006 using the Black-Scholes option-pricing model. We then amortize the fair value of awards expected to vest on a straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The Black-Scholes valuation model</font> requires various judgmental assumptions including the estimated volatility, risk-free interest rate and expected option term.&nbsp;&nbsp;Our computation of expected volatility is based on a combination of historical and market-based implied volatility.&nbsp;&nbsp;<font style="DISPLAY: inline">The risk-free interest rate was based on the yield curve of a zero-coupon U.S.&nbsp;Treasury bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. The expected option term is derived from an analysis of historical experience of similar awards combined with expected future exercise patterns based on several factors including the strike price in relation to the current and expected stock price, the minimum vest period and the remaining contractual period.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The fair values for the options granted for the nine months ended September 30, 2011 and 2010 were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: center"> <table style="TEXT-ALIGN: center; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr style="TEXT-ALIGN: center"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Nine Months Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2011</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Nine Months Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Risk free interest rate</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">1.96%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">3.14%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected life (in years)</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">6.28</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">7.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">81.03%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">80.71%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected dividend yield</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">0.00%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">0.00%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The weighted average fair value of options granted during the nine months ended September 30, 2011 and 2010 was $0.63 and $0.80, respectively.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Warrants</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We <font style="DISPLAY: inline">estimate the fair value of issued warrants on the date of issuance as determined using a Black-Scholes pricing model. We amortize the fair value of issued warrants using a vesting schedule based on the terms and conditions of each associated underlying contract, as earned. The Black-Scholes valuation model</font> requires various judgmental assumptions including the estimated volatility, risk-free interest rate and warrant expected exercise term.&nbsp;&nbsp;Our computation of expected volatility is based on a combination of historical and market-based implied volatility.&nbsp;&nbsp;<font style="DISPLAY: inline">The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the warrant was issued with a maturity equal to the expected term of the warrant.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The fair values for the warrants issued for the nine months ended September 30, 2011 and 2010 estimated at the date of issuance using the Black-Scholes option-pricing model with the following weighted average assumptions:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Nine Months Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2011</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Nine Months Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Risk free interest rate</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">2.04%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">1.34%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected life (in years)</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">5.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">2.98</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">85.82%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">88.65%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected dividend yield</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">0.00%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: center" valign="bottom" width="12%">0.00%</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The weighted average fair value of warrants issued during the nine months ended September 30, 2011 and 2010 was $0.79 and $0.53, respectively.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Results of operations for the nine months ended September 30, 2011 and 2010 includes $2,072,993 and $879,570, respectively, of non-cash stock-based compensation expense. Restricted stock units and options issued to directors vest immediately. All other restricted stock units, options and warrants are subject to applicable vesting schedules. Expense is recognized proportionally as each award or grant vests.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Included in the $2,072,993 non-cash stock-based compensation expense for the nine months ended September 30, 2011 are (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, (iii) $263,572 for 600,000 options issued to one individual and one corporation for consulting services, (iv) $51,207 for 874,200 options granted to 38 employees, (v) $4,263 for 8,700 options granted to 15 of our non-employee installation technicians and (vi) $85,951 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Included in the $879,571 non-cash stock-based compensation expense for the nine months ended September 30, 2010 is (i) $80,000 for 100,000 options granted to one member of the board of directors, (ii) $93,000 for 150,000 warrants issued to three new members of our advisory board, (iii) $44,450 for 460,000 warrants issued to five individuals and two corporations for consulting services, (iv) $568,121 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2010 and (v) $94,000 for 100,000 restricted stock units issued to a member of the board of directors. Additionally, we issued (i) 183,824 warrants to a former member of the board of directors in exchange for the return and cancellation of 125,000 shares of our common stock, (ii) 2,295,075 warrants to investors of our Private Placement Memorandum Offering and (iii) 3,333,333 warrants with the July 2010 amendment to our 6.25% senior secured convertible note.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The impact on our results of operations for recording stock-based compensation for the three and nine months ended September 30, 2011 and 2010 is as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 18pt"> For the three months ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 18pt"> September 30,</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the nine months ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30,</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 18pt"> 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> General and administrative</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">96,973</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">234,185</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">616,001</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,915,969</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and development</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">87,593</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">51,934</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">263,570</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">157,024</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">184,566</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">286,119</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">879,571</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,072,993</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Due to unexercised options and warrants outstanding at September 30, 2011, we will recognize an additional aggregate total of $692,344 of compensation expense over the next four years based upon option and warrant award vesting parameters as shown below:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> &nbsp;</div> <div style="TEXT-ALIGN: center"> <table style="TEXT-ALIGN: center; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="60%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2011</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">174,037</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">257,857</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">178,090</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">82,360</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">692,344</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following unaudited tables summarize option and warrant activity during the nine months ended September 30, 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Options</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> and</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">20,442,170</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.13</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Options granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,482,900</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.93</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Warrants issued</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,275,334</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.68</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Expired</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(201,254</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">3.47</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Forfeited</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(2,319,981</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Exercised</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">(455,098</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.08</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at September 30, 2011</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">20,224,071</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.10</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table summarizes information about stock options and warrants outstanding at September 30, 2011.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="49%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="32%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="15%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="15%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Range of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Prices</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (years)</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="14%" align="right" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> $0.05-0.95</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1,901,336</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">5.12</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">0.78</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1,273,836</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">0.71</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="14%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.06-6.25</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">18,321,135</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">4.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1.13</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">17,916,991</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1.13</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9.50-11.50</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1,600</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">0.42</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">10.50</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1,600</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">10.50</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" valign="bottom" width="14%" align="right">$0.05-11.50</td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">20,224,071</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">4.33</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1.10</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">19,192,427</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="14%">1.10</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restricted Stock Units</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The value of restricted stock units is determined using the fair value of our common stock on the date of the award and compensation expense is recognized in accordance with the vesting schedule. During the nine months ended September 30, 2011 and 2010, 1,600,000 and 100,000 restricted stock units were awarded, respectively. During the nine months ended September 30, 2010, 35,000 restricted stock units were settled by two individuals through the issuance of 35,000 shares of our common stock.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following is a summary of restricted stock unit activity for the nine months ended September 30, 2011.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="MARGIN-LEFT: 63pt; text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Restricted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Stock Units</div> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="13%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Grant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Date Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Value</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="13%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">950,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.63</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Awarded at fair value</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1,600,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Canceled/Forfeited</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 9pt"> Settled by issuance of stock</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding at September 30, 2011</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">2,550,000</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.25</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="70%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vested at September 30, 2011</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">2,550,000</td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.25</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 0.05 -0.28 -0.13 0.05 0.05 -0.28 -0.13 0.05 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 3 - Weighted Average Shares</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table sets forth the computation of basic and diluted earnings per common share for the three and nine month periods ended September 30, 2011 and 2010:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the three months ended</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the nine months ended</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30,</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30,</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2010</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Numerator</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Net income (loss)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(5,524,667</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,034,154</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(11,649,358</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,729,513</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Denominator</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Basic weighted average shares outstanding</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">43,098,800</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">75,844,526</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">41,402,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">75,240,313</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Effect of dilutive securities:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Stock options and warrants</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19,927</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">179,903</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Restricted stock units</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,550,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Diluted weighted average shares outstanding</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">43,098,800</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">78,414,453</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">41,402,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">77,970,216</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Net income (loss) per common share</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;Basic</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.13</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.05</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.28</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.05</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;Diluted</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.13</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.05</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.28</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.05</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Potentially dilutive securities representing 25,193,934 and 24,723,934 shares of common stock were excluded from the computation of diluted earnings per common share for the three and nine months ended September 30, 2011, respectively, because their effect would have been anti-dilutive.</div> <!--EndFragment--></div> </div> 341255 433169 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 8 - Fair Value Measurements</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Company has certain financial instruments that are measured at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-tier fair value hierarchy has been established which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).&nbsp;&nbsp;These tiers include:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</div> </td> </tr> </table> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div> </td> </tr> </table> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2011:</div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Quoted Prices in</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Other</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Active Markets for</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Observable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Unobservable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Identical Assets</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 1)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 2)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (Level 3)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Assets</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Treasury cash reserves</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">414,472</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">414,472</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total assets measured at fair value</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">414,472</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">414,472</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Liabilities</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivative valuation (1)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,095,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,095,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total liabilities measured at fair value</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,095,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,095,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" colspan="16" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> (1) See Note 6 for additional discussion.</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The table below presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at September 30, 2011.&nbsp;&nbsp;We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="60%"> <tr> <td valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Derivative</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Valuation</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at December 31, 2010</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(14,759,300</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total gains or losses (realized and unrealized)</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-LEFT: 1%" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Included in net loss</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">12,257,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-LEFT: 1%" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Valuation adjustment</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">--</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Purchases, issuances, and settlements, net</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(594,100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Transfers to Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">--</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at September 30, 2011</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(3,095,900</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Money Market Funds and Treasury Securities</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The money market funds and treasury cash reserve securities balances are classified as cash and cash equivalents on our condensed consolidated balance sheet.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Fair Value of Other Financial Instruments</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The carrying amounts of our accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their immediate or short-term maturities.&nbsp;&nbsp;The aggregate carrying amount of the notes payable approximates fair value as the individual notes bear interest at market interest rates and there has not been a significant change in our operations and risk profile.</div> <!--EndFragment--></div> </div> 167410 159797 12257500 240100 -1044993 5851300 -362 -49264 -954033 16000 5124883 3180412 801351 1280183 1907093 1512191 627646 758764 3729513 -11649358 -5524667 4034154 -485735 259419 68607 -279020 -103629 -10909 54399 -42295 -126704 -20393 1131836 745925 7379794 3531090 176047 244966 369591 52175 106574 2324 3295 338 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 10 - <font style="FONT-STYLE: italic; DISPLAY: inline">Interact Devices Inc. (IDI)</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We began investing in and advancing monies to IDI in 2001. IDI was developing technology which became CodecSys.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On October 23, 2003, IDI filed for Chapter 11 Federal Bankruptcy protection. We desired that the underlying patent process proceed and that the development of CodecSys technology continue. Therefore, we participated in IDI&#39;s plan of reorganization, whereby we would satisfy the debts of the creditors and obtained certain licensing rights.&nbsp;&nbsp;On May 18, 2004, the debtor-in-possession&#39;s plan of reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation, we issued to the creditors of IDI approximately 111,800 shares of our common stock, and cash of approximately $312,768 in exchange for approximately 50,127,218 shares of the common stock of IDI, which increased our aggregate common share equivalents in IDI to approximately 51,426,719 shares.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the nine months ended September 30, 2011, we acquired 14,571 IDI common share equivalents in exchange for 971 shares of our common stock valued at $903.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Since May 18, 2004, we have acquired an aggregate of 4,070,849 additional common share equivalents IDI. As of September 30, 2011, we owned approximately 55,497,568 IDI common share equivalents, representing approximately 94% of the total outstanding IDI share equivalents</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Since May 18, 2004, we have advanced additional cash to IDI for the payment of operating expenses, which continues development and marketing of the CodecSys technology. As of September 30, 2011 we have advanced an aggregate amount of $3,057,605 pursuant to a promissory note that is secured by assets and technology of IDI.</div> <!--EndFragment--></div> </div> 157400 26630480 12598400 10709638 4319467 19374847 6332289 7255633 6266111 6187984 6266111 -1157213 2005342 -422738 34827 -4135209 -1992434 3729513 -11649358 -5524667 4034154 10083421 -7117793 -4516962 5697188 775000 171875 8261001 6043756 1635351 2421798 -6353908 -4531565 -1007705 -1663034 381015 78526 792008 635953 1426834 1443044 1067649 151 67870 59121 5597 19634 24078 422978 190173 20000000 20000000 0 0 624598 476156 190877 238043 1335000 18304 1975000 225000 240 2419891 1732177 1414 -38904 1151439 1304658 1793596 2090212 588147 570197 -112492311 -108762798 6321495 5359907 1885600 2277074 824771 197276 55007 401826 2072993 879570 903 4024 399466 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 5 - Significant Accounting Policies</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At September 30, 2011 and December 31, 2010, we had bank balances of $104,367 and $5,879,632, respectively, in excess of amounts insured by the Federal Deposit Insurance Corporation. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions.&nbsp;&nbsp;We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accounts Receivable</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when collected.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Included in our $1,192,248 and $1,125,055 net accounts receivable for the nine months ended September 30, 2011 and the year ended December 31, 2010, respectively, were (i) $1,150,276 and $1,031,795 for billed trade receivables, respectively; (ii) $86,716 and $143,542 of unbilled trade receivables (iii) $56 and $208 for employee travel advances and other receivables, respectively; less (iv) ($44,800) and ($50,490) for allowance for uncollectible accounts, respectively.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventories</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years.&nbsp;&nbsp;Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Patents and Intangibles</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years.&nbsp;&nbsp;We have filed several patents in the United States and foreign countries. As of September 30, 2011, the United States Patent and Trademark Office had approved four patents.&nbsp;&nbsp;Additionally, eleven foreign countries had approved patent rights.&nbsp;&nbsp;While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amortization expense recognized on all patents totaled $2,538 and $7,613 for the three and nine months ended September 30, 2011, respectively. Amortization expense recognized on all patents totaled $2,591 and $7,466 for the three and nine months and ended September 30, 2010, respectively.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Estimated amortization expense, if all patents were issued at the beginning of 2011, for each of the next five years is as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: center"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="40%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="67%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ending</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31:</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="17%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="67%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td valign="bottom" width="16%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="2%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">12,231</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="67%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td valign="bottom" width="16%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,763</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="67%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="16%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,763</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="67%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="16%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,763</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="67%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="16%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">11,763</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Long-Lived Assets</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We review our long-lived assets, including patents, annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&nbsp;&nbsp;Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.&nbsp;&nbsp;If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.&nbsp;&nbsp;Fair value is determined by using cash flow analyses and other market valuations.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740.&nbsp;&nbsp;Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&nbsp;&nbsp;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> When we enter into a multi-year contract with a customer to provide installation, network management, satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold.&nbsp;&nbsp;These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and Development</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Research and development costs are expensed when incurred.&nbsp;&nbsp;We expensed $570,197 and $1,793,596 of research and development costs for the three and nine months ended September 30, 2011, respectively. We expensed $588,147 and $2,090,212 of research and development costs for the three and nine months ended September 30, 2010, respectively.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Concentration of Credit Risk</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management&#39;s expectations.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the nine months ended September 30, 2011 and 2010, we had one customer that individually constituted 91% and 87%, respectively of our total revenues.</div> <!--EndFragment--></div> </div> -15920842 -8278933 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Note 13 - Subsequent Events</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During October 2011 we issued 26,640 shares of our common stock to one individual in exchange for 399,601 Interact Device Inc. (IDI) share equivalents.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During October 2011 we issued an aggregate of 77,500 options to one member of our Advisory Board and two employees.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During October and November 2011 we entered into an Equipment Sales Agreement under the terms of which a company purchased installation services and equipment to be installed, used and sold to our customers.&nbsp;&nbsp;The company granted us ninety (90) day terms, which should allow us time to install the equipment, bill our customers, and receive payment to satisfy the outstanding payable to the financing company.&nbsp;&nbsp;This accommodation will increase the cost of our equipment by approximately 10% if it is paid on time.&nbsp;&nbsp;The total amount of equipment funding aggregated to $700,000.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> We evaluated subsequent events pursuant to ASC Topic 855 and have determined that there are no additional events that need to be reported.</div> <!--EndFragment--></div> </div> 77970216 41402000 43098800 78414453 75240313 41402000 43098800 75229254 ISO4217:USD xbrli:shares ISO4217:USD shares 0000740726 2011-07-01 2011-09-30 0000740726 2011-01-01 2011-09-30 0000740726 2010-07-01 2010-09-30 0000740726 2010-01-01 2010-09-30 0000740726 2011-10-31 0000740726 2011-09-30 0000740726 2010-12-31 0000740726 2010-09-30 0000740726 2009-12-31 EX-101.SCH 7 bcst-20110930.xsd EXHIBIT 101.SCH 011 - Disclosure - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 017 - Disclosure - Equity Financing and the Debt Restructuring link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 019 - Disclosure - Equipment Financing link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 018 - Disclosure - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 020 - Disclosure - Interact Devices Inc. (IDI) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 016 - Disclosure - Notes Payable link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 021 - Disclosure - Recent Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 012 - Disclosure - Reclassifications link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 015 - Disclosure - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 014 - Disclosure - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 022 - Disclosure - Supplemental Cash Flow Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 023 - Disclosure - Subsequent Events link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 013 - Disclosure - Weighted Average Shares link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 bcst-20110930_cal.xml EXHIBIT 101.CAL EX-101.LAB 9 bcst-20110930_lab.xml EXHIBIT 101.LAB Amendment Flag Current Fiscal Year End Date Document and Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name Accounts Payable, Current Accounts payable Accounts Receivable, Net, Current Trade accounts receivable, net Additional Paid in Capital Additional paid-in capital Assets Total assets Assets [Abstract] ASSETS: Assets, Current Total current assets Assets, Current [Abstract] Current Assets Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Commitments and Contingencies Commitments and contingencies Common Stock, Value, Issued Common stock, $.05 par value, 180,000,000 shares authorized; 74,078,153 and 75,949,016 shares issued as of December 31, 2010 and September 30, 2011, respectively Deferred Revenue, Current Unearned revenue Derivative Liabilities, Current Derivative valuation Employee-related Liabilities, Current Payroll and related expenses Finite-Lived Intangible Assets, Net Patents, net Inventory, Net Inventory Liabilities Total liabilities Liabilities [Abstract] LIABILITIES Liabilities and Equity Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS EQUITY Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current Liabilities Liabilities, Noncurrent Total long-term liabilities Liabilities, Noncurrent [Abstract] Long-term Liabilities Notes Payable, Noncurrent Long-term portion of notes payable (net of discount of $992,832 and $742,830, respectively Notes Payable, Current Current notes payable Other Accrued Liabilities, Current Other accrued expenses Other Assets, Noncurrent Total other assets, non current Other Assets, Noncurrent [Abstract] Other Assets, non current Other Liabilities, Current Other current obligations Other Liabilities, Noncurrent Other long-term obligations Preferred Stock, Value, Issued Preferred stock, no par value, 20,000,000 shares authorized; none issued Prepaid Expense and Other Assets, Noncurrent Deposits and other assets Prepaid Expense, Current Prepaid expenses Property, Plant and Equipment, Net Property and equipment, net Retained Earnings (Accumulated Deficit) Accumulated deficit CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract] Stockholders' Equity Attributable to Parent Total stockholders' deficit Stockholders' Equity Attributable to Parent [Abstract] STOCKHOLDERS' DEFICIT: Total liabilities and stockholders' deficit Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Debt Instrument, Unamortized Discount Unamortized discount on notes payable Preferred Stock, No Par Value Preferred stock, no par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Amortization of Financing Costs Equity issuance costs related to warrants Cost of Revenue Cost of sales Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Earnings Per Share, Basic Net profit (loss) per share - basic Earnings Per Share, Basic and Diluted Net loss per share - basic and diluted Earnings Per Share, Diluted Net profit (loss) per share - diluted Gain (loss) on derivative valuation Loss on sale of assets Loss on sale of securities Loss on extinguishment of debt General and Administrative Expense Administrative and general Gross Profit Gross profit Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Profit (loss) before income taxes CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income Tax Expense (Benefit) Provision for income taxes Interest Expense Interest expense Investment Income, Interest Interest income Net profit (loss) Nonoperating Income (Expense) Total other income (expense) Nonoperating Income (Expense) [Abstract] Other income (expense): Operating Expenses Total operating expenses Operating Expenses [Abstract] Operating expenses: Operating Income (Loss) Total operating loss Other Nonoperating Income (Expense) Other income (expense), net Research and Development Expense Research and development Revenues Net sales Selling and Marketing Expense Selling and marketing Weighted Average Number of Shares Outstanding, Diluted Weighted average shares - diluted Weighted Average Number of Shares Outstanding, Basic Weighted average shares - basic Weighted Average Number Of Shares Outstanding Basic And Diluted Duration The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. Weighted average shares - basic and diluted Adjustment of Warrants Granted for Services Warrants issued for debt extinguishment costs Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash used in operating activities: Amortization of Debt Discount (Premium) Accretion of discount on convertible notes payable Amortization of Financing Costs and Discounts Non-cash interest expense upon conversion of convertible notes Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash and cash equivalents Common stock issued for interest Depreciation, Depletion and Amortization Depreciation and amortization Gain (Loss) on Derivative Instruments, Net, Pretax Gain on derivative liability valuation Gain (Loss) on Disposition of Assets Loss on sale of assets Gain (Loss) on Sale of Securities, Net Gains (Losses) on Extinguishment of Debt Loss on extinguishment of Debt Income Taxes Paid Income taxes paid Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (decrease) in accounts payable and accrued expenses Increase (Decrease) in Accounts Receivable Decrease (increase) in accounts receivable Increase Decrease In Debt Offering Costs Increase Decrease In Debt Offering Costs. Decrease in debt offering costs Increase (Decrease) in Deferred Revenue Decrease in deferred revenues Increase (Decrease) in Inventories Decrease (increase) in inventories Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Decrease in prepaid and other assets Interest Costs, Capitalized During Period Capitalized interest on convertible note Interest Paid Interest paid Issuance of Stock and Warrants for Services or Claims Warrants issued for interest Loss on sale of securities available for sale Net Cash Provided by (Used in) Financing Activities Net cash provided (used) by financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss) Attributable to Parent Net income (loss) Paid-in-Kind Interest Payments of Stock Issuance Costs Equity issuance costs Payments to Acquire Machinery and Equipment Purchase of equipment Proceeds from Issuance of Common Stock Proceeds from the sale of common stock Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from the exercise of options and warrants Proceeds from Notes Payable Proceeds from notes payable Proceeds from Sale and Maturity of Marketable Securities Proceeds from the sale of auction rate preferred securities Proceeds from Sale of Productive Assets Proceeds from the sale of assets Provision for Doubtful Accounts Allowance for doubtful accounts Repayments of Debt Principal payments on debt Share-based Compensation Stock based compensation Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects Common stock issued for research and development Share-based Goods and Nonemployee Services Transaction, Expense Common stock issued for services CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Business Description and Basis of Presentation [Text Block] Basis of Presentation Basis of Presentation [Abstract] Reclassifications [Abstract] Prior Period Reclassification Adjustment [Text Block] The entire disclosure of reclassifications of prior period amounts in order to conform to the current period's presentation. Reclassifications Weighted Average Shares [Abstract] Earnings Per Share [Text Block] Weighted Average Shares Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-based Compensation Stock-based Compensation [Abstract] Significant Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies Notes Payable [Abstract] Debt Disclosure [Text Block] Notes Payable Equity Financing and the Debt Restructuring [Abstract] Equity Financing And The Debt Restructuring [Text Block] Equity Financing and the Debt Restructuring [Abstract]. Equity Financing and the Debt Restructuring [Text Block]. Equity Financing and the Debt Restructuring Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Capital Leases in Financial Statements of Lessee Disclosure [Text Block] Equipment Financing Equipment Financing [Abstract] Interact Devices Inc. (IDI) [Abstract] Investments in and Advances to Affiliates, Schedule of Investments [Text Block] Interact Devices Inc. (IDI) Description of New Accounting Pronouncements Not yet Adopted [Text Block] Recent Accounting Pronouncements Recent Accounting Pronouncements [Abstract] Cash Flow, Supplemental Disclosures [Text Block] Supplmental Cash Flow Information Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events EX-101.PRE 10 bcst-20110930_pre.xml EXHIBIT 101.PRE ZIP 11 0001214659-11-003916-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-11-003916-xbrl.zip M4$L#!!0````(`$=N;C]GU_%]&(,``#K$!0`1`!P`8F-S="TR,#$Q,#DS,"YX M;6Q55`D``^5BP4[E8L%.=7@+``$$)0X```0Y`0``[#W]<]LVLK_?S/T/.#VG MD\Q(,JEO.4WO.;;3\YUC^VSWM7V_020DH:%(/8*TK?OKW^X")$&*4N38OFOJ MS#2U38'`8K]WL5A]_]?[1)=(XP:?_WASW_Z_B^MUF7WE_=79RP*V43,>3!ET91="OX)_A=/ MHWC!0T^P2QXG(:S`YDFR/-C?O[N[:R^[]Y,X:'O1HM4R= M<1>VJ$<&,OQ4&DDP1?$,1CK=??QXPI7(AN.G>1;?[\`'ML.6XK:Z;#4]5:\;Y,G]E MRM6$9C8?U+QR>GW1Z[C#;3M5$8[(7@C31?U@/XGWD]52[,,($4O/O+`+#H&H MC'V/&S]0WEPL^)68,D+$`<[XKJ'D8AD@KNG9/!;3=PTD?2NC^0VVKR?" M3PY._B^5R>J##&$%X._#T#\6D^1*J"1.O20%-IG=B/OD?1!YGYCTWS4>\D+; M'7<';0<%R(O"!!Y?(4C3&%@\PS'\ET3FKW$+0,S>@;=^^"Y(W@*_'U\<*0/=CE3^_/3H]8H[6__W/W:'__^.:8_?*WFX]G#"25W<0\5#(!H>'!_O[) M>8/5<-#-E68U%U\VO[82Z\VVGP">6JWO9LG;/_\)H?#E+?[!K-\-<-<)R/*' MF,\6(DST*]DH4!&K`.AR?'I]>7;XZP&;(%;>L@\7YS>M#XGY\0LFF[#P;VMU0E%?0O8)'X'L@2%)Y"003(8^T%+XH5#*S+].W,:;MH7C_+<; M&/T`%F$\%LP7RHOE!/8(L$ZC((CN5'L;V:H(?,O*A&QDHC>)V7X^P=?`!#\+ M<",2$0,N9)A$0+G+@`-3P$-V.`,/8P4_8D$/FLSG0*6":]QASC4RF;/+N0RX M+X+E7'+V/HX^"5!`@AU%\3**.2HQ]KIQ^?ZH\:;)EFFL4@Z+P)IW<^G!V^^/ M&,>E?'S&O02)@T04]UZ0*GDKX&,$"Y@)'Q]%BR4/5\2FK#$!(C,Q!5\F40T& MWH!4&BA@Q*7P:!U\2W'@-Y@A7=(J;,'OY2)=L%D<`>\!4RKI"P,L#-MS^TW' MQLA MR!!>$&G)5YIL-(%4RNQG]"K#D=YP-)T*$C[P$3UX5P%5/`$4]=ED9>.RB;/" M/*F@>7L:\<4>-0JL/0*]F>#`/7MN3J>82U!?3:T$-)"X1"RX`C.*^L:+%$R$ MGXO[I0B5GAQ7C$5`+&ZX)0/\\S@)5%2+F+(>G`I4=C0U7T2I9F:^!+0`%\+" MP0HV,M+;2)>1'HGJV"C19)NR`T[BC*\ M3B=H*)8DI_DX556#G:Y6@UKA*!&@W*.#+)-4NVY:%F'Y&!2;!_/+A-:X!0)% ML2(V1N"6L;R%N=DR!Q*([G::?-8UOHHIWTD)D/PE2.-@$X M(5[@RU,T$2O!8RW:Z+OF^TY@N5B7.1%*H8`Y]:Q0(:=`JX!6\) MXGJB-VFC7--K-*/GMJ[E%*I`TK5`==*$1DG!0-)T/@`XXT$321,FF1K3(E*C MGBMZ>5K`>`?BNJ9"N^T^V-P@`"AKV0B\GE1I]@>'P5@MG#BT,;-)X1H%[T=W MH=Y^MKD8PE_T96.P86PB<"PM@^)]%\6?R._E2YE`,/D6Z[E;"W.10^*"]2&/";R'$EBHW MQ#/0BS/2NL"*GERBNLZ-,RJ,K:STTXYFNDE/`X'LH;+H1QBA``F(:]9?@M]+ M^TPU9@3*F4:1]F47(C<)4X.^[3["NM1OQ#3*50).4V+"I#1$OXU\JUK/.I?) M%\K:IR%2-10E1MU`BI24!'Z,QBO7-!O,=;,4[UA>9BR6:#AQQJD,A'9Y?9G] MA3``0PP<<%A66:";Z7$4"LKZFK7MV`7=UAG8>!.A0,R>:&_$`]F-LQF`_B:8 MHO?KG0`5!3E73M==UOJ7"#W!*ELH,_@;/8(-T-X!V_K""SA*!L2&2!IP$?Z> M@E/B#DCYN"!$B533?*UH`I36$V%V$-1Y(54;R/-"^7UC^HABH2*'5)^'J:5E M6830%Q#(PS3K:_DF4^2@J0X7J$A]8B2]THQF"JX[4$T)<< MQ'*O8ZT&4'E7W8CY8E8T`PL@UM M>=)*CR,=`"@R.!QQK6.OU[!LR0E`8IR)!#&M#?>Z92H5T4Q."X[DB&ZE7R@'VD_9#^8YV'KK&F`X5KEM&:.(N0XG.3UK:P@%-XY-8X2NY*S.FH1O&N3).6`[,8O([;$FA:];4(O5/'>;&.@M1QM1KDFQB0MX=K6]!M=!(VRYQ4E=.(9'-.(Z%D9YB=@=N)A6Z_2"R4\[\^ MGAVAF#T%<*!&(G2[8OP=_#^#_!6#P%KHK"&0%,&:K$KV(8)@]`L`T.9<^T** MW?(8C9#6=)(T/3J,'EBK+*%-FK%($&AMINL28KV`!^@`28E7QOVE9U&H5;;V MIZ:PX)KPR3``?TQ+;MT^[J(BH1V"YRFU+``IE/0E0`X4G:4<=3BZT'0DE=LG M97GE&[&A50X"EZF/EZ=_=B$/LM1&8U/"869(E*UE,US,.?1%46/XTA\<0'\<6`VG] MJ:=&%X(B9KXIC6!L9LE3SDXV+)H:F3F\TO;ETK@'R"T1.'G:6A;IYG5;NU%# MFP"0_(ZU,'"+O.?0&EGYXXB*)@:ER#T/@UZ3C8:(`MU#'U$(1@]/G8#TFG:W M/$B+T-W."2([@!-!/B!['W#8S+6'WHBBU?'Y(O)%T%[G59PX!+569MIKL4RT MF]K-N,M*^#"8&BUR=HQ#CJ%-K@P4C.@(+SDM3#B"'\L,4P4I\'%WV&EVAITM M!^AM=DBXT'IYAGQ!CEZO9V2(CK&CV->A>"RF=/!'BP%]9N2L$3(SIBU2S07. M"_>:_#<\Y"8+8HR:;WSI@M`O5/MM2*^N9Y;*V=)=G!5N=`D=`*%*RFO5IO`6+U6GGVV8?GFWKXMW%;+<4O@/=`9;J?9&X^; MXY%3G"EE(!CLFFR%Q*2VLK M';16K4?E)/P_9"A>)HL=)C66CURVW*!@-J7.6@223V2`>@1M45$94CX@MXUD M1JF*&1LU.T:+9"[:;N;YD8:NJMR<-KO9],*FO:+"]'C@I7K+FL]P6>*T5BVG M%3J].`;C(&(+.LU1!W2^$$OU"<"D(BV3:,IR64Y[U'UE!1"8.A7RX`7QN4_?']_H.K[JUB_=/0P](Z M`92EGZ.J)8#:_1W&&>5YM\K>1#*X%T#%A=?6*E/9^/TRD_7Q_D- M#B7K[F]T',?=_^7CV37=86@55T3VGV^KP\VW$)S2WIQB;\/ZO?G"DPMP$=XU MG,8/[J`W&G0<0]8=@+&V>(F',Y?P4>1?X=&I4G(J/=(=A[FU*E^^>-@KWZY? M?#W7+SJLQ:HD52_39!\9QXKJ/$TA`U8NYL4&^DS9%"5.A,`0-,.::V_\=-'@_G/KH9PXPJ;0,1=;`(P_^S1X.'C.@#S%=;!T[#;-*[]Y$E` MTX_+`)9660?O9K4L0X4/'@T,V/%_EL'`:8O53\($'+`C>![SX!0\\/M_B)6^ MWUCWR:/A`5_:&?:<86>@H:I=90T\BCZOT1N]IO3#A76IRX)UR[!V9S3LK@/. M52N::E@!4UTW'U9Q=VBZBLLS[(^'_4&_O)$M(%1W]4$&(CX"7IA%L8WRTO-' M(_P:X(7YP*92V3$@S*2I;+!+2U;AO#)'16%RCL6?!:#E#QX-Z?NKB\/CH\/K M&W9Z?G-R=7YXG'CAB.T!/`'1O*R_GR.WM`K0S[(X'PR\#^HHN5>&P>`>;8=/E=FJ=OIN]V! M\T1;S%.-1>9LVX!GE\O_%# M$M;#6@X=_X?VARE^(ZZ?WZL]^'>\4;5NAJFR;:5$MBGZ M]:G]>V?HC`==VS.F97:`X@D=Q5[7'?=*8=)&($H!A/WDB1$S[(V'$+M50:H/ M$3X/V5/&,F,PVMTU9-5"]AX/4X52QR*_Z0:\]A[;J5Q,+ZV$=?D(Z.&O?3L& M^GJ.@5S68D1+ZI)B4?,/6(M&=T67,C0%K;`LGYDN(E0`X9EZ0^H! M$/)47U3'>FYL:."7+RC4G"<1KM_'$?<]KA)8,1%QR#4+-N%/#^\9WH'9,\4; M#9-);+S)RXT(CJ+"J(F%NSBKKDDS'35,%04TE2-$W`2DU=@;DT96I%W?"# MJD?U6KJ8QEP.D+03/T&WG$+Q!_H]O`#A4B77C]$(M0\2O$6 M!_5R\@WF?TO#2DFH)6R?F1"IF!5.93TA3&,1 M`C56]E,>-<,WE^7K<5G&IG'HDFHS\N#I#Z-K']JIX3"=@1_`.M2PT1GK-I\1 M-N9-=+&IR)$5H'!8O3K6VN]P2YE:7<[:5@O4:M.U4K^F\JWT[$(I7@:/<4I> MM"DK:C;K%]0FQ'H!-2*642:ZZ`8UJ4H7"UCB7WB%7(#=_^/8VT?V^33=*T@7 M6L7J?M;P!\S'WU.P*)V1YIG/4*.^-0.U?ZDR0>FUO&(=V^9%BP4$LJ;0S.)) MF&$BZ#5.33'`DKG-\XT\B*9>%%U/"]ETG[Q(: MQ7(FD6[E^V\O5U3ILD]%7LUEYI5U/?-+)'*F#_](BV.'!>K&@M/F\UN-QLI4 M`^4]%W2;/XSN6'2'K9&`D-BF1W<*Y!X,C;/>J\:%SD0#%J##1OM^,NIG\S1G M2FK[H^_5^-8M0NNF4H4S213RAK+Y+5:Z;H``Z.N@U7M:V74I\/]A$M)*B=H! M"3F/9I=_J!4G-L+28C+!RRY%+S3PVTT7HL$+9>>;N;#P4T8/HQ/IV4[<7&D! M:;42Q9M)RR#*56AF4GS0*EC`H`!&;$1=T%"K7[I<9;ASM\8V4E5<&;`LF$;U M*VT!`,8%_R1LU9OS=TW'7W.C5+?[6RX#L(#4,(7C-9:$WPNE;\E4.U/:>!1V MP\ERJU4_LYSZ1NE6K)0DEAK+P4.3RZCVL,0UEI':T'\6A)*,+\6@V$.!*`=B M#$`GPG1#)`!)=P"^Z%INM\"4Z5UE7D&\8O_D=?SU^M3\V4QDKERB604"W5'* M`#MUFNQ729BW`EZ^"$?$M]F5VMQGF-"*Z&4*^!??]28)6G!?5/V2_,)EE="= M3M,9#VB!/;?9&0R:G=&PR&GN=0?@%@[R`4YOU.R-7;HP1G)%HG&';6C([;`J M5S,?!U30WL!INEV=X]OKN,/F<#RHYA/M/%%N*DRWVF]L\+"D[3.P@0L*=60H M.(9P=SAZ,!.XSJCIN&:1;G_0[#O?N&"'JZUY$$9I=WVC=192_,VM$^U,%1L3 M@(ZC.4,P.GX/VYX/A@;_((2.FSFQ7&W%_!>G4W5.WRE3^=&&G+L5X., MYXJ0=@Z/LW1MI/N4Z*]&HRRK^0JSP5J/[K4O`C-]>G@"CO1H3*,Q%7-'5](5 M?6>4Z1Y4_6(R\SE"K;);)?HL)J8OLBB^P,N>*:(F@G2Z074%NIJFVFLPEDDB M0GN)/#&LLUWYT4&V]_Q+5:R8@M8R`(`B\I)LM2QWM3NV]\`I:/:'G;4`0V-Q MPG65R@*##,+0"PWQ+D+3$;*3-YNT.JXUK>\VV1N.>LW.N)-]=9N:0P#8HE0^ M=3VDDPWS!9,0K$7I;+[65'+M*Z7L?JK(P]E7JIB#K/Q+4?+^/^9K!*M?Q-$V M+>76.)Z."8R<:HCUZ0-V>%=9MZO)_[?WKLUM(\?"\/=4Y3\@.G:57052N!"\ M[,9;)4OVQN?Q6GYM;?;D(T@,161)@,%%LO+KW^Z>`3`@P:M(":`FM=D526"F M>Z;OT].=Y4/R;EE$::M;85%D5^Z%Q>MEK^A/5:Y@E]5\TVVCIYO.JLK]2VNS M("85M&4)W-&F;<-J4AZIKT$HK&*PI+ROS M%)Y..F`M$D=1\;"\^&=6%9(V3)=ZS^Q9BC8OYR>4_ZN.P0^9MJC*E\FX$DPG M4M/U90J&C[N4^"MEP`1AT"*!FP57J10?50ZTRB5P,V.+^K+)(=[5\D7MQG9. M@&3OOC)U$X^D#!N9P&-S^,WGPI.TLQQBS^/AF9#)2Q_RO'"QFZECRT3KV M7J1:WG3V3"GR^?DP'2U[H`)&R?0!#7_4P6%Q7AR+^HBO'!-/T/KRN+P+!/`R M2'_,8<'FCD5>"14YI**)KWIZU[1IV#F\RPMKY2BM)9A'=WC?U/3@1+QOXV5R MW6[>MR%7T.\877U@];;PL7U9=I+##2S6Z7:Y`89*D^LL7Y30Y=]ATOZ=[Z7N M-,YLXR6W.W.X]2Q=+Y/&W'+WE^\N9%D;)!<\;$'.FTSP\[C+ M/.1"XE?L[24^^/V!K"/LSEMR?K0L@Z6@")ZN$F#)6T;W6'"0H3LE+SN>,,:3 M\2C'4PA<)MZB%D/D+TJ:05'.KC+$SOO3;T$\MFX-C(Q\)$Q&*+&<:LW]1.G\ONC>O$1->;".-TJFI:RL0/_B"&L' MD]#0M[#0@8`<4[>[QA8VNNB752(E:G'(S46RZM[BD&;'UCL])Q]E.Z(4MMU; M3*GIZ?V^D^<9%HZ!O?S>2Q4QNU'"LG/0&^@V]B=XM'/0-6S=L3J'=PZZ?=T> M&'LZ!VA+[>,(A'&-*!]JIO6+H)Q`)K`4B"CIED2=X4)9Y'_HS?>_5XRYPTB!BLV7_% MA5X@R*S,B]Q+='4#T;USN[8[UU]('8"U\?GE?,P]".EJ.`M&OJC=MN9W*65K M30&>'3*X#E)SYY$(=;9':',^T\$0$B5DO[K1=42Y>AXE`WUET7<>Q!:(;7CN M<4EVV2AR%HMU]@L\)2>Q;(;BJ.CMGX!V=/1X`>"+-`&!0])A`:W%WQ^9$EE5 MHMCL&_Q_E1@M`G!03!Z1&7AT3#YQ]Z@2"_[;$?8"JU[W3<=>@P"?^R#`'WCY M>\Z@,S#,[O[`2[F7"U\>.!78[AE@ZO4K(:U*J=P6Q`.FNMJ]0:_CF-N#&"?7 MXV_8IBN'3_KFJ#4J,2M7KB]:FGEG,(]6([3?Z?7*U/D8,/MKP=RI7F19B%E. M;^!T#@7F8.VF[U3V<:&*N=FW36,K,+/RJU653U;\IA)-&W%JPR\0:RWZ(\Y: MYKY,?_=F(K7)*W($TTBXD'/13_A-P`I',?,#W^[6[0Z=QG7UG?BELCQ2]M/3 M[:IT^)MR>TFOA(=YEK!/O[ZV]7'[[EH`\IKP<0 MT*CXF>"BB\^??OWR$^PG1CZ641N%N.T!.EU8VR%RY^_.^'_/=A8'F_#<4APL M@[TR`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`?8.Z+N>AVZOD-UJM M#MX%-'I4Z*^Z'SS6UBIZ/>>MU?V@:/D>N51H_Y7IY#5(WU!I_5<#NT>Y2%=.4UYV35G%ERX=- MPP]#:GXAVI:ZB:#_.;7<#M*9YL-^\,V@/@B5$WW*WL\J&HS]"#Y1N0(L2Y!M M*`R/53^PX\VZ85IA('PB%,DXL'*Y0I!S_A82[98;ZDB+"$C+R'1OZ7W'$NW!IU-;4@J M>W>\7+,P:C:3#V/=\-_)Y!RY.6O13T78^UE*L$5ZL'`Z0E]G$XBDN M[Q,B5?]]F3*6=WX*1-L4:OB,BX:B5A89%45N5]5LN@4310TV]H-O>*`Q?CS2$?`F1AB]GB#G+S\\RL3 M)`%7(KQR_6P&T"`QZKB2U)EKS$2E4%[G5:9$484VSGII9_Q&?,0KHU.)_)80 M:WDSHESEF=@G>CU.I"Y!/T4>U<5^6-V>R&[W2F)!KN<.XF:5S+_@KLC7 M8[&-'!6B"<=C1E)%*I.--61$E6RIH=U.E;$?W?L".Q[YXX>5[2_*AG$#6/PC M&B6B&U975.O)>LQ=CY*0S*N!5$=YR;PB62O74(\S#MLD$[@8SNVO,GL6/;BV M&:K,;Y+HHD8'U59-KY.G[C6EII[Y<7'\_5\H=IGV<(7)(AV&HH`;G!AR3;R ME*)TE'!3Y`TLJL?&U!AL"!;S?;657E9O9,JACJ,YL+9W9@<':YVR17=LK57L MM!UMYD^G..$;?.JL6 MK:R1B<8+,>_HEM&7V&>YH>(;_RY?Z/X2TR[J)VE^[%<'#!./A8I$"11(5IZ0 M+BZW+:F?7<%2,"],NR#*/K,$U_!8T/,6JL;%-8?_3GV6 M9L),[ML)NK3T?$632E&5%"89&UXX2KGLIBT5 M&\(I]#-.5F:P?(V0X*CP_)V_N)Z!H%18_&\8((NEE2534EI$CV`JN-WFW%YM M1<"*B`+HV8("U;';D&Q1:5#X]I;Z<\YA^7[X,Y@#B/E5KVWE"TX.?;_."FES+XEP\FF2B(*,7HM,F85MPDFT6VRW&`I;I_P`;TMA="V] MX_3*;2DD1VM=M;VB2RGOZ.KY:$RAIPG",+EG3#BJU+X1E2D0V@,.G%<)3&1O M,W>1R&BN?'8EA2EC;+<3MG5KJ:_B$AV[6F7!&EUJ&T`[1W(::!\+['/Q@:VT MD'[BHJF%B'S0I$/Z20Z[H(@+@A1H(1*M+BD0H^G#*A>,F*D< M@)':E>;S$?V#0]6Q.UFOXG5QF;5+A@NS%!)9U1=X91#$;-LE;R=.J4,O^4MY M"]1#``=\&TZ1\_!O:DU$BR_"+.DRZ.?%*J:**.P##(3-.%QJE<=6!/`,^-^`2\C8D;/8@VLCS.%7#]R`W9 M-8<1W%:MPN,^E%KP4&(#H5&*]]RF+H65T#1<&?#9(*JRHXR7:7%OLSU(4BL5 M>_DX2%@ML4RKI/FSAL.@M46S/6Q;R\>B!X`&YX+%I![?DKB0HOH3-O7*#+&* M%6)6.:,(/BR8CT*U9>W%$Q$^DHT].88E6Z;C:@0]YGJXC+'&>Q<*IJ!6X<#7 MPISUF;>2E0L;K\RZ>S8_%L8DULA.EGNIQT(PAN6V5V2RT":Y171)",MH68#2 M`0KHH!4-HH$Z1I$_1(8KG+J MNT-_BM%S.GTP;+TGHI*O>%`3`X""M>#YZ8,N=Y=:V)\Q$S;#)ANOJKF1>+GL MQRS,=9T9F%]6'11D7`$(R$6QR[H=AHK;>>M2UJ+/E`A MC#*>DCA"+(&6;TE;ETS@#1L"]LN(513&YM,8`[VT+]S5V&&/LYC1ZDVJV!SR M6]SI*.7;`K9&Q3KP/N,X-G5";U5W0L^/!O+N:'@XD\[F).%XI[3(C_\$BY-) M1WJ9.6EPPAY!'D0W@LOV!7T*=S?LN#*O-_RJ?X.C1/@WZ^LGF[W^_QP2\2>Q#$B1]"- MEQ"LU)6[]<-$]C&ZNF7VM#<2*X7C,;:S1?ZR'+UK#K(TCRP6D#<&)*7U=KN] MD!EK=4O!%\,\K_(*CA5,4ZV$*;J(YZ!TA(!F7'Z27!:MWL)P\RDX],A*L,&6 MP]\HS(IQ2G9`OFD\V2D+OI2$(RIX5'/4":%!FB M$!:%\M&.O8E\%RS\2Y%(]YL;P$=^:@04SW_-@K'N@N<&8I,F7>G"KYHY/^&A M>*T`@8YY7A4)*13H0SG+?@@W!'DPC3EZ.`SBIU,_\D@X(NZR MB25%5/(P0_6I:2+$?L+U"P%,MG^Z@`KH$8'($+W7.3@0_-N*Z<7A"P]`\%.5 M_)0\EL($=)Q;"=>'\9C[3\``=V(W5E&`C&Q%6B@N4$6/;IT.GI8#2/)[9`%@ MF'**V6EQ*9]`SL=93D<066[902,Z:!1E0:U*7DJ:'<;PU(B\0W$2@=-%1T?W M`2>MC$;O)R%H7\I$Q?G<\OF;V!N`"K8'H`7VXM[YQ)]E9TAY3&KU`,T1T8>M MC;B00KLVSYCWA@>"6,E)-;'`@MN?(KCX7RP_`P6I.5D[GWE7-79KCNE==JMATY,TF/6XID.GXB4`LL<.+%B!C#'-@VZ1%7Q,=X8D/Y04QEH%@?3B*&PO,E M]I\49XG=*8$A5B7G(S)Z\^2O+%BZ@#1W+E=N7]6:,-PD/*L7SAQ%6>\!D@=. M./QK?2&>N]<"<@VP?AG7[&^.!<]&W9WZTCE^S+)HUYS/5B:CFNVN(1_/4JSR M^8$J9\@FY>U_'%!617KC=F!9;;.T5EGH_NKY0;,7\KA?I%%QM4V&#]YS6K<_ MV>)Z6L?IT%Y<2(+HCT5G2/(F"ON.>S>YXR#F+:Y+K9L_%XW=)>994B2+OHQ( M1"P?P5:0Z4IQ1.)3G+=*T8>+LNA=D!%H6,`.\=4F@?Z_+E@MT8-FIV],[";LDYL+8\6L1FKA_@[!9,TRV]1BAFDDM"4ZB6%\I; MI71BOI:#Y="`E"1:G&K)N>A^+&58+7N(G#W>T`E5[B"+#:D+Z5>YU4VT"IXJC-5_G5TH0Z+(.-?L#GK&8E1`HO"2SK"4JKG\`R_$8 MT>)5"7B6S[SF)M#+SN@2&DI<\#%0G17^J6D[NMT=K,FW+^\$:N_5E%.5D?^J M;^J691(%YF='6:(G#V2L'K`Z)X0N\E7?2URW3,H*N?&\NNY(H MK%K+U'M.7\[]VA!VJ#1QC?:@N^&JXHUTH\B/%R\[YKF@_)K%&*PL'B6"0?W0 M:VL[G`*:W(YX93H]LCI*9U$9")O.]U1^]VYY7I6G>UFJT3XY7DZWR/&R=+Q` MLVN"5TEB:IM2KDS=[/#L*IY6-NCAA\5)2YE71\^?6K2W%Y.I5F=3;KV^J_.) MEJ_@%QE5Q\^=VCYQRMZ0.-6SVQW[]<\J.^I8E^8+MV+!-ER;'B7L.;#=AZS( MH\'#=L'0TN4><3)0>K^"8(=L'(K4S"):F$.WFEMH)NV M(P0667Y6F5WSN]YK]4Z1K#/B%5WA19&R$Z`KM#9AIW0ND9W9@2/N@HTDUJT* M-Z%EMTH:?645)0%>=>GO!30?I5IKQ3U'KX@T&N$)5PQN$@:6:`N_9F''_.I! MW)CU>OJ((;A.Z=E%44B'_ M8R[ZRF77),(TR1,AW`RHJ`!J,4KH>G']_G@KTQ1 MU"2_9Z+9KT%NQX1G=I4"OBJB.HRCR4!T/X!T`9_[@5_E%(/&(D0C+]P"B.!4 MA;@H6\*8G?D5,)K&,I!&VWDTF"^>3;EJ*6E+[IYG.6\48>*^L(CJ%,'>5Z(# MW\+-Y6F8)2^],L'^M0:6['(C=RQ<9N9"P-1MHZ>;CKW6G0V\ZA26\LWWKF/K M3J^[9B2NM/.AQ.VEVMY7PH"9.I&J=EEW]U0QUL2O'Y7\T2S0@,DJ2;'7FQU1 MV^S0JX:O&Z:R%PMG9ZXH#EPA^A@@L?7N7N?%OK=:'P/L8N;=H=[9: ME8_GZ=QZ]9UYS_A0=@5V)O3,$XC=@.[_AZ)ZI>__D73_BX_]"G`PS(< M^_<@KP=WE5FJO@=DN>FIMCFPK3;(G#.R0F"N;VS\[LR-6^&XA5O0,JV6;>:/ MX8-IX/.G?O]^=0:R?>3/W&G\[LPX^V4PL/JV549E[?Q'0ZJS!BFS90Q:MI$_ MM@&I7@>0,AZ!U)AA'<1O:*VE+.N[PS&I^NG`>V+:@X[=D\&OFO0`,!]PR6VG M;_1W!7D.UH]/QM%%X%WP3>&V$H=[Y>\(57<9>#1_!.ST3Q(N8-+=`A/'[/4< M4T9E)1@'Q:>W&A^CA(]1X-/;!I^>TW>Z3X]/?RT^O4I\^MMPQ\#H=YX!G\%: M>NM5TMM@&WRZ`V=@/1(?^'O*MD%LU8/'Y"C3!)8R[&H45P%T9%R/Q6V`*I"Q M\3A<,]_KLW"]?!:7!?KJ!PZMBCH]9V`;)7Q63WY@/`ZIG@Q@LGW1P,L"Y'I> MC\$E$)%G,-B_1F$`?XYX=!CM\_,_[,OS\ZN;*^W__G'SVV<-,ZMN\"ZKB(6=GW_X M;H?1[?G-M_,?.):)+XL_6XGT9MM+O#.-V\Q__8OP MMF3/*S.F`;COB1LE93.[SO[9ADRV"F^9WB/'%CRV5KFTU.)H5;=OMYP!#S]@ MH(*PM#)EJ2PR/,>1;HGEN4,?+[Z_SW+)+K[_KG%FZNO[[`Y-]"E(W.`6P[:Q MUM)^#4./CK[18;VFU-4W-^'<'VFV8[QM:3?@L^)VY<^AW_H)W'`_XB?9)8JY MH5(3_Q9W8K*\PM_GE,_H\VX!_FP^]<,Q#!*@OWT_882J3PE@,PP# M3/T_\<28HM)8**RX<0M@%+%-O-^#G41P35",X_M%.-O'D'M6O3,[`,/KKT,W MQI8D@%<&!%V_+8$1`(_$,97U"S$D#D^+&.E]V(H3-N==3G@!IC?F6QX.R0,R M93AYR+,$*597D^'CSU(TT'K+=P`>F3$78P/R$5Y643??$5X&RA\OSEM:"PH. ME^9:&AJ,4_J*L,P6R>1"P$#S%13U^ MID[Q/AZCPTO]LY6[$6<(,9Z_,O;C$;S*2[L.V:T?$"X\R2?/"#`=$;C3/KA4 ML\83A.?3>#PH*O>9>`14O#J"RW/&1=Y1H4@R2')NS32#!Q?BI42%1`0\4OR72Q.9R3C?$3YB9?)""I4)4< MT^('J*3','>YD/2`-L*2=T'!C:!Q!6TP-ZLI)(,J8"(]A-?U5K'JB[54LCCZ M6B/%V=](02*+V(2!F+O#4J@C%(G",+$LXRU8+E_YW?O\%EO5*TOF26%'@.J8 MT;E`+.\XTA\?E[1K&!!_X#D[4?>H-(?/P<+2\5A'.$L*R:_\HN2FT]$XETX\ M#3[.BZQJ[#\I[\2DX>DJ,4!V*TD$H\1HS1\(?A1F@=AT.)U+K:%?\BR=:-;U=RJP9L[>(PZY14T M_"#%TL?E]:E"A==FQN2IF,'*DEQ+26?A+0:2'Y+P>N.6A\QV)?#*WZ]>N^K& M%1=YV@7E+^9%J&,A%G"Y0>]C:0&?BG?PA*;5.P3[$K`D^S2#XF*O%3&-%[*%X6E4:+A[R0E*1@/'[C)`]04$(8/Z"+ MA>N3ZQZPP-!MXL2'2\$]MDIIB:9A05S9A=R2]IY/7>J04&0OX".WJ>^Y4JZS MV`9N9^1W=OGZOEP-^)O[L%$!=O97@!_1J_HG>56_<8^,Y)A0@7VN`B]*W:`N M1A,?S&3<8DP'JQY!5,7(24S[QHE04&^@_?Y=^_7BXBL]1JIBV<.7IB42*41/ M1JA1F%=(01=5RLN1O,69#%694@4+\*/S2I.5.DKR1%O*9HV\@B4745A]D?U] MZ$8>T?4PQ/3;Z-8-1*@[IF:?=)A_RTU;O`@9T)I)2$Q$_X_8G1%&0=;A@>YS M2CLGH445G^\S(9V_+2X.4SE4/T!7*;]V0`L-\(@L!_`Q_`[2@;)@9>` MI+F798Z46+AB6S!%;`Q,)=01^=A8P@I=,O32,O,`=N)G]$,OIVY$OXEF3V!/ M_`<3-3*SWP_(-^2-'X4H1BH3=AA'5LH3E_8P-635;TFLY M>9!_^UWXB-*DLG"C`($XO/9G)8T'T0'C.:>#ZFK%"R M&(T#2QJ'.MDFY5EI[^(\Q3I/"HD!I7.Q(`\9--SODIK;<)T%7GEA@4B4D^U@ M88JL8JGJ9=2+((94ZC^-170+=''!;]3[D]MQ]^X#1Y(3I=36A!Z2AIKXMQ.J M8TIM3N"/-)9;VPB8^&8-'T#,(EB%287+(="@0IAR>"E8-K"EP$/(]2??D*+( MK32`M(I^G"WDLGI>$&JH2$7]-D$U\[(UM2K4(,JAK[$^-AM(F[QP+V1\S7C> M'P<\U^!89XX'*%[!1;@17J+/EQ1?7W1 M"/P2TH\M+#RRKQTHG9@AV_Q3]`\B,Q#=`S::!#YZ0Y=A%/%L?C(&OW^XU+Z" MY74;N?-)#*8B93GF!VZPP1YU.!("=3Q&7@?#22I(AF3V(;L1=)DWTUT34YFY M?\)[F5%`)4`I/IS9#PA4+A'`(L02$ZFHP2F$^V7HY;J\DFXI.)Y=O!0S<16+ M$^*QR+7/@ZB_`N?D\%^3UM+IJ&-A3:]\;+3C9Q>-7>U[UO#H08$(Y' M!==S41@#!P,E_8V77(VULZ]I/-&NPOO@3!SWN,4\$'46 M4V!Q$N&`HAPAS9]=Y<"*.Z*A7<5X,8^Y\HJTLL++NU?CB'0UZAY)"SZCQ>?C M8F11$#S1&Y&9)'?/RTPG\3BWYO"J">\21&V+M]'>A93T9S,&.YNLN[)^7-4: M,=&+2.83>?_SEI\X=19+$#7^A?TA^%8`>L#LX#W20!9R4'(+ZWJ,X($I0,SR MC>_D)>[8=[SI\Q[++GWE-POC/!&99Z,\;@R5E]*(>Q64<]+16MIWC"NWAE2& M2][N%VM7+(8S+KY?;BR>7D`?<>0R-9*^Y1"#)..)+9#090@^"U/Q0-1\BA`FIFN<#F?DYI M2'[428,7=Y5`!-XUZCRMRGP[[+4C.LO^%&#:%"JNKU,0%(U9GB=OF/A[7E'W M?12ZWL@%5OB$9DC@P<]4K'B"Y;B1 M;H&(>:('YDB0?T1&B)\/(6[&SG,;G,WFT_"!L2P,E;U,%2_"H$4'XG1TM/0J M1H/2:>**T\<\E!I4FRUED_Q:C'/+`LK.>"!P19RIJ(3)NX&`M36]RV\@%<5* MR'C*BG@AQ+RP)>R:N)PHGN66B7BP7[J\GNH2&Q"EB^((B;)6.)#$G M,D/(H<8"'*)$*)J^NT8E'D]%=%KB.\>KQB)497VP+LKBIFUU>/J12##2'\9_(QA46 M0V.6Y*.=W7[9K*4..&USY>63A[68"%8M@ MB+'*5AH7!&M-J[)EO;N]5':S93L)ZX*T*NJ"E*RE+"T1Q%:=C:9MR!B7>A7. MU,94CDSPFB6C-+H3,?G_LBALC4(RY']O?Y>@N(GHM/@!55C^OI;G)BEHM?+`W(JJMHR?G,A*EK84*T)=_H@PO[2RN/KD9\E M(606@>`JOF$9N/E,HK5D4039Q;9W@;24V?E+EMI?IDM4YG]F=9I`=U*X72AQ M,F+$%<@214IF/_=KZ/PWG7%V%\R8'?<7-;6HA1I`49Q^J\KAXL0WEZ.%/1-&[%`N12QU';#D:F+F]7$[NH@BJRAW=\Q9*,#I2VBTKU3_:91N>IW`UO7OQ M^=.O7W[21E2[L=#+":]CNNK!!0S`5UU=W0.7]]??KCY\RU$9 M(FG?W/:,38>%PR2=:8'9KXB23=$:CD MH$;ZM^H"GINHXBD%V[Y2;!>M4Q^H'\L#%:;T2KPMCKC9'G1?'V8=*[F\O`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`M+I(M%[43@^D[%$J?YT._TW]E4+>X&A$:5&+^:1QFVPM;#Q"O1OSCB3S M*!05]:DD+"6+8E(IU?J$)>=U#G&XN#GYUP?N*2,Z]HF&8A(E;4TJ.U)OA.'S MM]HK4W^;6/F>/JVJ))[3&K:A=[09C9M7`J[J!O'&IWFL8A9KVSG" MH"CR3@/A2%;7!K:R:*2N&&F9%?!5/R";/Q79M_C5*(R`%OG"X0"B,KS<\@PG MNH-Y'%.WC!X]U>]UX&]CZ2("S&/WBS+T\":^",]V;?Z>WJM^RW2RU@^EJO5^ M$">PKJ+&*^\%JLTC_R0 M:MHO=:-43(A,R.6W>1P6-%!($@?VC8+]%LA9HA@D7LYLFWEM8![E`EL;$ ME@XPYJ:AJ8U"UC!_/K,JR4!%A&1%PF4#>5W6S@&,TZ?B=@?=+_=ENR<^9^.13Y M!'G[("D.D;A?GVC*\T#[C.F[>75O*58+O$J"9E.< M_F"Y^/5/U-V;U$\)EZ:RK;'(M4L*MHE,6YUAOR7/[IE<7W]&+1^RUD;7*LM@ M5Q%C-4K$%!KT^#=Z9NTK4418P-(T;+[NAF_T3KZBMJ;!@U=LVN;ABF MHL;G!U51X\^F/C`=?=`=G"8];G\5:0=/LK'6]S<6,S?"M%@POSUVQZ;A')-A MMO3$=BU+5%-V/V1)M>9@]>22I=_3G<$.+D`-RUX=,QRE&*6F6#TYHSB@@^V. M8A3%*(I1UOOQ="ECA[(\BE,4I]0!JZ?WZIR>;E@O2:<G[T>4_GE,Y[;L+$Y;WP M=C_<6;<030LP`"Z:%Z;#*3NL+_[(P]XGA76[N$&_HSO=[F/B!IOHIF8"0S&` M8@`YQ-SOZJ:Y0S*$8@#%`*?$`*(>D6(`Q0`ODP'RJG@OB`5J5_BUA.L35SVZ M2AD6A\+"7[Q[]XK27V&:Q`E\0V6HDHK*152.Z]Z?3HLZE3""YN85NS3W]C9B MM]3S&CTU+*OTJCNP=+O3P;\KR[^%=TS4=@!\M#%69:+V1*+_-C78YO"6>I+S M0IA98;.Y&[DS;`A/)97B27@?:$,V#>\/4%:IM.=;U5BJJ)%<<)U<96GYP5W9 M8MO*2]URX:6]SA/[30L7;',IKWGJL$;:[NF4F>D(A[[7T0V[]]*#?2?$H=;I M<6@SH_M/S\R6T]/[S@MCYA-7N+9BYWI`_1RZN:\;@Q/M,GG4BU=-9/3.GN=P M*M&W05@]O1#I6[K=?4DI\;O8"7O$=1LG6M09OPIP[R8R1(11Q;=?9GP;J_KS M(OH8"4X#-_5\ZO^!ZQ)K<3J;N1'&JJNBR-A@RD\>=FTR=H`&"CM7ZU\;23Y. MU+A_D'+]W2PP,NOGB.:GL96O;KYE?>N^9G67M+JSK@`"*IT?#_ M(.K;1.'P0^1B-1N)K MY(\VUCI]0?)R=1N+>EO%M8Y6[B".Z^%<-/FD0Q&#(H:]HM-K!%RC(M#7Y43( M*S82P1_1!'63MFM>`+J9AU=/&&D6E50L0^]T+-W:%7Z1R=#-D7O#!8BF5D#)MQ7MGC#M&NUN_S3) M]N7Y2!]^S/U(*:*Z0/WTS/S&,D`7.6OTT%/&@ZH$PEM%CR^('NUV1UU@/!GU M\C&,QLQ7P;?:0/T<"D:WS8$^Z*^I&:54C*+(ISSCL4ZTU^M1+]4V3OED^8`; ME8^Z65M_,5&CF[698NLXCFX,UH1"'@M3!4$>1]&XVZIZ,VVIC=G8GJ!W?3C%Y%T(J@3XJ@C]JCI"E>W*KL\>7:`7MZ=Z=: MVZ292O"@&M+`0DRN-D MU7]BV(YQ&,UX\7EW&*:X80#SGL7PUU8`6ER5G='\=QHG_OAA%::-*!XT.&CQ M(+-3)_7_[+4PCA.56XE#9R!?KC6-6ECAAR[G-+GYP`%=N63,7= M!A"Q.!(DQ:Z(>.?:&C51&K5FJ37%-54Y!44,*XFAWH+S"8I<-:ZBU8$!_L9F MKA_L7RU/\:WBVQ/F6\4$=0%.63**&)1$5!+Q*1W21P9;.J\;0)G?W."6:>&X M.92995CSJJ7+Y:I5Q*SQXO)+BL*]13K-9/UGJ"(_#-6C%<,IQBN9N3;-`-3'2$KIFL\TRDMUU2& M.\`M1(R&E=.U#XG(*Z-M."VC/:BJL="\_/%F7J=XPD3Q3E;0*CBU0O^W]UO]DVNJUN5K=/U1%]=JB?0:GBM5VU[7"/>7L"<4^ MBGT>'UGNK#DM5MRCN*QCV(?Q3[*=E/LH]A':9\:I0T\R>[M M&+OA6>5%?$3)!247#B@7MJGU?\K"0?&0XJ''YSC8:PXN%/><)O?4*,FT?BRQ MOGN&8HG39`FE4`[$/0/='%AZQ^HI'GII/*34BE(K&X(83>S/Q+^X^==G^,9/ M8-E'!^[9](W%2>2/$N9IWZD;T^^!GRP79JSK^AR\?Q60=HHU-;6H6!C>IBK% MA='\6/-8PJ(94*ZGI3%UNL*^5ZX?%2^'::2-PMDL#,3+\`<^Y;D)_8Y_N_=N MY%'3*WARSH*8=\9B/_!OAA-%;!3>!OY_82(_T-S1*(P\-Q@QX+=D0F/<`9`( M03R:,"^=LK9VE4892`&`J`$(R2366.#A#B]UT:+YX0_X2"<%NF$8])TI_EZQ M#/'YFR4^'=L^K`K"/!OV]DX5Z`]V%P_ M>8`7HZUIZPG7M[1`7;MJ.:2(]?%;K_4/VGJM)EW@]X#\"0Q*\<4?'S@K#,.I M]]16LUVNYG3T1-(EA`^=6UH8!7L+M1I@L.05+N`:4K]B[B8SQ!!T-CH[# M\;LU'1V%7['3;9,1N$)OYB,X/DU&XI_HLVVI'S:WK]YD#-5?*>SZ5`S3U"?\"#(XG@/'(KJGB:K-Y)R:W1N^?3D:+:[+^SJ^M8U MUYJB=`:Y0\X/@U#A%&=A2M/4`^IG8.WL-/$T^5O1[BG3;MOHG";9OB!O*%=, MEY@0,&7>^<M7YVG+F\Y[Z>MTB-4WF`"Z:%Z;#*3LIH2.C]?12Q]*=30=X!]V,N@FBK=$\ M23:JT5%A#7G#W*ECQK).WB1\:\8*CW:>3THC_Y/%"3][5,I8*6.EC&NU.2?) M1DH9*V5NZ\Y^N_'@T M#>,T8M?C2^FN^#./--][=U;Y2]L'Z97?L_&/=,\-O)G[C3&-.=?L%!C@6LE$(_&H+<: M`Z.$@5%@T-L:@Y;1MOK'1J&_%H5>)0K]75`P[6.C,%A+1[U*.AH\'1U=^=,4 MK<@J',1OS\T-`HR#X/&L/'%(1)Z5,PZ)R'/RQU9XY"JE$I/\U\=RR2]"5UY= M7][\Z^L';9+,IMK7W]]__G2IG;7.S_^P+\_/KVZNM/_[Q\UOG['7KW83N4'L MHU)TI^?G'[Z<:6>3))G_='Y^?W_?OK?;871[?O/M_`>.9>++XL]6(KW9]A+O M3.-Z^:]_$?ZN[/MF"AN`^YZX45)6Y3MYR%O6_GGDU<=U3O.7,&&:K;7R^\#9 MI5J-MO.%%@'B>HP)VM;FK"@:@ZN"!5.P7@_Q\_!!HSHT>!`0L`1,3?B):6&D M@;D6:^Y\/O5'5&TD"4NC3&`W6113.9L)T^ZS#7#%!@0IA3#P_%^4KY&.'#Q> M7X>YHPF"YX=>FXJZ<+!X%2%XTQ-"9RTJ0[08L^I$>X&!+S[`'+HVGZ8QKW*$ M,_MWK%P"B?TG]<&D1],4GG(3[3Y,IQXX%#'34#30J^P'BT;X39;ZH(5S1"C6 MM7LWP@O3,94G6E$K:`5\?)5TJ5Q3$C$7#.H'\?:,)9.0%V.BTDP"_YD;_0G; M.H>9:!"Q;A4CY[BS\9B-$@3?C>-TAL^!#(3Q8K$M">T4?I/X2!D>&R;;[Y\` M($3G)4SX'*PT0U1>0S8"8!.?E=9\`@@"LO!/XK?RW":'%U/9$=LE9K(-V?%=I#,-N>.8\2 M3S:2!TMFU)Y\MV4&7_V94=&QHN-3H&.E5.JP"P=@1JN9S+A-%9U3YT%%ODTF MWVW3XA3Y*O*M(?DJZ:O(M\'D^^*E[_959IN4AOXEG;'(3<+E@LA/'9T]7"BV M685(:Y88JK9:;76-(%);K;9:;?7^=LI>5]_77?9WK(9=M)/6+?_K2Y'Y]@;S MWMYN:=R^D'(U=;\I]"QU-`8.[E@=O=M=T['WL4!5D-GC+]Z]562MR'HE M67=TP^[HIK-#%='&%XE1#*`8H)#KIJEW.P/==OI*L"NZ/AFZMO6>-=`=N M!8T7[(]N9=`X)^>*!>',#_8(Y-:R=D8S*W[LS)OU`[N!%3V:1AF*GFNTV(J> M%3TK>E;TK.BYGHM=-WH^0#>:QOD650XNM-MS]'ZGHSM65]'N\X.J:' M%3W7>HGK";6B9T7/BIZ?'>RFT;,ZON!_?9?K]%*-TJQ4[_[NAXH]-#KV<*HM MRQ7-GB[-F@-]8*VYAZ3H5M%M'>E6R=HZ@*IH=B=9VP-A:[SX@XD]+A:=A,?P MK;)[QR9OX65=PVJF)*G=C:U=M&/CKVHI)E%,L@^3;-'*6/&*XI4Z8J44BF(2 MQ21U8Y*7J%`.4"IL7=OSQCE^6=/;`]QKV6.YFB:#`!?-"]/AE)V4$)+1:L2M MF64QM(G*:B:&%+LH=MDS8;RO=\R.WG$>5=U&L4O-Z4JQR_/=#5+LHMBE'F@] MO7;IZ8.>H5OF#M=`&\\N![FC]-Q(J+Q=E;=[2N?SBIX5/2MZKO42UQ-J1<^* MGA4]/SO83:-G=4]H19\8;IZM'G(([Y'-G)Z\M/&-T9[7=W# MIUR:;;N,*0)K$H$9;<,Y33VA2+%AI`BRSCIBFT4EZUXZ@9VNK%.A^=5_B?L; MRBX^)596=K$B,*4KE%W\$DA1V<6*P)2L>[1=?)ZXPRDK/LJVH&3B+AJ;TA4# M,GISG(:1=KYQM+4&\PWA^@5P_?84!O/7,&%!XKO3Z4-5DPTM8O.(Q?A(<*M9 MCFX.;'U@=Z@2KM71>Q;_F%U['N*EU!EM'$;T8C*)&*.YX4&FP0/))-98@*-_9_.$S8;P MJFWHFF68I@[0QW,V0IRF#[HV9",WC7$4YD<:X\U%[L-TZFD3%]`>,A;`X(G? MRE:BO;2-?VNU/@3>Q\B]G<&BM%K9QI>]"/'A[^=IW+IUW?E/'P1J7UGT'3&Z M@>UYC[O_RU__HFE_SQ^;S:?A`V/?V-2%%?GLNT-_2AMQF4813*CYWKNSC4^U M89>L-G#P&2QC@*3PC8W?G;EQ*QRW8&6,EFFU;#-_#!_$*F7TU._?K\XTCXW\ MF3N-WYT99[_8'=-R'`F93?,?#:G.&J3,EC%HV4;^V`:D.K9M=@=[(_71]:-_ MNM.47?GQ:!K&*9!:OJF$T-HG$,KN,C+((0(7^B<)%S#K"LQ^$;1X=7UY\Z^O M'[1),IMJ7W]___G3I7;6.C__P[X\/[^ZN=+^[Q\WOWW6S+:AW41N$/O(<^[T M_/S#ES/M;)(D\Y_.S^_O[]OW=CN,;L]OOIW_P+%,?%G\V4JD-]M>XIUIG.[_ M^A(TW)5OQ>A,VY`$E^""'>#!Q"+Z@3;V`S<8@2X!+1XG44I+ M!-+63304XC.^<)X&G\>XGG>TGB#D71#4H'$BU#%#-_;C-E]P_H`?`^?"V/AF M3&I@'ODCQ@?FXGO(<`0&$MO3DA#TUW0*@AP>CUFB@>Z8NS[]0)0\!A7A:E/! MX`\`+#X;1AZ+0`G2(^Z(=-.0)?>H$V9N]"<,-`=R]D?^'*N_(Q((RJR@!LT# MP='6+KB6:H'HB&0\)_#9C483OF:D:UB,YH2SX3(5`[=I/XK1;V$5^,L3L/-@BFS0!UR!-'"]?Z.Z.8"?SSW/7\[+/F?%L&(5S-()%89$4M8URFSL)YV<51OH? MGZYN_@&S]^<;`K>51O!PR-_ M?!PIN":P//,]+ZRR]TJ8'GZIET4S!^HS9SY=EH_+W!6G(%C@ES*_E[E;%MA+ MDF`]PCNX4XJ-%!O5EHVL$AL)W@E!BZ'K"0;")G69VSG,IY<\'TR2!"P*9+2@ M^%3PYVK&C'W8)S=:SY8X\#J>7CW.$LA!F(C!?T;=K?A=\?O)\[M=XOG!D*F>7?`SZC2>#_)V42<&%`D,UP M]A@P]FB69<#HFL]I6I>>:STWD5D2S)ZS;G1LW&+\/ZW$EZ!,DJW?F],$BV-']/ M@)[J!Y$2'4?(LVT4!=0/(D632ITMK6;#U-O_QX-R7[-(X,S93%-HL"GTCKE*]552JJ+3N5&HI*E546GLJM5\6E6X=UVQ4/UJ`-S6IY5UAWHK#JH?V$UKD*?H6=&SHN=: M+W$]H5;TK.A9T?.S@]TT>M[^..54CDRD[J*;CD::QC.*TVNTV'7C=$7/BIX5 M/==ZB>L)M:)G1<^*GI\=[*;1L[KOLLD3N<)&@RX5Q[W+VPR^V;H.ALK\K,61 MY7-F?MJZ,7#T@6%L+T(:GP"J&$`QP,M,?5:4KRA?4;ZB_!=.^2_1Z%&W7I9O MO6SNUKVG(Z62/U]@\N=!I$K#*GYSXKV%>TKVE>TKVC_19H^!\E[ M>VXDUAX9+WET]6!5=7YJ?`A%SXJ>:[W$]81:T;.B9T7/SPYVT^AY M?X\@KX]M=IMUCO+&?*M]9TS[$B9,ZV)G=LWU/!_ST-RIYOGQ*(UC^-#>\B"E MT36YSQ-J_9Q_E-&5]F]Q)25_G78TQVD8:><;1UM+#3>$ZQ?`]=N3G*I-F$9K MH`W9-+S7YEB!.TAB+4RC]27FM##07"UBHS2*_.!6&[JQ'VMIC'_',*\_]DCT7'&ASR.YLG;#9DD68;NF89IMF6MC+_ZP^FC:8`D3]^T,9^ MX`8C'^C5#^(D2F<$LA]H8EPM'&L)8"9!._%9Y$:CR8-V/V$!_AH!.#$@,/5A M+(Y.`FOEQ@G\S3;@H"4AS5#D<,Y"CTV7F>9H5"3O\`CP9Y$DKPA0\>!NK`1C M35&RC6`?WYT9_/,<)83X+(1YUW@MS;>V_XYXH]^4X$EM`IVK0.V^;G*[JB(# M^F`:IBD&AN(2Q25;HBO_?'BYFU526Y*F_MRXX^UH8:=,PCF'Z-Q&#=_^+<8G``Q<] M^[CQ*F738L&G&,'.6+!^<#?;>-[IRC7G3G/U[>K&28I/P6B:>B`2_``F34A4 MG)[2;J9P>'K];EJZY?1T9Y9Z_T[C!$\$%./7`^JG M9_Q=$KM/@>%/V1__FD:CB0L&OZ[Y<9RB;PY_HLD?LR29,CK[TU';*WZO!]3/ MX,@[@XYNGJ@7OV<,O%%,?A.Y03QF48SGZN(0?\N@ZXN(L.\>:&L&5O4V#5Y4 M_'Z/RV&-$S-2;'\YZVA/>:-NS[VDVW.YQ;'%_;G'0E5!:4X8N&W9@FE#+H_AZ2C/[O3Q0"?FK^`@]`?[ M3^H#G?/,U("24T=AX+$@AJ?A+S(GW`0^B"&U>,)8\H3IF(>@XN\W__H,W_@) M+/OH^)3]$;-C_\ES>6;T:,0_1VS$?,H+UHLOY^X#)>`B^<*740IT*1!%?-@/8)M\+P7*X.\-F0O@8=XQBQ.TJ`3[YU]%-!+) M`4JVGL!(\"J\R#!S7,ZO'DWQ/V3)#_ZW5 M^A!X'R/W%DD5K'M!;F5+3GSX^WD:MVY==_X3TCZ1_I4?CZ8AYK?'-T`8[Y'N M?OGK7S3M[_FC?@`N^6?_CGF?@@0`]6&Y+B@U_@OBZ[T[6_](VQS85MMH8S(U M&&8PRSNKW[U=GFL=&L#'3&!.P?S&[ MO8YI2*BLG?P(N'36X&*VC$'+-O+'-N'B#'J#WGZX_.KZP>()>X/PFK;AQ'P[C)^8[#1!'KT3Q(N(-O=!EG+*]U8@; M)<2-`O'>%HA;'7BEOFCWUZ+=JT2[OP7:+=/H=`8#N[:(#]82>J^2T`=;(.[T M'=,^Z(;[\3R,Z8[:]9B+@T5DEY\X)BNW[*Y5B=XR&`?'27#IC]C_*?"G[\Y@ M%=EAF/;';!K$/\'`[\XF23+_Z?S\_OZ^?6^WP^CVW#(,\_S_?OO\?31A,[>% M%Z_0T#[3S@^.87\7#'?BS[I@.-@:PUT9\<`8?@>GZWI<^+B9E;#V"8GSML-P M)T:L"X;'TI:MSL#J=JJD2P4@!\>J,;RW-X8-X+WX,Z6X7@3V^8L,"R[5/'57[#9R.82_8-6NA.1J*#5"&!\*T`8QY($R/99::76/1*-V% M:%G`(G=Z$7@7W@S<5+!>R8[]\&..84B.WOIGCLF3CFEU^GV9)]?#9$[EIO8-TS;,9\7MZ.QG`78[4^5$7#G5XS\">E1?#YJG&9@](R2 MVU[,NQ.`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`NO" M!7@:@NC0'6%QY3L?K_X">;:U-Y^N/KTME2YXF7=._\`^/+=N`"N&/()W-OV` MWR,EEL(O9F&`X8DDU\&<46&WZ<._&(!+NV#28M,;?S2! ML4?NC&F7(MRXD[!_K63%/[R#S,=-/>N\&?43I/1@]XB16V!.5&&W?: M8[&/;962B9O0'=LT@%>F=%-W#B(3F`O>`!Z)^7]%I>/\<;'3*$SP2F^VJ_*V MC_B9-FOC;>:(#K-U[9[!\%'BC_PY79D'$@(L:#_^QQ[\#+--@0)AQ(B!"'0# M_[]T&*YCYZ2(#1]P@/LPG7I:##_$XPL;IZSQR(R96HV4G47*744XUNZ0/GH,Q/)K'&`JQM MO%RZB$C0'<'&H#PQ.[K3,VECUFU5VPEZ3H((75U!'>(\">(%+ M';TSZ.D.R))UQ**#]!-]`:F(1&F,0>=U)E@2*M,?I@DZ3-@OCD9=&DX1S\&( MA[M97HE$4&<(VQ`9&S=F[CYD1H*HK0%[PWB8+LYD?V8JQ"6[`M40+^R![XB- MKK`T5E-?!;0RJ1-G!OHUC!ZH]`@W@$`) M4R$AKL=%ITHRCPKKARNW@]4,>;R7N^!\BW*VU^/O*&1AQ#_<"%S+)/X81M]9 M1/[1=70Y=?V9.'W:Y8VC7I%P>AWY+M5.@#WY*M0\RVTQV6`,5VKV[6- M3E_:N)6Y.!N`.F1,UW(&_1(U;0,4[#KM_B2<@M,4?P#]DCPL0EKYT('7U,3+ M0ETY]+8)@"/A=,`MZ=CFH".GKN^-TF4:1:A'%I`07Q]Z*X!/._U.-=QBRD=` M>L`%[MJV9?4'>P&*">?5L!:_''AA>Y;C=.4+WY63/AKB0RXPB#IPLW>#.`QN M;U@TPR!GEK7(`:[XX<`KW#7[/9""$KP5[ML*]X_+A)X);5DQ7[]F`](?9'.^KM]*W>T7"_SOS0[7"O>/RX.V_: MCB6GRVX/UQ.B?[Q=([RJ69=P;S"6_N/@[0I[O/ M^C@XG^R6YSHPPR`/B/%GY%RZE;\>-;)B&'U0N9)IM1*,@^%R--KNF6:O)RZ!2&/>RNUSQ_:$=4*R;:\@`+\WX M*%`/&"FBM1L>9<7BY]>TRAT[>Z('&%5PKS(%=H3\ M>/>^'-MTNL[Q(#]BM6NCUS.."/FQB+QEXK&([.YLAIQN3BU=9Y8US?I'#JP? M[;YIF/+2KYW\"+@<4('V^H[5?0PJO%U`.>9<^_V>\8QX M'Y2+7]]5"8:=&7MLCSY(V"N M>2+25YXG&(O$JBS/BNZB"ZQ6/W#<2[Q&KR_OR6HP#HQ10W;L)KS@B<2_N:.) M'[#HX2+P,#6'9W'*F*Y_])B[B"5-JK9Q/41/@/#1JCL,#+-G/Q+A2)3M(/K\ M$GYU>=\ZCN**'R7C;QO;:;TM^)5%WS&'^U`D6X*91HXOTF021GDECO6//-*R MI=&6\QSH?])6K07A"!@]PM-X&HP^\1M.J[#A/Q]A;S:@P.<](/@'WHA'@[^* MVP_/Z(?32KLA4#\O3U1,JJR4M.#`;O?HH;,%K8XC1^6W`^()<#QD#G*O:\KG M.X_'\7(E2L=*1S;ZO=XJ#"K#/7L`?,`EM^R^T;%W!)@N)E,![>)>QB7=)",N M%\!O>$HR.^M:.^R`F![-WK1M9T'G;X!F&Q2YHOH=[Z:#[XZ7`.^0_>CK]WA9 M&,9#`J'+T%^G;A##8],4+P#2'-=SWLMY]?(<:(:C1@7ZMER%\*AXG-RFU-V) MEO!?2J9?]6/#)-9.>!W/'^ZMED^K;P[(3V%/1Z#"W]P$FSH^7(]_H\NI^%+1 MZ'$)P:W>:MB.'GDECG:EP%I-`EL!MWY%KL?PC9>.2%H595LW/W;D\.5JA)=! M.2*&]9?$,S16/G!48ZQCEFVQE5`<&*&C97W9_8&Q%TK? MV#P_P=2],!VS8TN)`8N3[PGO\7PDH].5;UML@C=F;C2:`*-<%64Q MY(/6M4\<=>5[`]L9=&5,UD!R<+2.=^=P8%ARK]>G1>MHI_W]OBG?3']:K(YV MUM\SS,&^6/&BU2AG=N^-&[4%B@0'_<$PYUP4#IB.7'MTG1N9H>M4Q9!Y\$ER.=W75[%O[;$QE3)8C M4OG348,=1L\:R'<^JT$X``;'XH]^;^#(&:>[(?!K&'I8).E+&+#9?!H^,);5 M)*.*XRX5`,;;]!^GX?V'\9B-A/?YR#&.N:D#HW)#]X*SE@MW+%KJ&'+7AV== MN9)\V^_=!H3(GVE5CE:%93#HR.UK]@1Q88W\V\`'TQX#@#RJ!)KE:S@%8Y\M M=';8[M''BA[5O>'INCJFDX<>Q%1)E.A6?KCPW9U MC6NU:H?N6`$L'_L>BS1W*NH/@^DVH:85`747&+K!GS$O:3_Q;R?3!VWJP[IY MHLL%!5^U>S^9:#-^].=GU>HCEM<^#R.`(X9ADE`;,CZ/5%6ZK5TD5=6'<=(K M-A+?FO2M(4HH>P09_&M*=7RI"+%I='2[VZ/W7CDZV()ZU[:P!'8\9W2:-GW0 M1?ET[,R`Y?EGX@0AB-.HZ"N0-8"X8O,0Y(WV"7_&B;3+,)J'D9LW@J#RR$&8 M4$WFR&>B2C(L$_4XP-GB=`14)XX`^%(.V=0'#YI*OT?Y^V',VQ#@Z['$YKPE M@1;Y\9^X/:.,BI?6\662<99J-^:5[&#;>-5K)&Y>6SOFVX14@[O+R"3CO2;B M)/)')$$Y76/55OB!EA9@=V\9OY0@43OQ`HY7M%S`4?GVC#6,C-`7LS!.JKB% M-P)AVIVX.DD3QN&,21B@C>0G*4_#J>JP@3U(0B(<04NZ-@GOX;^1GG<9B9F\ M!/?^%%`B69(\\3',$IX3\JA-'N.VQ#K0&,2 MWIC:`R41/(%-A_('2",\:"EUU9GX,7:&'@'&A4K!Q@U3/],.FGLK*OIG0[3% M>LH8XSK>@T).&+;5&6,'H`!`9]@^)PU&X72*.A'3QI`8PSL69:I[::@Y+EF8 MQK`:\H@X`SP61MC9A(87HS*O.5+@H%3-TRAY7R84C:],W1Q8NM7IE'AK8%UP)!,>./?O=7>O.ITL$_36WKQS2M`M#.`3]1KJ<2O M)5:0S#1YY.90\W/H-*F;?6/6Z5@+P!VJ..NXPI"PN#`G@SVVFXN(-&U6Q:@\PW&!@8A120!#)\Q M/$ZJKMHCPF0P7W0MG+E^`%8*"?D1%0R@1E8\H`HXH5].M\X\B@7,$VZ^D*<> MB7$D#QR])2_O$)A#/V;D">6YNF"VSMV1<.C(,L3D78HXB#Y-8(1R7S&#E6S= M.5'^?YMD-3T+WU)?3;[!GP*PV6]19;]0G9,M1M[>#:@,''U0-%-V2^WFJ$Q& M1N6\RR.R%%!LN6LF#_2!?@E@@`>^V@$\PYT?(WA[UG,IBBRL7\0[RLIS!IL*#L$^8_?PX!HY[C4Z9A' MAD-R%&-8HQ'O?HP/3%G"%GOAMK7KH'4;4CB.R#CK=%=0,A*P6)AQB)9\*YUS MTA@R%A0RGG3'_Z9$5P;Y-/=NU"`)>]BP$^=2KKO%$I'K#BHNX]UIP4[4#9*A M6Z8[MG!=>WK7M'/WE"ME_&&['J;N'E1<$[L2PZRQ^C>VK9@Z4=26A'`MB1J')'SF"LZ31&NR^XQ6-_ M^CS'KI[B\[WO)9-W9QWCM31?5/SI9?.^O_YV]>%;Z_WUS1` M2\&T94(]3[R*3?QZ<77UZ:PV`OT#W\:-4("]K(B\^??OV2B;Z=\`*T@O`^64^!+^\GX$">%%=:I\>5NW)5/:!^ M!@8V]5[7?ED,?(J*U58L7`^H%0LK';P/`W<4`]<#:L7`2@?OQ\*.8N%Z0*U8 M^%@L?$YQ](V1^%H=J#Q')L/G,+AM??;QC)?7=VO,:AWZ_E&6BYU&VA0794J+ M0GDS,2;.B*JDV1$4YAT$*>4&A1'E[&`B`%VY2.A:PFCB!K?\VLW(CT;IC%\U MQ2\\?^32B;,XNL(<\X_9.3R,_+(C\,@.RA;!Q"F/Z5)2J?\GA]3P@",A%G$ M=%5EC(=I='"'V=?BGA5/I$J*:TTT5B46G\;BFA*'G?*2Q-6P?#A_ADE+S*.T M`)XNP+^BE#'^C'2(NX`QS<\1@T\\'VH%UCFH,65G,2]>R!\;PZ0B_Z#T>"5J M'XN'`20IDS)/N<]7$-;;G3[$I71CD8&)`[CB.DY3F/5YDH&Q191VX_YXJ9E9 M?^19Y'04[O,%27!!4"SA;Y%'F8F4')-3+]'<-+\3EF5/YI<\D%*7!L3DKU'D M#SDY7WR_U&["N3_2>AVCDAFH)O2&.75@$M[K`2?)18+TI"^NETCX>L13_'C:8%\$8^S\8M[`RI4[,15(U8M2D"WX*P0B$&4EWZR)=D>[[9$+/ MQR1:%^PP>/L!^1YYNUU>'#4BZCVYOL^D<-C3^4R>?(9P- M?9[\+,S)F.5;1N4&"D)()D0NG%6`*O*=15`S,"^[, M?4XB/"41A59I!74*@81H(,RG[HC+LF+'^$U;?Y;=F->"E%+!@$+PO:5U$94= MR%$IMGT&&/H\O7W(4.G'ILG1M.W7HW(6UH+R8*H6I27*6H^!5I6;RI& MW18Q7C_D3D@?6D78:[`\*`M98D,A?(#E(X]N[/D\>3V->=T#*9L>'^6;X><7 M@O"*-&Q,<+L@0K"Z!QJA_.X0=6G*MKFX*Z&A0LN=VPPF+E?@_3D2(E>7J'!P M)*(!L/S3&`1@,>`2NSQP(]*-@B;1Q//8B;P@LJA#DU]2:,RB'6\UI"L;5??K MR(;,;FRLNLZ3/_W*Z1FZ.>AEU]![`UMW!EU1GV7=I(>YC5"&I=_7S8Z`Q=*- M@:%;IG4L6!I[#>%9JG>%U,LJRBVU2UX7Z9L?_]F8A3OHBGPLU0N*R-%!BY6L M@'F((7->ZR=.A__&8C^IN'VUL)!2@2D]N\&.CM?,C?SI0U$3I*)@11LU+%WS M`&N.[AVF44QAV:PL$*F_S)`5,Z%VBY>)T5 MT5BP9YO=_\4Y;7NN!,^@\C&.J\R"J<]%*Z5Q>@1-(EW!UZ399H=23D?N")#=`,/^U!HJ2"6##< MP'Q-[_=[K\OB,Z,%NB^6FT#+V_&W5NM#X)7+02X?SHL/4OW.K>II+I3KQ'9Z M>%T2*!-+#6"\`4MS+GU]\$X(SL`R^AVI%\?RG(\`]9"-#?I6KS^P[1T@38<\ ML)Q\H(._A;*GJWY5E4Z;4^G4M+'4:;Z3&M_*ERE8KU+T(K7K41*B#"7Y>9]? MQ+2Z>K=C:#&U_,RU(;6)!620*5#-!DR2IZ($)AV5DUJT!P.]:YA858%1W`V\ M'8RZ?@I&;>W-IZM/;_GXJMCDALV@VFS@K=]BI@'L1:^G.X:AA:)CJ]B)&@K4,,8\8B$D,<7DHJ/9O52>*Q>56W]%-DDQ^#@591XS%J6M>M4S#-TPC+5\ML@O)?Y!@W3'=P[9"X3& M7K"W>[U!S[!,J3'!C@`^RXH?DG&NB\&&G%R!R'ZM'Y)QYCV&_XKRRB&18FH)`$$]^57H/5P>3U M,,I_W!5G>N-\W8C2=%_9 M#5I6G@R7_%)@D`\N?CG@"BV=`S9NA4HT=/`5JCC4;=@*"0R.N$(Y#364RXSC MTA`,GM.0T\@5RC!XQ`KQ;^"/_Q]02P,$%`````@`1VYN/\[T"`UZ#0``3:H` M`!4`'`!B8W-T+3(P,3$P.3,P7V-A;"YX;6Q55`D``^5BP4[E8L%.=7@+``$$ M)0X```0Y`0``Y5UM<^(X$OY^5??E<_W;O#&"+ M3=TP&OQ'K_VSUOMD&+79U_!"FSB_?>*_%HCA&BCML$\+DWF?ZXF[+RAQ^+UO M^'WT00N,":_D0JW]M8$.+GV!Z_3.3?C/W:5G1E M\KZMFUC;.NA?JX464-?&3WA9XW^_/4W2M>?_O!FYIK_"CC=TK+'C$6\[<98N M72$/``8%@KN]4KS\7.-Z[>8BA>Y< MQ\(.PQ:\8*Y-+.1AZQ;9R#'Q_!5CCPFI99H+5JY:,T0!QU?L$1/9PCJN$96N MYMR#WYQD-EU.UY@&Y(K"R-QUJ0K>(?9Z;[MOXOJ9RR(5O$6,@!HSBADH)-X. M%L7B](1-&S%&EN!-XG11^%:16OR*RP-'!Q\4T>4.%-K^YYYI! ME`._6:W!@<2)80NS4$W(BQ.P`C'3-%T?@J;S,@-/-HD@-`P5ZBF/KHX87WA)E'?=/SX?(7(=7P$GE6 MH0'Q'A'Z;V3[^"M&S*=AE!'29;E9%8W2FDO?`26&R/=EH=WKQ/&@*9O>"&^( MB=G$,2<6$=*$6(18A>H",0X?M"+J.O#2/(,DBM:%NLO<7\.WN7QDQSW1N1D1 M,XNE;.XO&/[N@T[CC3`PS,>;?"4@4S%].S#M`=['UQ//AB_H>K/6J.WZ9GA] M-WT2R5ZUY(GA>JC]\]#-^P MPC0W-L!VS>@J&RVP_;D.'_SW@:`%L8D'`?G.ISPKT[IZOZD9;:U["%XR45\B MM@BR:I\U7A!:!]G]#;8]%G\2P-S0C4;+"("./DZ1=Z@ZZ(0\E\;09^H>M88X MH,?Z&ZW^P)!F0+I0(2,2'C2DL3U+ZJ[$J?!<8=-=:F$*]6.]]A9D)L'+-24N MA1X(/+9>\QGHZJZY/OLL'%'SR!L/BZCHBAOFK\*6WB#@]8<(P#5"%(ZAG;E; M#*W;YCZ=`H'1&C1U:6SFRB^;V/,`B3AN:KJN-,U3J/4H^"SU3YK4E\9QMO"R M"3X#BHC=ENKLCO`2@_;6$X8^U]\%HRX$(VFDILLLF\Q\RR,.VZISF*R,8C/Z MO4Y7&H$I`LMF+\?FB+J.ZM0%$24ME!CMOKR>\X34JX33'.,C(KNJ$SG"E&S@ M)AN:9=16A7,V;'>,5G9Q%:B!$F8 M\.@ZYJX?,.1EI*DBK\%9NL%5J2H2A@P=*QCV?G5MT)V%PZP`0;=7!HFITB\? MUTBQQ&AV))IRH?+BSBA(3^RA.0!4(JSB1CUL7A*&,[K)WF#Z*<%7X%*0104C$KILR*,82]1!^MM>77C@:S+$QX^ M>\A[!/C#X^4&V4$?X=TA2K?01P23TEJG/9`WG"&D0A'.F4?/KK,\%Y-*1)QX MWHI/9X--$#0?L1>#T>XWY57'69++Y%44@:J$FXG#)]I=N@4SM-[`D#=BG)14 M)F.G+*Q*CC:C>(V(-7[G:\%V`]V#=JLCC:I4D65REFMS5>9E0H/!TM9`7DX= M"BF.GQ1U=^'O)(&5Z+]FU%UCZFUG-@K7@<E4Z MKG`B/K`ZF?$WFRUY0S.I,DMA+]_:JG1G]\2!+S^0#;8FCH><%P(Y5&09[Z![ M37F-,%MV$42*>F7,JS@:%8FOR7X;HLP)/-K0<924O9Q2XAIL7P!/5<(QF!:N MI0E&3\/JUFAV!_)FX5(D%L&IT.Q-@M!,JRO1:/FXONLD+.CT6_+&#C]**YVS M+'.KTMJ&ED5"^3.()Q/G#JV)AVRM+;.`/R&T=`(%C*]*,O2$/40<;(T1=8CS MPH:FZ:_\8.GP""^)2:`ST(V>O+XR7X'2Z3T3$X5&`GZZ^0C&`[P7WX/2%MN# M,G^&/U_'C\_SVO2^-IV-GX;/$[@@UNN2W2C9^V;/WI;RA;J,0<6Y!+)Z[9:\ M)"`AZ/+YBVCY+]/Z_6Y+8E,+I131H#+QW3>D8[,JDI`P;[J,U->Z>E->GW8@ MJC1F3AJ8FG\TC."M:BQ!?3IQ(*K@![!8ZWP^-#% M[`/>+5ZZ%(?7/:-WS,;O'D7`"G$0W4X`JZ!.@V\"C'#[EV"/*6:\9M,EUCH2 M-2_"Z7-<83\34P[^E0AR.R.CT8!;[&`>-*!\U&4[TI'4TIT@V^Y*A4'7<4/_ MY=[(;8L,XRM6)(;$4V)_)#QNH"7Q)#"\X;YM&6V)@^JGQ!;BD^+D)*>+2)VH%E?B^A*0%!HLR![?6[G4([\'MYDN=\>H\+J!:1U=8D&= M)?E*1(N"D;KA4^$6SKCW8O!?2'+!'I^P5^ZYTR4_4`B*1XEI8*[X*[9I85BJ MLB\T$:@(6[N,A(X*]S\Z1C:?+.39]&NXVP![4NA*'?C)%7[T)Y\!1E?G4Z2$`X0A& MORLO,*<(+&1!BH@=.Q;3AZHK4=ON#(U\E?%5-VUYDS='\DIG*]OB*HV8?<$. MF&(/'6MHK8A#H&0+BK==T=XVY*V5SA%>**T9OKEK@^)85*)=SG$P+`_V?$7T M-YQ`03-TF>NK3PLNFU)!"*JS1(5AN)9O9AOA#;;=8-'XSB*C.9`W-)PINVQ> MQ8&HRBC3"*\I-DF(#D2@Q#B+UFU+;*P9@LMF51`#!1/9'!#*G>P^RE+24QK5 M^C`E,10JR!1RR!]=]M:Y9-G;W7#^2^W^8?IK8CI[&A-0N.BNDTY4W9""NQ^63Q7!S$V,K:!@3QGQ^EO5T&3XU MX1O@1<%S`5=(9?F)*OSCVX^/-.`[T?BI[+;/GXT3K!&=!K[*>./HR"OFI.I> MT%**BQTIL=^O)()4"^HGTM@UVD8M/9A(,-K]CKRYTX_B5/&*3!BJ-(@PVYD1 M^&7LX>&DH*'WNQ+WEV6(5H5G87BJM"PB&=(.#FX:=$KJ+8H^M:KH0'\*E:I4 MI.F=5F+'%A@E<7]PKG@5.<_%*2)?USIJDW\"F'!!WA$P\D:=Q/7X@?0YBL_/ M[M#\[A.*OR+SE3B8;I-',VA&4Y>X(T5,"8D^+T3MQR[M#,B.,],*]&Q\2C48 M/.8/$_.VTV4XC,Q#^GZ>%=IW6UX+.%L=97SD1W!4:$CE+&?A3W#D#WP-:KEP M%6H!Z7]Y-*;S*[S(.%>-J- M!9^ROQ*#+LG)%7AMX[19%J,E,YD344$5LL^&JRHK),-S&OY%'&L__='2#8F% MW)%`53C.@:(J"R)CY8,!I>@`#O([MO@V/HFGP)X2JPJ[0K!$'`]4YSA]4D#K M#B3FENDR5:$W'Y&X6]95)_'P[\0Y?@R*UNFV9!;^^1JH0O^Y:,5NT*M$HG!D7/Q\%8Y)IRLQ^F>*5I?\ M$_C$K/>KR3HO@J;+)63#\4D<+5W7T\;Q%R;S`DKU04L/".6?B-Q274ZSK8^I M57Z$[]BPZ(3Z472L>>I)]>#%$O=\7::3NJYR+J+Q*@2]FG$A[NJB18A\]LHT MJ8^MY)-2H?.3MZKI,IW4=:!S$8T=R*A>](D;27PR+G^21IDYY0?YZOI$%E`Q M_\JO8]K/IGQQ78L_>?G1=?!J;;M;C./R^!D*9H9,+FJ_B[HG<<'`A5JIXBM% M@%J5U>+GVAKO\!M#YF8&^R!Z77DG3?R@=E5UJ"R04T_H4]"Q_M#'/14Z'2)V M_E.W"KGLX3&3O,(;$1:D7I#"KXB_TCK-OL0''.>)5X7\LW"JRIK:K#-&^8$? MD85\M+XI\4&N@EJHZ0IBJ%5EE7WZ`]QG&-2T/B;D?&&NO(+V'$V*\(P?LSRQ MEQ+]@_]:``3PR?\!4$L#!!0` M```(`$=N;C\\A1\P8#L``*!0`P`5`!P`8F-S="TR,#$Q,#DS,%]L86(N>&UL M550)``/E8L%.Y6+!3G5X"P`!!"4.```$.0$``.5];7/C.)+F]XNX_X"MVXBI MCK#5U+O4-\T]E>V:<4RUY2NYIV]BX^*"%F&;.S*I)BE7U?SZ`\!W$20!$("@ MZHW9:ED"D$^23R820`+X\W]\?=V!-QA&7N#__&XXL-X!Z&\#U_.??W[WZ^9R MM;FZO7T'HMCQ76<7^/#G=W[P[C_L__[?_OQOEY?WX__SX?.GR\OTS[0=,!XL M!U.0?_T2Q_N??OSQRY\*!92:?7+F)0=+I?+'\FO6=%:R7*[XQ\SM.\0 M?@`2#<)@!S_#)X#_^^OG6SIZ_../U\'V\`K]>.6[-W[LQ=]N_:<@?'5B](`1 M`-+:2PB??GZ''\-EIO'@:^3^#_*-ZT`O*QA_VZ,7%WFO^QU\!WX4`G05^"[T M(^BB#U&P\UPGANX'9^?X6[AY@3".F&!MMX^17ECW3HB>XPN,O:VS8\:X=T+E M,#_Y&C]M-[#D+QX%O;#7/7IS[)XA M>MQ*1>(]^^2M(&>UW08'Y*W\YWM$H:W'^&@B1RJ5[X(8(JO_YCSB-ACD^\'> MD0G@YO<#('7\#'^#*,X/&SC`RK^S`0-/CFQ*]43?72\ M\._.[@!_@4YT"!/S9L+R]/8J^RGML?3\0;$]D=^?I/9KMWZ,3'D;7\,W;PNC M6W][ZWI,2#S7\URI6)"/@Q4K"@,??=QRO*30V4NER^:P1[6Q?&>7=0&\H4BT ME?O*-H?'"/Y^0)ANWI@?3'2`;^(@GISHD81VA^CRV7'V"9"=\PAW/SI?O>@: M&>IA%U>1E,/-6@,8X8]P%T?X&]Q:1$!?6L/+\9#`IK0K%[@/OZ#>?@OW5P>IG@=N$>]>@X-/F$-:#"KE3=A>%QS4OHFY$*O-RD;]!V4_+2/&Y3^E&$8<3N2CJ=<:[(9-.D\/J%/64DOWJ&BI#:P MK"&X!-GL1?FCX[L@F',(M)/-R2`R>NH3^Y:^;=\!SZ0+M_`N`O_GSCP7";MI<'<*0#%NB MK;/[!W1"U"W@+AB]G*5E26)0DY!^9.*`GO&JLJ@F+`\8NZ-+!_^9U?B_*ND\7)PEGPO8_(2>?B>$GO(0VDV;I<1Z4HD] M+1%[I8;8B<=/!F,?T7<1[G>G8TDA0Z,4.?1F`7],:4J=T?@L2-R`7)3L51C-#HC*A[AUDO$JO`:#4D( MVX.$^>Q:/A:92:9@18(<`G:!/J9?M?S8[-%3,VA=Q*M)+EB7>KU^8Z8'!(@X M#=K8J`_5<,-R&-8`\9A8I-CX/'Q9CE47C3*!!7OP-WR422+!*U0Y=':WO@N_ M_@U^PR]F+"MTHTKH1R)6T!F;&LI;0Z-YU8):-<.:1=OIT"']#9`?`?I5B';! MZVO@DW2?)-MH?8A).J;G/Y/7*H:[[.0@3GR1KVIS2O@S6=@&NTK1:>FGV6DP3 M9#TTK,G-:$=^`-DO(B3[#)\]/%OCQW?.*XFCQK(&MC0!,FC6";G*L^/BEMEC MBF;0>KA&D9RQK?@)X-]J="M_\0E]8E\-'X%+D*=1H\]7Z[OKF[O-S37^M%E_ MNKU>/:`_/JP^K>ZN;L#FKSU`Y<^0I[FW0[^Q6D/U^`M`"? M8^]ZF?/OA95S-E;.R&Z]_! M.'NID\5HHMQETB3+H2B;3L<\I=8:SI.H&K\N+-B(HB%H4N0"H4$^/VOJ6 ME;K5$S&WT,VF@%9OVPK%?@@=%P(G(W18(K0/>7GLNE[R].\= MS[WUKYR]%SN[P60Y[%I*ZD%ANM">[&75)"=N4P7#AX.MN)4[VA;A=O$CP+\" MSP?I[W))J<:OGH*4=6]*KT",?WR>Q"RPZ_&A'2C*+-VC$I>(I5LAED81C"/4 M['C9M930@Y5$2$\2-@'-29<46,RG9D^Y5G`J]W0E87;R1S]^#*?G0I`"Z1%# MR*C/<"=41.9H.N]9W^A)'3B9O%^XJC?)R MR\E\?@9D.L*KQ_%4A:8.2#B1MN$%J0FDU!.K'C95RY&\Y+.B5H983XA$E6VO M-IN;A\U/(LS*)V*'UJ1KL;`OL^3,=73`KA(K*[>PQN<0(57AZO%7%9FINQ*= M6Z._&Y7QDTI.-453I8*CN=G)_73`&F.K(]%IB+5--P2*AUIINX4K7"Z[MC)+ MHIK,_K%3"RKQ\N+(9,^AKZ3#UNK=JK*/O5S/Z*SI+2H,TC1RL2%DJQ7'L<@9 M];$UX!H#N`8(^3YID4D+?%35RG?Q?_`Y8V_.#K44K>(K)PR_>?XS.0%M,)TL MU0U,F2#THZJ@EOG6?J;JPZ'ATVD\:JAVLQQ8;%R(;*$F'TK%+X`3@ZP&(%54 MLE^)8S:._37'S?JJD#-:?A?\3Q31XMBY(!6&L,4?8%&!D_7!ZZL7DZ,2L>R` M'*$(?7P,Z6`XGHW41<0MDGM2G$NEG-EMM89+R^Q!&@-ZY5Z\$X)=*I+X\'(A M!;Q5XZ1/RMNZ1U[_\LOMPR\W=P^;U=WUU?KNX?;N+S=W5[X7<,G&(;0_0S?H'_(MP_,QIT'6(H;`EUF/W-@U2,_\8!>?C1C.B"KL5C=X"P?_6A M$_J(GF%2@)>5H??F8`?[R7,>O9T7H]@V?Z?3SNW`?;C9++DO0WET*GC:4FLT MGIM]R`<#>O5.M`N"710!I3+"#I7A-2MRJR>E+L7%MM0B\9W9B9Q,^#4YVVXD M91;CZ)B<>\EY^L+K?A=\@_`SW)';'BBRQLN1NG6W3OG]6"RB7GYL0W?=T61I M]B9)9AU4NV16('96\#),2DIPSQPD4.*DS>%XS5]WUDVC.\,/:V+70HOO9L=C MWSO?D+0=F7;(&`^_XBL">2=V/WJ^%Z/.X@VZMWZ,8'F/.YAD8]S!>#"?CZ;* MO'B[['[TYM4KHW9'O?%\;O:$,!-^U6Z;!82=%+HDI4!1#&29:G>\^X,97[D2 M9VT`E6M>NJ,>R4\U>_Z"40,MWID-"_+,<9+>P[V]_=;'%QT&X3?R4E7N:2]+ MZD?-=LP9$2NE)J@',YIT%+2J_65=I)U_)>`(J6]%B=M3S*2:2ZN4(B9G]D"* MBE>+NZ))+DC%QZ=2)#I86%-U)QV5!/5C4ROBC$SE0A/3M[74P:IV2C6)=NF; M_@12LT5**8/JNZ/*I?`FJJ'9Q[31X')X(_&=413!Z;ZHG01.%;L*K,E"AW.2 MLPF%20,*T_+"D]'Y\.T(M$;G595<=F+"FZ#:WIR2.$LK]VI1%[4PGHDR._AJ M@ZTE!FL!8'^Z77VX_73[<'NS$>>>[Y)$J)=@AUY"A+/PXV^HMYJI.^.G2[H\ M5K+I1J,HM>9D-#D?MK9HH--Q-L.H>%%R0R3Y42Z32XZI\_X\=8R6[V_Y=&5E M>*F;FYB=ZL&IR:D97X73P'PIH003,93'%P8906LDTMX"[F:_$S/(=-$>L["@ M*@>*0M5"7QR=[89T%/X7/ M^:K[8G0V@[HJ9HV.NB*X[)(%2K5I&N=M:JDAIV-OSQ&K7L.ZTC^ MT1$_,J:TCL_+F"RTC.FD'K+"H4XS,XO^9F'XK=*=V/7[QRH`JI^4$;@VO%W5 MD:IFLK8%H[3C;1;G2]<4O>Z`LP%'?DB0C/6G._3LLN/_YD,MJP6%2&D4;=." M0L]2\2EZJ.?"RQILC1[T6';5>1:_RB2B\E!3#Q-;`\Y2>1(]F9TBW`Y<=]A9 MAY`MH@;^\R7RP:]28L]"3.&)1W,M\6==M`*B-FO5RM>\VG1HF;U%GP7^25QI M%4.32Y41DK:\;=5AZ6DXW!:=TJIA_W$V"V(M"NB.49NAV)]R+RP>J*(F'E`+ M=T$,LWL,\;4>"ITO16)/OC+ID-.45GHZ-'R710MJY8ZU4;1-OBJN7Q4.4MM> MH!KOJ9>$=5])*TW,VO`Q?!MN/9ZQ!4')(>Z#$#\H?':.3TB:7L$*WOLPQM^Z M7D2N",2?_WVY'%TLQB.RO/KO\PG^P^ISE$X97'[V_WRJ;H,%16`_.C-ID+&9 M5A@Y"+-'6LV@53O41LG'_E1H9:GMS2GQI5JY5_.DM,)D&L_L_KP-MA8_V@(@ MG_ZL>$X^%J[C%QBNMMOPT+C36]U4:+OP?N3D5BPC:E?%Z=+P*]?9%%#M/)E0 MV*042(M).)J!]:TK<;`FT+GF=[LJ8E=B]LFZC!IH\<9L6%):.RFMQ(K4WKZ@0_D\;.XX*?!?Y)7&H50Z-G%5ZG8GO="H/7$Y*X(7)MJD:< MR#D$KET*:(Q;.Z`<\;F?*Z9&QY.%NI,?&Z1*H"Z3*A764FHLEH:?(]$.7(N[ M;9*>$E/2]$#;ZU3G6K4SD^Y/&\\./(-8M@V[/B_:@B+E:18%!(\[[YF+M:'*M. MNG:ZU^.1,K?(;!5VL_=A>@%%^;JJT6RI;L&+(K$?4]E4 MR"A*+8V?JM'4;$&MVHLVB[;SGR1<:M;Z%I5X3KU$K/E*2NGTNBZSLP%:<6OQ MCVT(2IQ,[SKS@_)-9Z/6B\[0.Y-LLJU\MV&6=_)T%)W0"0; MB-X<%U.T1'NF!D;3N=G1`I\B&KPT.QH[+0W2XB274,X2&2\_5'EVXPR!YO^9 M&L#SDL;W"#R:Z.HC.##9UW`?1%YZ$W!Y-:X/^[/IJ.5DK.Z:"*I(F=1NU(). MY*SXS)J9/=?;!ENOMZ[(/O;-@K.\[>]0@]?5P,0.EUI.2#+\?K]VX"=PF$<0 MAO&W>R0Y1KX8'Y:UQS>OX^/7E[.)2N_8++DO-7ET*AC:4FLV MGID^"]&)7KWG[()@9T4N`"F4GT-(B@E<&,'TIA5YU).RE^)?6VH15V'ZD(T! MOR9OVXTD)S)A,"P8S'UYSF<8.YX/W1LG]#W_.5IMMX?7`[D8[1H^>5L/YTD. MY^IF)KH!]*.SD((9JQDJSRW#$Q>8=5#MGUF!V%E!D)4$[TME05KX!W5$5^*Q M32)ZS7UW5R;3J&/+[&"91PTMSIP#D%WFN)O\R$?Q38SJXGY@_?31\QU_ZSF[ M>SQW@5Y)D4]HJ=L?P0*@'\F%5,Q(SE09][`SLQ,GN?10[=5YP-A7Z[OKF[O- MS35`GS;K3[?7JP?TQX?5I]7=U0W8_/7FYF$CG!Y,.71_.)HJO-1!]C4.3`H4 M;*X7MA9CLR^F;`:MGJ<-DNWR+W_*CJ5?Q7'H/1YBUUJMD0 MI).0]:U`M-*X;S-[-T4+:HX007P34+/\=`=05.&G8&30?!S]?P/7-Q]NKVX>?%%TYIOP`VU/>.58/%![6#ZM/I?M/5G?7Y<>= M7'Z2/O*D,S1[BDU('RW!A0BR^@6C9):9+0PI?_$)?4J^K'Z7*>'%6'>B&$#* M@DN0#R;19[:QXOND3WF!L;=U=C\T/M;'T/,'V^`U>:)7@>_BQ4H7?8B"G>?B M29V@1I`H)\;$%,Q\P1,M9$?,;M;X]!"=:#&#L5.BF;YV:@T>L2) M!;I)MC9`-0"IPM?M<5%"2<1F%NMK01Q3;>R,S1Z5\*BA):SC`)2Q/\T$S]/` MP1YQ/NK%>2(G6N6YXX/I0N$A<2V"I5&\6R,*LVN5AA/#+\KJ!J_1>],1'#GM MI!`H2LDGK6K_K)^T;>ZX_M2QNS`[]8H%OF[WVP3DR.W6]MGTY&^RNPR_:75S MF@U")?.V29-&SJ85T&,>GTW40$.NW<56Q%/]J]BNQ:Y7JL>QZB!GMT/-GC%Z MR(;?HM4%_32.M`J"[D1%]B9>P\?XUH_B\(`G77[UG5=\WCSRP]?IL?*#V7"I M[@;A3O']>"N@7<;@[JK#Y=3L+!%6%50[7$8<-BX'BH(7H%049&55T5N),S:& MWC4'S?!.<+QF=LHVNQ):G#8S'+M,[.+^#K_/.?75?>]WP;T3IH<,C*>6.@?> M)+8?L3F4H9^84*XRG!F>?](%7;5_[I!?/\GCCBSD)U/$LEFJX30/?2SM.->C M\JB19S#[R*Y.[%J<;!>*]C,^^K"U-J.Q'&L["4GN'!FO7G3VUNK-D"9GQ.`& M_'J]+1U$W>7VG.=E?.,:G.])F-SAA^ESE68/[A@U.(%/;L)2]\P])W]I8M-Y M$O3BU>7F[N'#5A_!.O[F\^K MAUM4H$^V7BXV6C^M]S!,3C@5SM1;)3,RI)5\)YO_?!5$<3286F-UH7Z;Y'XV MRJ=39J7MM69FCU*[P:ON53H1V.42^-K>O`P@A?CZ%:9W//D>B3OA8R[VC2.S MT\B9\#/P=YGPUX?/V%&*]3(L6.QTFP_N5G#F--CB7T$(DSWL<0"^.&'H^+R< MQD+63Y_A&_0/$,5B(W473E=$]5TE;T5=K(V7BPWG4[,G36APU:=HU&3:^#OL M+--O91!*40*&8D)1DBTJ3VLTM$9FK]O1`6M*K*"(SKD5.3O>X^NNX3Z$6X^X MR97OEKWF8#91>'I=B^"^J\H<&A7KR\,:M[,CEK*='A^[X(H^J'8IP8NP:,D?B(O?>WM#C&>2IY.ANKRQCJD*R!MJVJM_"W7'"VF M9L]_,FIP$@];@]'L:TDHD!96Q&M]+E@[K]G\%'9 MN$)F#8$/W+P6R787F$(K(?"B?7J(\_HIN1H-4T-=Y-PJ6AKW6;2B$)Y2C;P# ML\>";`KHIG8S%!N7P$3&ZW!X/4[DFKU"T@:ULG[:P.TA3*[*AO%@H?+2X%;1 MLBC,I%6=PK1J9/G3[*--V!303.$6*#4*1WDI?AI'N#&(!-Y\C5%H=/"BE^2< M?;S3=#"?6&JIW"J^/YTYM2M3NKTJ\29F9T"P*Z&-VDQPK:#"86=EDI2*"KELOM5U?!9C<,V@<]U9]U>,9DE'9J]TXY9!SVNFA&-?<1H M3/+GI"XGJT/D\N_)Q`MZSPKGETN">K*U#7'.S%*A\61L]IE4=;#*/>BQ1)M\ M`Y*O^C-(S7GW2BE4/\6^7(J8G>%],P4NA\\2/X.>(CBETUZ`3K?^-GB%.!#] MB-[75>"C2/2`@M%B#]@'^!2$,"GWX'R%$0II0P>]&<]WPF^W,7R-[M`#1361 M9JCYYUL?>608(7032^&9#@J1]Z.[WD>:F8]2J:/IW&R?KD%[U9V$>A7LI"IX M_XG,<6/&@D(.*`2!1R()I.6)K`M0D0:(.)(?71((,HD&.B$UG>0?VPO5>W&E M8O&TB=DSK#K4UQ)E:%#$OJ\L0*<^QTM\3HQ;%/$B^4;V_`JJI:5NXJM!I@S3 M[5:D:G/U\B0Z-#M3N`NZGDZW47[3#;M-)S`(W\67FU$Z\_`!^I`$^*.9I3J$ MKDF5P5X65:K\I=2P%@NST]`ZD.MA;Y-XNPC?LBE8\#XM\H-D>BJ9A3T-/6O3 MKHTU<$[J.0R+FJ%KF63M`('#@#D=J#H/10J_ZD2]')>=)(H;9%Z`T M8F9@F8RC79KD%WR#8GQ[0W5Q4)KXS]+H:3)6=QQCD]B^#&16IJ!B0Y4%^C_# M"=F*7+WS:Q-O%S^GTWL7PI-V7>]445!X&H)2PL*F*MC^3>^6.[!K"@S;410> M-`D*^?AY!^-B$FNPF(TL=;/`%5G]F-@%.Z-?M1R)IZJ$#UC*9215=WP/# MR:_`#Y+)4#RUB5O/XJO%?*CN!NI&L3UIQZY-SL#&*E-K:?:.E2[HJOOH#OEV M^?=L%>Y]6D0Z316YQ%/QE.(J&^N0E0BSN^IN\'I<:!<,^P$W#H+X!>:3..^A M7,H6T_.CN;K3-#K%*V)PLW:=1"ZJSA8+L_.FF'4XF0\^`M+NC(57?-AIH&08 M90S):^,JEJIH>&!VFC.[$EI&6LQP[#75?__$Q^UU)BN5@F+NT6BB[N"XFKQ^ MY&6!G[&54M8:S\V.?ALQJW:Y38+M_(=L;IYSZ:?EC:F);O4QKA[.4@KC;`6S M$Z.:06L)7QO%9V%K3D`HAX"Y8QTM1^IFZQO%2J9CLS:-I"QZ%F3B9L],=6+7 M[A>/`%#\HW#=C8)9A]"$4W>"WQ9">,$F,SARH:0Y9G MPQ&1V>E$S:&T>\UARB7B5W0[RR*SM7=B-$NNR;VC- M#<]58E-`N?-D09'.!$E)[(4XD8*[TQNE=V/S+QJ961NK[>8S,T^ M0HH%OFJWS(#!SLHD)[H7I<1RFAE?MA*/?'H.UQQR:[WT+!BSXPM&#;0X9#8L M54:[14%>)I,[Z,@01]TZ4R:E+SV;L!9$3$M,33_Z]PBI>A=9%F=G?_;DBB+_ MIH0K%*>5EB`&=29LR;!JL\O,717;V@4_PSO#J^/,%P_I==7 MD*LLHO4ACF(D`S6.@_FQNM,].-'THW=_U3/.\[:T&$_-'IV+*:3:F0NALK-: M(*T&DGKXT.>D"BC5$;PX2)A*2OJ#\["B6L_!W1*^6L?L[`%1E;3T,(+@"H-R M4H.*$C,2O,:H`49-?GJAZ'`T49>2P(5%B=TPJ]UA-0WM()=H]H2:B#HGZG?: M,/'V.@(W-`L22&>/8Y#=L/8V3>U@WW>6,5N'0J?L:=JAM?0S`O=%?"8]H%!"`Z^%T?`BZ(#[B*1108E.XU?G!C@NV71 M&W2!YX.ML]L>=DE66>WZ;G!SOQF$UEM.KVD_RSD0?AW-"U5; MT'9%KV7SJUE>^8M/Z%/R9?6[3#$OQL^#*`LL:XK:SP]71I^9CE.^6FW^"CY^ M6O^V:7S(CZ'G#[;!:_)\KP+?Q2L1+OH0!3O/Q8?YY6*C]=.5$[U\W`5?CA;C MX=<8HIKNNV[_LG+_ZY`<5;5^^LT)0P>U^Q?\+W0_!N$&AF_>%D:#BR?%\KFXM6P5B M6;:F\AG6+5.BM.%T;OC\D4JU]?5\TK&7>LH(Q`'(6P0R.,]/6+T&8>S]BTP#)-?.7WO1 M-CCX\7T(7[W#ZV`Z6DS4A1M=XGL:.;]VN<5V5AW.)B.S3ZQAUD%Y%\T(Q"X7 MQ&-37!1D9<'[M#3GCF)V%JCI^TSA>+U7ZGXM>%';[-TB[$KHZ2]8X=BK[3:$ M&='=C./H3_18WB!JY!%W!$&,`L6]\\U!?_6A_4?/=U#?XC]?X6$LF0-.).)I MBI'"`24C"IE&P*,KW1;:6C#\"#T^1?1Z_@XT-?>?EP>D0K*=.:NBV!HT]`7& M6$-'S]#2PG@\G5CG%`4QZ'*"?J(;%3Y?^I)$_][1A5'@L,\[C2@UG%H7PF#R#0.#_W/Q^\-Z<'1ZBK.(K)PR_(91_=W8'.)A.ELE1^DHZ#B8,_>Q$5,W, M2MCJX_Y^;O;^,3Y%V.T#C4^]`*^QAK&8E7`!L\G\&^XCB)W`HL(%>(3/GN_C MG@191P)+J4DHZ3W,,XE:Q\'QPLQ.Z>=3A-)"KL@E7G=NMH:&6RG)D]\A;01O5P@Q]282/D MPTW91I)Z(*L(WF=5.2>@A,BCY@!1PRVF?N0H5S/$[YF](B*D#\>(1/R04A%D MY)`4+[WPIN]-8)/$2V^G@M2Q08(\1UAXO_% M\7R<`K)&8D,4W\3>&[Q%G4Y(MF)%*#JZ#V'L?!W,QY.A,J?/BJ(?_\5US4R` MN87QV/"\)DY-5/<`?'!L7#Q+6T0F4-0!I4H7.,<1C8%)1<56,?DCF<5$W"[( M\>1FK[9QZ\)@&\O$-GSXC+=LB741O+@2(T'6X1;6L?.<1V^'GC9`(]E#O^[" MB_9!Y"6K?ZLH@G&$":+ND*!6T=(L@$4K"NLIU9"G,GN!@`6^1K_?A*'F[(N" M>/X_*:J"Q4$!PF%*\6SG+Z53%<7=!A!,7IP4=[7=)EFC^;PJ:$QB"$ M"5`>B$`)-$]VE#TX7V&$UPP'0VNY4.>WCZ3UHW`W](RPQR7G2\,/^:`#5NUP MJ5+M=,,:UF'!M+\*U M2L;(K;_:)AGM]\EF)KP\L]V&!^2CTVDU#]_8-!NK2Q<4P]2;N%*>0XG>(NT- MQV.SMRWUTDN#-Q8&9U/2!W%Z5-8"2)M(EN"31D"I%:UFIZHC.#>SH_4J`NTE M!^M-OT?+*U33U4OU`5DRPDJ.HI,9X;YDA$YJA.G^*FD6^!ENH?>&Q6">J3M4 M@06!*NMJT[';EDJUA[/)V?98=35.UT'5L'3V1T4-A<17,U%C&//KTS5L[PG[ M++/3'[GTT#1IPX/)S@J!]UGV>K4_"*49`9X'6C\]P3#;W4M.5J9E`#><(LW0 MI&Q.LV!NIG2]-GGJ9B^"\JBAWYLW8BF\><[H6S\Y-B&]V/ MZLZMY?D%(50=3A&!T(`T#2:STB`MKHSEFB8L3\5R)J=^5!6N$-(:VB95.[5:MF5I>K#<>S^P:AB9G72JH@L.ZIOHTDYAEOKB!(JTG M?/T$/VDT1>FFV`A#U-[\$K%C^WZ,)-7F1'%\%R[[Z@4U!".R]$.V$)$$@%V1 M0KT%!&IT;<5F]9,7_2DX-7J MP\J2"TX);.V+HH.#GLCZ:8//S44!:':%=NEZ[75XM7.\5WS'T%3=R8=<4'JR MLI_6.6WYFIF8?0B6@#;*_2!DBJZK`9 M-8[:=)NINWJN9DAD9OAP3$@A/9V%"#0[MY7>9ZBSG5^E^G"Y$QW+59^'PW4" M'Q]S%CQ%>1WGS?%V>',*>L[XM^1":;,YSZF)IEDV/E2U<^>**B"O0\B/"_`1 M'_&`=HUX?C-@<8WX8#%5F'K`CJ.?1?31-[,.CC8FBZ79^S:X=5$=2/$"(G?! MD$N4LBK@\1MX_VMR6?T/IQ(^+V`NY&VF?VB-##CTI_?=BJA^%G&90Q*F=/E'"$3Z7MDCWQ8 M"*9SY&.B@;&.?%K;PN[3[.2]'EJ=U+>0ZSW->@46K4XYZ&/#5 M1CVT_HI_U)/<,823Z@:+V4CIP*80U=L*VE"7"%XJ-ED:?B(?#:X&KW\LD_CS M].*I]);451R'WN,A)IF5<0#NG1#ZG#G%]'>FRBFK91K-E1;%DF-GS0]$:(AU MN4"*;,([+^7=#O..CV!X9]6M_S?/=[-M58/AV!JJ.\*Q+K`?UY@4R!A'*SR< M3LSV<,V@5?NY1LDV_N72\R_Q;^!6:+O$O?,-'\L>I=LULMT;Z9'JUF*F;N=P MF^B^;.12JN!E2[7YPC)[JS$#>O5,[8)@9T6*K7+YYCF!:R;87K2:S3ZGIF]] MKT][/9PT;/;\'!-^!@[+V-?#@L6^^?V`GA_9LT88+'`@?R;G(5AM46LA_,79 MOG@^#+^M?!>WO\<_HX&P-5-WKRD;"#FDYE;TF-T=#2P7R_-@.9,>NCPV"YC" M=Z-A5%H\AEHC4.O03;*"9B??U0)>*#![)PZG)IH=/QLJ^QXU]X)/ M24/Q#!1D?QAL(72CCX@EQ>[IJ^#U-?!)YS-83D<*AX)=XGLRGE^[G.J=56?# MA=G)EJPJ*/?S;#CLK%PR25L^UR(IF\3LJOBM9$;-&'[79MXZJ\X'X_%H:?A9 M%!Q::)FA8\=SQ/;X!>;[\K<)VR-9;-^\.`CZKSYZB[?H"S_VWO#!F^3K#ZC[ MED62K3 M2)>DL??^([DDQK!!DMQD26MF]@*@IB=PPG!%MBZ44`=^A>'62T:NR?M,+J_X MDA[%)>YC[H(81F@<32Y,7TXU!2QEJ?(,NUT7FDE6:LQ&(\,G8=J1Z^R9Z^*/ M6$L*@+2$9'HJ[[PTTK.UQZC4(`L99N\$ZL2NW4O34!PQU2=,W?=E*C[J#WG] M7YP8'Q+W;?WTBQ/^$Y)4IN+\/_3:)^H.,^"&(X_;@MK32,_6U&QD^"T,HBKI M].(EZ7L%+:.QXN M>"V3F\YA2^880B>&^&J?]![J2))]K9_0-RZ6@<8LR3U1R^E,W<%PW?+E6A"+ M?DTF0ZD[&TW.9XC0JH/N;J8)"*U?0;0O"@O=%<=!`RW]Q@EIWMDS4.H2MV1X M9@Z[%B?Q_!T<'N.GPVZUW08''Y-@IO`^CC;)O>G- MH5.)V,VU9N.YV?O)&-!K\-D=$.R\"#GX/"L$LE(*J*O*/Y^2NC2?W%R+W%]L M_,IC-WY=?K@3B;W:[8(O9,4/L]C-6.P(L?@SW.?YQ]?P,1X,)PN%7O=87#^Z M,H#/.%HO.I[.S5Y[:H*LVI$VR+6+[W%OCW^1134U6;:ZN%;/G*V7Q7.W9L]. M-&)FH)N,;-@F^:C3]ORMMW=VH*"?#UQN^M%7-`>SI<()`[K,?D1DU2,C8T/Y MT6)J-B%;<:OV@6W"[:94&JE\5!(YGH"/M6B17C[)'YB8'2AV0=<2(W:`L)/T MK82=6PGL_$L0N-'*=^\"'[[N=\$W"+/+U1Y"!S5.IGCQJ1L?45QZ\_0$MV3S MX'RF[IS:GNAD$5[6HZF;AEC+J-W1F1A0'P7U.?\>*"N]!&F'K#B66BINZBRU M=9$<$H6;`VE[)S)ES1GE"T,1 M!(@>W0LQ:1>^P5T@L!V/%^7-5]R90\)#=7DX@JCTFF;SHQ`UR:Q%9.+G$H2* M*&9:WUE!)]QGIJUH-C\C>D@SS*]WCYBWB(^Y,CLWKJ]J1O:`1R`;>[XHK/:`_-@_H/[_C)>5-.<_(P-S!<+L],=^!11;@X\ M:.QRZ=)D0ZF"-E-0$T"9:`KU^(BU`;P*9G@\Q*F*GOB'#U35*EPOVNZ"Z!`F M)S1D!TH#KVB@?H)T^8M/Z%/R9?6[3`LOQLI?PR?GL(O!)2`Z1ER>`A6L/A3X M-8:^"]UWW7;ZX1!Y/HRB:QAM0X^P!P6(*%KT(ISY!R/\&/"W#ZC1#SM\M,AP M,E,XY\`/J)_Y2GD`F2F+-#8>C\R>J1=72G5O)XS,SFJ"4E4RP4`J)XG;177P MG[@!0%K@[`?[T$M)GWA.]E7K*D4:P].W9N\V[:&5E@Y4')]--2<^"UJ'SX[O M_8O4O`K\*-AYKI-B*+>Z?DJO`'=V^:"P&`I.1@JOH),"L9^9*7I*F>'):9ZP MPNS.3JZBJCM`J6CIQMHV`N2/$V>6V,][DCX'E/Q'J)_W>-&5^Y_':(8/[22I0Q5[G_G@-(WS;^7 MUD7>/T\SA'!F+ZV)*:3:WH50V34;$9[589)?1`%CRQK2>MW';103[EO+L468 MC[_A;%T#[]LTX6+^46!D^M9;(8V,X'X-EDVJ@:1>K98SQ1+@T7WXU9 M%*KTL0NSU[L$-6*W"S?8'EZSN$N+?V0_X5#8_QL?J5^6`SUF-O]N MK(RRW9*GH20QW/#U-%&5M,R$"(*K1V`2AU+CXZ'4;]![?HFA"U9O,'2>87H4 M+..`*JN=5J[6Y1Y4W3BA[_G/$7IFI*4\-ATMQ^K&3TU2^UDMNRZ9>3;6(+PP M.\FW$[OJ>*\+@-W`<^'!S;'`\J+!U%*7L-$H5RY=V]1I(FRISF@T,3L\Z\2N MF[#'`.RL`!Z-)&3M,>A@>+U*UH].Q]9:]--2![L(LU,ENL%KB6@Z832Y68D1 MS.0X@B'[%BF[:AE#&%+]L7UK*T<,4T`C-WKD#7Z&.[S'G=S.5^38YE#9+30/5'14;C$8.J\ERF-8"6^_9)Y.`?IP= M-8BO6;H/=M[68YZB*[52-'+86V^J6/:?#-5=I](LMY]%\NB3F6-+'<(@ MLW.7&-"K-L-N"':'#8CO.&FSBE)O9BTL=61F`]&SJQ%5-.]TV!J8SPU/3.?2 M0WD'Q`&FVP:$1SR\Y%"S[\I`*ZAONV)L`+LML_/'.371,NC@P]1E$!)CLMEQ M3%:YX(LQ`FN^5XMG7A$^Q@62(C@9CR;J9@NI,GO.)##JD<\/T,L3*IB=%-J! M7/ED7*MXNT)DX3"J*J2PU-EPK&YDWB!4)B];-*$3L^2DEM8Y\?(8N%Y:'DFW M\:]EA]MC,K?C?:J9HST%,^M3JDV/&)N^V=G$7=#U3(&V@[#;+_D4#S;FQ\'& MS>\'?,=> MB7A3QJTN9G<)]4TN;)UOU6<9GI8FIA&[/?3;Y"(&3["3X-R?(N9?Y5G&2;L) M4=LX\F)FYVR)JF26==3P\9E'J>/08B!LV[=,MX]Z\C+?NR)[B2:6V;D@PCII MF0001<=C'A+G#A;'K(Z6E< MBZLZZF%?8G96$YL"6B(F)BA-?EEB*+2D+:.06W:*H(QCN834K%7DCH&NG+T7 M.[M/2&<8W?J4$];63Y]@%$%(6WI:6`H/$.L%K9_=2GXJF5GW:W8R-/S*71GJ MJ>[=)&"TTS9`T@@^.29O!A3MX%UB24MR,@?D<%))#WKVEEKK@/LU2SH5L[-M MY"BHI0.7`M6F]+9\]I?(3\$4QZ;,1NJ.Y*6*[&G$[[*?4//`\7GP>KIR=MYR,"CS?8%NH<=7#^52I>GM-1E M=/:&U\]6%3R=S*[[-TW(;'9VD#PE5?L+:4CM%@L7GF,41E>^#<$:+\RS4TE! MJ)('U-M42XW/$#V^3U.M*6FLJ1XCM4N_X3$D7H_+&L,GCQ;-78"L03RF+%<3 M'TW*I*R2,>7W9-.UX:6,QK'#-SLI4:*66@::\O"V=<,2X_LAY0(*>+3Y,`Q\ M]'G+M-%/:\DAM1&"O8'[USOKI#GYI$G`7Q/^`\>H=K.]XGV]X!M$%ITT MT6OC62_6*=J7=F[&1]G4)M0>[B;,SJ'NIYB6_KH71+NKK^0SKQ;Q*)*X>D'X M\6Q9N8SG;[W]KIPC-)JJF\N2`+"?Y2EY0ID92FD<$\/LW&V9:JKN(R5B[;15 M-=/GM?O=NJ\:9PRP.VYS[I'-D;15;K\A]6AHJ?,UK##Z+OT**ULL\[(V85F& M3W;SJJ(^T8(+CYV;TT75S.3D%_)S15&BA)F&06C#YY:Y==&4U<"' MRB8%V_H>B3U?[3J>S>$Q@K\?<"=\\\8QDU34JU;C[MF.&RH=@SE2EX+8)+6? M?;+KDA_SUE2#D,/LG/9.[*I[HBX`=HW?HF_\/4$L#!!0````(`$=N;C_&9>6?8Q@``%%D`0`5 M`!P`8F-S="TR,#$Q,#DS,%]P&UL550)``/E8L%.Y6+!3G5X"P`!!"4. M```$.0$``.U=67/CR)%^WXC]#UCMB_T@".#-B>GULG6,&5:+#%'CL9\<(%"D ML`8!#@YVR[_>6;A)XBB`2.+01DQT:]1D9>:765F96559/__IQT[C#L2T5$/_ M;7U>UL=3^?WW"6+>F*I!DZ^7*C&S=_^I___(^?_^OV M=MG_V]?7Y]M;_W_]<;@^/^6'7/CK=]O>_W1W]_W[=W[?_[$V-5XV=N&_[DU# M<62B3#,+7Q.&-YY_QA^E!(Y&O5[W_VL.)U. M[]Q_#3YZ]LGXN/V[@-L;X)_C/`E,0R.O9,/1OW]]G2=S3__Q[L&0G1W1[9FN M/.JV:G_,]8UA[B0;``8&W-'>3;+YTUMI60" MCN_$5F5)8^9Q+YGH;*YL^),JV5IL%GMBNLIEA=$R]E=E\%ZRWI\TXSL[?_*F M2@:_2I8*;"Q-8@%#[/-@72U.KT36),M2-V!-[.HRX5M5ITNFWL@W9]7)@-[L]&!"[8JRU7"DGZE9WM0(^4Y8-!YRFOEV" M)?S(:WI&`ST=6,O53MG3R0 MM?U*+-MT9-N!CV^96",;R58J=8A/DFK^5=(<\HU(EF-Z7H:)E\UA5S5*>TH] M!(H-D=\WE2ZO<]V&J2S;#^2@RL2:Z_)<49DX415552KE!7P<.9I%IJ'#CW(! M)9G2OE)S63E[^#:E+VG!2E0T(K+D:E6V1NN2!"C/\(43KGA8M<`CJ4ZPM#3H]E\L,F$"XH7F@;,*T9 MLO\I35H3["9A$9G?&H<[A:ANYD%_<+F^%<3;ONCR#;\Z&IB)O;@5S,R` MU8UI["["UC9R!#5,A9B0#=YP>U,U3!@8;.Z&58?/@$DV9FP*WBNFI-V@+'D\FT(M44P4V@T07TLXOO:&S=>>]YR'0E0E>M,I=(\#:9!X.MPTD`=>D(_J1HQ[\%Q M;`W3\_Y5><^$\9N@MSRQ?8U-&ZNQ>V.W,W2W9.Q5K!>.[>XLJOK6E:2J3#N? M7'/TR0Q*D)4+]>CWY[O$RE2!HE6/N^7"'27X^7[Q\O#XLGI\H#^M%L_SA]D; M_,_7V?/LY?Z16_WY\?%MQ5B[8M^=+%S!"EE>;/P2,3A-PU*/M-P3W/Q\G&Z[ M&\E:N]`[UNU6DO:>`1/-MH+?G%JR_VLF!LJ7NV:6!>A$@@Q%`4V28UJ5S,%2 MV@FK+*FRUU("`UDW!()CY=E33^IX[F`V,2WB?I))S\^JM%8UP(58X*]T3A2B(@A<#H%@`*Q?UVT89O.JJS5W+\WX(.25:#0N.(<-Y)_V M\-:]7/IU64,Q8#KIWA;V.S%A5IA.JOP3-,/()EZ7512`I*Y=#523>/#'?B4' MHCNACQSU)WA!?C+-NBP@'X&Z=D90%1\_LA7(/!D/1VA:3R!8E\IS9*]K1P7? M]R=Y.'$PP8L&4JC6ZNUS0*AK.P;9S9OJ`9`\D`3I1T-O$QC)V:=3KL_ELZ%1 MU]Y.S3FN.&Q+DIND/F'2NZ805[+A2)R$HDV2['7M:16T7<.6M'*%O:@F-E:#2`;B4Y6+;*@0O?R ME:Y1_$08#J["-KJ-9JY'1W*VI&R2NA`50:G89E/2]DN"+^B>9Z?G`%3;O6$# MD-T;[LT;HM/;:[S8'_7P2D\9E"N?,N6,@16;3KKZ+,"FB&:!O#E[N56P`=,2 M5XN\F8\?$UR\FU]*4%A51]?)SQ/)US,3,N.,?)A:4KHOF`4;^O:-F+MX&9O6 MKQ'SH02*5=L#2XX7VD`.`MT+F4XKUQ%:;O$:[TA'.N$Z#8`1CDX&26R0H2\2 M)0LC["+!A!:OD^378M.9*UL*"BT)\(HM9\M@<'.O7*;7:%)TE=B?7J9FBJ![?2TE5YOJ]M%?! M,?"#J8AWRB2%:&U:9P"A)4Z]F/)?B2VI.E$>)5-7]:TUDV5GY[@G+Q_(1I55 MFN*)XP&:(>0S4)M-%,2F)3ELY94^G+`/HW*34(00>T/,8@U2>::05M)KD\?2 MM^0X7;&@U;M.=;H=3QNG(M\HJ^SL#&TM1G<8X"^JM8.DN7L.]KUDFA_@EOP@ M93#%.QW(Q$(EALVHKC!6*XI-]Z+TX/(,;9`'`*PU\D+LX*#18-+#6[FS*-=A M#*Q(=#*(G^NTWY]A?H#,_!@S)V,J3V MKN*Y0B>4S7M]`6]_,Y-T>8-]4G75)L_J@2AS,`Q]JT+PX).AB\RXA^=NLVE7 M8M`%%1;8-3LJW8NJC]<>2#$2,>3%``H26)1^F#TWG=F!+CH*3POHO+A+$GIOVQU"2OY5KP M<`-=(*>C`6:6EDZYPB@X7^NL$+3=[U>%%_-*VQ*W4B:[/4,),S6L*I^%S*X_ M15S'/2J8@860JB+ M$5K\V-Z+`;/*/[O7'PIXAI%&MGY[8`*D[<$:@REXC8UGCOT.PL%TX*?]JYUD M/:7=-*O(PJ:386F2^'/+7,;0XGB'TZ,P@WRC2R4.ED#[/K[&T.'[BD MUI#]T'OA.L-42J%I6F"MO)+#X''9S:?.6>YA?3L*RE:6Q4 MFQ\/^HC7IV.4KF&=YWL,::*VI)!0\&RZ"U)_HM-]Q=#-X[E#H["Q;I(X.TRY)*O M9?H7`J63%8!H"CP!BEYO0`?0B/*LKV1CF,3[W)OT@UB//P`:``/R:_-C#DB[ MIT/@FT!?OS2U731DBI&,0<7HN)/X:]$)S20$WLC M`:^TF4*U%F_&@D!+>K@7?'B&V/&E?-1#/*EU1*L>/Y$N;EUO&*-.[*"G1;!1 M\U6R5'FF*P^JYMA$`<$'(E[@DD.]EHE>!)':WCU&G?&_$77[#J+.#K`T;LF+ MLUL3<[$Y>P+Z!)D'QUM(W6>EDQ:%M6S9KB4(]&%P:@?T-Y>2J\5(JH0H,"*Q M4T:4.(WX86^,5U!/)-D<'Q(7/M!YMVJRIV('+G,T[N,%B2E$&Z'W!``"S3>] MWHFX9/"BV!O@!16%>&G^ZG&$5F`]W2J7IN#ASYXS6"@B?;SMY(+<-,F"F!`+ M;*CI)=CBC6\L]QT.#\NH.",.^G@[+FED*[&*$F7E>'><7#BZM^'/CMA@U-Q* M?(J!>QKT!^3'X_$(3Y`3:E(>SFYY)O@0)CQ:(^9"56OO'^Q>;/S+X>`W\7+V3-)-L`PF7#IY MB,%M5)&*'C^9CO&ZFV33KMLNV)%IR9D`K%P+:;,8+]?*4.H8LU-)4TP]85N< M"9&6'(`HMD4>N?^5I)'%9D5DQ_1>?2(V/\%\^"B3=-WNCQF7,%@:-MHJ"@9+ M1`?8M)FNS)2=JJL4+9ISA@6*@8A7HLXA7HEE%#C"'EH$.R;=*SVNB'LH$(3_ M)IG_)#'D>%'`;`&73K@N.V"$HN%UN[(/*5D$J-#G*![(@6B&VP0O%%_L(;:1 MR*1=ES&P`]+)"4;SKC5DBQZ2\I!Q>+> M!P+#RZJ'(RSIL?HI/QH@+F@9A.MR8HQ8-+QTC-C!8%BF@\'];/5G[NEY\5ME M'0SH"U!/FO']H@8&)I$L\D"\O^=Z:"[^6Y"AM?1'B'LI['Q#4YRRF[CW0.0O`2$V3^(+U7]+R6M<1H-]A, MTA!J>`94G8GD@8AU?:P&%TJW"A<;@#?<7*:'_9.2OI3[$`Q#UF3J29?B"DG? MR0SO'`3_.90'GVCBLRC@![S$]UJ>DH6I!KO0PI@V/!:OSK<&,Q9MR/#77B15%M"7I_Z5N+9A[08LI^OH-WJM7N?2; M:S]90'7RC`A]8!(X;E?=J]JZ96-OI>AR.[<#[R(E^F*PF2$ M6"K-HMT\\V!'JJ.)6GRU>3%L$F03_'1XI14]3K5N`\E=0&(:$V7 MKK:,LM/B)\,18G\[=D;JGCF)+:K*@-B2S+/8(87DF#[VV`#X$\17VW/)UVT] MC$E0"F!-WK^LU/MZU^53H1Q?/8G)8.B"4H4?D[T9,_EW1S7)-PF4H!/S(_Y@ M+\@J>&\"X,:QV5Q@3IQBVCZ-:(N@U^0)5#:PO0#4JZ[E*%.(G19=>Q'/=[(S M4O=,8@Y@\D!L256M8.OP\L!>LW2.LQ[%8A%ZA\B], T0?BXUW=8"FA-'% M(HA-!IBO,!9DI^Z9E1G<%08T6*LZ=4WK%)'%!GZC.+);Y?<.#4R'([R=J'SZ MC3>B;,A"JQD/NV,U*7"&6\/)<.*=9"O.ST413D(#;"RQ*F[W787BLCN!=S(K MGBG_YWC=XB"[>26RH#.*`ML?C_'"%`R.&V>!V&II24"=:LO7U$6I M@T(-WP6]^N)XU508:W5DI`6IZQCWJ0Q&1NIV:\SY?QZ(#=\H+I?_QQY5#B^O M11!.$9M(9%&NQ&:*B5;<.)*<=JMCLZL"RI@;=CU&J!13QAVY3H8%3$#BK(47 M>[)$@>A0,UVA?]'=G8.DT4!\24!?RFDT2--#Q$8(15BYGNL^7]A+0_9YEW81 M98_UFC-B!J[0-#_`Z_U5TAS"#P=3`4\R)AZN.`?.MHF+@]2.8VY[=Q8#**9= M]11H9GA;Q11`D:QI4^`L.BH.4CO.IGE3X%$O<%ABY>SWF@NAI`40SO6-8>X\ MT",P1W@]_!F9J#'I*P%3)WOJ!L]<+"55X8=#$?-Z942I&L67M?33)SY.96]U M2I^BY?"-:5=849A.KO"*LD>M*-.Z'W5 MTEBHQ#JNLYV8U)N-"=GN.10ZA>;Z7U1=B=[YZ@LBXKGW,X(M-)P_A^1N7ZK_HL]:]40\_VC@EVT*K84*P'2E]T0IOXI5X?C1%/#^73+.%9I,/ M7CMRX":=+$)ZQ:RNHT6)`+(]/H2#!/ZK3%1>&_ M`E>#5;&#VO`W-7U0JPTW^[.$YZR4`=U%J&AMG=I1+O8!$#\ M0O\D2@P/P`'Q740V'EIH:\7!#8Q,[)21N6!:P#A(_6`X:WOC:$%74GXZ0O1F M691;:%"L0`9FU*U-AZCH\(MA*!:X[A=#)[N]9GP0$LRF-YA?%H`(\D6O=(T1 M]R%*;\-:`NZ5$WTE4+3]"&4P16WVP M*%:G+'AEK%O!JR?27W\\)_[7=J(Y/R; MA5_X6YA;2??U%[TCZ)T9BA,(_8:D14\,AN8QZ(WQ&F-4PF+Y/<>OCJ7JQ+(> MB"6;ZMXGG*"#-X#]JT:;1HJ#$6+&6)RA2OP*DJ4$CN1"F%MYC.URO]([]2O@ M\#7)LM2-*KM?LAA]2NKW"GN4)<7?N^5V.FBT-,7L0<3L85:`E?(>@HE,9+9] M01"3O&7*"WC%1J]DJE^HPJC<6!J73SJ=^Z?3^3>B;M\AF^)F!PC.MH3S'FAA MG-3!M_TO'W^W\,1^E$P=HD-Z@]4=*?90=!]O#J=1+3]=3T>,+2C]H8"WF9!* MMY(YRZZ=8'JRX?!)9^+@=":ZV[VW:UH5Y)).7^9,1??KZ^RCFP7F8O(!RE#G M(\3MUFS2Y:=EA+;;@3T<^95HM)[D5BLBVF'_ZAT&KMO+7$GKT+E M3-KTAZ0*S-&@4.IQ$NFXCWCM*)GF!0OVT7B1H8T@?+R2$-5./E:E1'A-V+48TQ7WMX) M'2UQL.+)[MGP9V-'FR,"V"I[0:?`T![FIR[G6:4`[T@15\&W&Q4304U6ROYG2@./=T8^W1\`^VH0?D0SR=5P.`E M9;OP@-5BD\')BV'_G=@S!>R:]O,9B(DE@JJJ>B5XJL3WH-A*5""\%.I/ZG#. MCK7%6RQR]/`R1R_<<+$NBZQ;;MF]&LMOR'>MM6U*8N0-&B>4DIR+`I[_9&6C MFEWW2[M[E@+MDT[\LP-P*V=MD=\=&FT\'@J$%M'WCK]68F(?#Q3;C^TAW@I. MH7K!3OK)B/$`=RH@7A]-HUO1Y&353M1'-D550) M``/E8L%.Y6+!3G5X"P`!!"4.```$.0$``.V;77/B-A2&[SO3_Z#Z:GMA/L)F MMV'";@F0+C-)8`+;W;N,+!^#6B,YDIR/?U])ML$8DD+B#IFM9S+!%N=(KXX> MR[)\./W\L`C1'0A).>LXS5K#0<`(]RF;=9RO$[<[Z0V'#I(*,Q^'G$''8=SY M_.GGGTY_<=UQZ_O9]87KIJ=I/:A5.ZD=HV7Q7*FH7:_?W]_7HM:#)\(:X8OE MMY'@?DS`1]KQJ-%LNN:O@7Y'']OZ8WR9&#[(MB1S6&"DL)B!NL(+D!$F6D^N M>D]09BJOFXH:)RW3FQ`6P-0Y%XL^!#@.5<>YC7%(`PJ^@W3WF6Q[1*I_JRBQ M-/+IFJGM$!/$=2UD:NM0%"R;$>N^=RW MLB::]>^7%Q,;"D<'!B$3&LP85UCIV-NBM#"**`MX6J++0LK^;IM_'I9P#0%Z ML"6"A_!,C\S7=8)#$H>VA8M5!4Y:PUQ`T'%,$-TL7C?:HZ:[DIF8?G8<21=1 M"%D9%F2C[;2CS9.3D[JUJFL^(A"*@JQGVI=!,@7/NV>F&Y;KG5S57"\E7B'V M(-PQ4MKV?QRI2(#4U^<^:&F7'R)@1N%4BT?FX.OUQTEB" M/V*?['%A"DF=4XOG'%?U[^=7)&MWS^75N[N+QA2$OG/"TVYI:3;J+X>AQYD/ M3%>N#R0/J8\5^&=R1Q`R1P;A'BR5#@:1YJ'B0ZKO:_JX][HJC^XF@SZ MYF@RNACVNU-]`"?"HEQV6B]A M![U;T_AKQ=(;8FDYFOKVU,-R?A[R^_7Y1W(2E$O1\6X43:;ZXW)PI0D:G:-> M=_(%G5^,OE5ST5OE9Z178[;;18#*7=XTWK^$G]%X<-V=#K5!Q<]A^.ES$IL1 MZS)_P!15CT/]>"L6Q=6PCX&6RXM=#J>-YP\Q\U&B!.6D5'@4U5$`.MF"QWGS%P6$XF-`9LZ.P-F'PD!(*>28D+ODM MWG$1B9R2M>DBU5(!7T3`9'%'2WJD7#+>;Y!A)+A6`\J+J)`X M$!)Q%"6)2SC,WJILW^V4I.3]B:.-.TE>##)JD)%3;7F^!4P\";>Q[MO@KK#P ME#'`:3.19K*XM[7&X*2',#A4P! M2B6@1$,%1`E`G-8+R9Q)P7K*ITGXI(N("X78UM38_#B?)-@PF)DWL`Y*,FLO M>/*@L-TM%&+-RS7UN,TCM_FA]B#]++OM61VV,@FD-N-W=1^HS:YU&TVWU7Q2 MQ%8?<^"NG/<3D`;AV)[Y:K?NYQQ,SX]W;C+`TK,UQ-(UF8IRYT[G/6<81TG/ M(51R6==+8O!KF8K=Z\'UI0\Q:NY2[733'VKJ.,\][*_ZTEE]L-7M[B; MW.^U.;5NS'(EUQ2[W:T17'YNP/P>.H MXR3F5,'"04D6/'Z$I M/*BS4#_N[A>BG%LQ1F\\)D-&!.AIN@_)YY"9SHT"O1S1[?6XS#\WW.QDO3T" M7I)6JKL/'E6EQ67!&2@L'LN/S%@K$V.KK[A;VO7_BJ4RMMMXV=>Q=&*2GQ6U M5=9$^;$I/%/H^XD'8A0DZ_I1K.POPC01YI7_9CV6P7EW3?W6] M60&OB9Q=B"=W1'WV#U!+`0(>`Q0````(`$=N;C]GU_%]&(,``#K$!0`1`!@` M``````$```"D@0````!B8W-T+3(P,3$P.3,P+GAM;%54!0`#Y6+!3G5X"P`! M!"4.```$.0$``%!+`0(>`Q0````(`$=N;C_.]`@->@T``$VJ```5`!@````` M``$```"D@6.#``!B8W-T+3(P,3$P.3,P7V-A;"YX;6Q55`4``^5BP4YU>`L` M`00E#@``!#D!``!02P$"'@,4````"`!';FX_/(4?,&`[``"@4`,`%0`8```` M```!````I($LD0``8F-S="TR,#$Q,#DS,%]L86(N>&UL550%``/E8L%.=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`1VYN/\9EY9]C&```460!`!4`&``` M`````0```*2!V\P``&)C`Q0````(`$=N;C_2^N4.=08``$PW```1`!@` M``````$```"D@8WE``!B8W-T+3(P,3$P.3,P+GAS9%54!0`#Y6+!3G5X"P`! @!"4.```$.0$``%!+!08`````!0`%`+\!``!-[``````` ` end XML 12 R3.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Sep. 30, 2011
Dec. 31, 2010
CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]  
Unamortized discount on notes payable$ 742,830$ 992,832
Preferred stock, no par value  
Preferred stock, shares authorized20,000,00020,000,000
Preferred stock, shares issued00
Common stock, par value per share$ 0.05$ 0.05
Common stock, shares authorized180,000,000180,000,000
Common stock, shares issued75,949,01674,078,153
XML 13 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net sales$ 2,277,074$ 1,885,600$ 6,321,495$ 5,359,907
Cost of sales1,518,3101,257,9544,414,4023,847,716
Gross profit758,764627,6461,907,0931,512,191
Operating expenses:    
Administrative and general1,280,183801,3515,124,8833,180,412
Selling and marketing401,82655,007824,771197,276
Research and development570,197588,1471,793,5962,090,212
Depreciation and amortization169,592190,846517,751575,856
Total operating expenses2,421,7981,635,3518,261,0016,043,756
Total operating loss(1,663,034)(1,007,705)(6,353,908)(4,531,565)
Other income (expense):    
Interest income338 2,3243,295
Interest expense(176,047)(3,531,090)(745,925)(7,379,794)
Gain (loss) on derivative valuation5,851,300(1,044,993)12,257,500240,100
Equity issuance costs related to warrants  (476,234) 
Loss on extinguishment of debt16,000 (954,033) 
Loss on sale of securities   (49,264)
Loss on sale of assets  (362) 
Other income (expense), net5,59759,12115167,870
Total other income (expense)5,697,188(4,516,962)10,083,421(7,117,793)
Profit (loss) before income taxes4,034,154(5,524,667)3,729,513(11,649,358)
Provision for income taxes    
Net profit (loss)$ 4,034,154$ (5,524,667)$ 3,729,513$ (11,649,358)
Net profit (loss) per share - basic$ 0.05$ (0.13)$ 0.05$ (0.28)
Net profit (loss) per share - diluted$ 0.05$ (0.13)$ 0.05$ (0.28)
Weighted average shares - basic75,229,25443,098,80075,240,31341,402,000
Weighted average shares - diluted78,414,45343,098,80077,970,21641,402,000
XML 14 R1.htm IDEA: XBRL DOCUMENT v2.3.0.15
Document and Entity Information
9 Months Ended
Sep. 30, 2011
Oct. 31, 2011
Document and Entity Information [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Period End DateSep. 30, 2011
Entity Registrant NameBROADCAST INTERNATIONAL INC 
Entity Central Index Key0000740726 
Current Fiscal Year End Date--12-31 
Document Fiscal Year Focus2011 
Document Fiscal Period FocusQ3 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 75,975,656
XML 15 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 16 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Equity Financing and the Debt Restructuring
9 Months Ended
Sep. 30, 2011
Equity Financing and the Debt Restructuring [Abstract] 
Equity Financing and the Debt Restructuring
Note 7 - Equity Financing and the Debt Restructuring
 
On December 24, 2010, we closed on an equity financing (the "Equity Financing") as well as a restructuring of our outstanding convertible indebtedness (the "Debt Restructuring").  The Equity Financing and the Debt Restructuring are described as follows.

We entered into a Placement Agency Agreement, dated December 17, 2010, with Philadelphia Brokerage Corporation ("PBC"), pursuant to which PBC agreed to act as the exclusive agent of the Company on a "best efforts" basis with respect to the sale of up to a maximum gross consideration of $15,000,000 of units of the Company's securities, subject to a minimum gross consideration of $10,000,000.  The units consisted of two shares of our common stock and one warrant to purchase a share of our common stock.  The Company agreed to pay PBC a commission of 8% of the gross offering proceeds received by the Company, to issue PBC 40,000 shares of its common stock for each $1,000,000 raised, and to pay the reasonable costs and expenses of PBC related to the offering.  The Company also agreed to pay PBC a restructuring fee in the amount of approximately $180,000 upon the closing of the Equity Financing and the simultaneous Debt Restructuring.

Pursuant to the Placement Agency Agreement, we entered into Subscription Agreements dated December 23, 2010 with select institutional and other accredited investors for the private placement of 12,500,000 units of our securities.  The Subscription Agreements included a purchase price of $1.20 per unit, with each unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock.  The warrants have a term of five years and an exercise price of $1.00 per share.

Net proceeds from the Equity Financing, after deducting the commissions and debt restructuring fees payable to PBC and the estimated legal, printing and other costs and expenses related to the financing, were approximately $13.5 million.  We used a portion of the net proceeds of the Equity Financing to pay down debt and the remainder is being used for working capital.

On November 29, 2010, we entered into a bridge loan transaction with three accredited investors pursuant to which we issued unsecured notes in the aggregate principal amount of $1.0 million.  Upon the closing of the Equity Financing, the lenders converted the entire principal amount plus accrued interest into the same units offered in the Equity Financing and the proceeds from the bridge loan transaction were treated as funds raised with respect to the financing.

In connection with the Equity Financing and under the terms of the Subscription Agreements, the Company agreed to prepare and file, and did file, within 60 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold in the financing and the shares of common stock underlying the warrants.  The registration statement was declared effective June 16, 2011 satisfying the obligation contained in the Subscription Agreements.

On December 24, 2010, we also closed on the Debt Restructuring.  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into the Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents was issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest.

The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year's interest of $350,434 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.

The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company's securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.

During the three months ended March 31, 2011, we issued Castlerigg 400,000 warrants pursuant to a waiver agreement dated March 10, 2011 allowing the issuance of shares and warrants for the conversion of the AR Note Payable without adjusting the conversion price of the Amended and Restated Senior 6.25% Convertible Note.  These warrants contain full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model. During the three and nine months ended September 30, 2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock. A valuation gain of $144,000 was recorded to reflect the change in value of the aggregate derivative from the time of issue to the date of conversion.

In connection with the Debt Restructuring, the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013. We also issued 150,000 shares to the holder of this note as consideration to extend the term of the note.

Investor warrants totaling 12,499,980 issued under the Placement Agency Agreement contain price protection adjustments in the event we issue new common stock or common stock equivalents in certain transactions at a price less than $1.00 per share and were accounted for as embedded derivatives and valued on the transaction date using a Black Scholes pricing model.

At September 30, 2011, we recorded an aggregate derivative liability of $2,500,000 related to these warrants and valuation gain of $8,250,000 for the nine months ended September 30, 2011 to reflect the change in value of the aggregate derivative from December 31, 2010. The aggregate derivative liability of $2,500,000 was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate of 0.83%, (ii) expected life (in years) of 4.2; (iii) expected volatility of 81.51%, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.
XML 17 R17.htm IDEA: XBRL DOCUMENT v2.3.0.15
Supplemental Cash Flow Information
9 Months Ended
Sep. 30, 2011
Supplemental Cash Flow Information [Abstract] 
Supplmental Cash Flow Information
Note 12 - Supplemental Cash Flow Information

2011

During the nine months ended September 30, 2011, we granted options to acquire up to 600,000 shares of our common stock valued at $389,000 to two consultants in consideration of consulting services to be rendered by the consultants over a one year period pursuant to a written consulting agreement. The value of options is being recognized over the contract period and for the nine months ended September 30, 2011, $263,572 was included in stock based compensation.

On March 21, 2011, the Company, converted $784,292 of its short-term debt into equity through the issuance of common stock and warrants to two lenders at the same unit pricing as the Equity Financing. In consideration of converting the short- term loans on the basis of $1.20 for two shares of common stock plus one warrant at an exercise price of $1.00, the Company issued 1,307,153 shares of common stock and warrants to acquire up to 653,576 shares of common stock, which warrants have a five year term and are exercisable at $1.00 per share. The Company's objective for converting the short-term debt into equity is to conserve cash for further market development.

In March 2011, we granted to the holder of our senior unsecured convertible note a warrant to acquire 400,000 shares of our common stock at an exercise price of $.05 per share in consideration of a waiver of the holder's reset provision that allowed us to convert certain short terms loans to equity without causing an adjustment in the conversion price of our senior note.  The warrants had a 5 - year life from the date of grant, contained full-ratchet anti-dilution price protection provisions and were valued $404,000 using a Black Scholes pricing model on the date of grant. During the three and nine months ended September 30, 2011 the warrant holder exercised these warrants using a cashless provision resulting in the company issuing 372,272 shares of our common stock.

For the nine months ended September 30, 2011 an aggregate non-cash expense of $250,002 was recorded for the accretion of the unsecured convertible note.

For the nine months ended September 30, 2011, we recognized $1,117,703 in depreciation and amortization expense from the following: (i) $599,952 related to cost of sales for equipment used directly by or for customers, (ii) $510,138 related to other property and equipment, and (iii) $7,613 for patent amortization.

2010

During the nine months ended September 30, 2010, we issued 406,927 shares of our common stock valued in aggregate at $399,466 to three companies and three individuals for consulting services rendered, the expense of which is included in our general and administrative expense.

During the nine months ended September 30, 2010 we issued 200,000 shares our common stock valued at $216,000 to a corporation for the purchase of a H.264 codec software license to be used in our CodecSys product development. We have included it as an asset on our balance sheet and will amortize it as part of cost of sales.

During the nine months ended September 30, 2010, we issued 3,000,000 shares our common stock valued at $3,290,000 to our senior secured 6.25% convertible note holder as part of amendment and extension agreements. We included it as an asset on our balance sheet as additional note acquisition costs and will amortize it over the remaining term of the note.

For the nine months ended September 30, 2010, an aggregate non-cash expense of $3,251,360 was recorded for the accretion of our convertible notes as follows, (i) $3,143,475 for the senior secured 6.25% convertible note and (ii) $107,885 for our unsecured 3% convertible notes.

For the nine months ended September 30, 2010, we recognized $1,179,380 in depreciation and amortization expense from the following: (i) $603,524 related to cost of sales for equipment used directly by or for customers, (ii) $568,390 related to other property and equipment, and (iii) $7,466 for patent amortization.

During the nine months ended September 30, 2010, the conversion to common stock of all of our unsecured 3% convertible notes and the conversion of $50,000 to common stock of our unsecured short term notes resulted in an $802,190 extinguishment of debt primarily due to unrealized note discounts and accrued interest.
XML 18 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Weighted Average Shares
9 Months Ended
Sep. 30, 2011
Weighted Average Shares [Abstract] 
Weighted Average Shares
Note 3 - Weighted Average Shares

Basic earnings per common share is computed by dividing net income or loss applicable to common shareholders by the weighted average number of shares outstanding during each period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year, plus the dilutive common stock equivalents that would rise from the exercise of stock options, warrants and restricted stock units outstanding during the period, using the treasury stock method and the average market price per share during the period, plus the effect of assuming conversion of the convertible debt. The computation of diluted earnings per share does not assume conversion or exercise of securities that would have an anti-dilutive effect on earnings.
 
The following table sets forth the computation of basic and diluted earnings per common share for the three and nine month periods ended September 30, 2011 and 2010:

   
For the three months ended
   
For the nine months ended
 
   
September 30,
   
September 30,
 
   
2010
   
2011
   
2010
   
2011
 
Numerator
                       
  Net income (loss)
  $ (5,524,667 )   $ 4,034,154     $ (11,649,358 )   $ 3,729,513  
Denominator
                               
  Basic weighted average shares outstanding
    43,098,800       75,844,526       41,402,000       75,240,313  
  Effect of dilutive securities:
                               
  Stock options and warrants
    --       19,927       --       179,903  
  Restricted stock units
    --       2,550,000       --       2,550,000  
Diluted weighted average shares outstanding
    43,098,800       78,414,453       41,402,000       77,970,216  
                                 
  Net income (loss) per common share
                               
    Basic
  $ (0.13 )   $ 0.05     $ (0.28 )   $ 0.05  
    Diluted
  $ (0.13 )   $ 0.05     $ (0.28 )   $ 0.05  

Potentially dilutive securities representing 25,193,934 and 24,723,934 shares of common stock were excluded from the computation of diluted earnings per common share for the three and nine months ended September 30, 2011, respectively, because their effect would have been anti-dilutive.
XML 19 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Equipment Financing
9 Months Ended
Sep. 30, 2011
Equipment Financing [Abstract] 
Equipment Financing
Note 9 - Equipment Financing

On August 27, 2009, we completed an equipment lease financing transaction with a financial institution.  Pursuant to the financing, we entered into various material agreements with the financial institution. These agreements are identified and summarized below.

We entered into a Master Lease Agreement dated as of July 28, 2009 with the financial institution pursuant to which we sold to the financing institution certain telecommunications equipment to be installed at 1,981 (subsequent additional locations have increased the customer's network to an aggregate of approximately 2,100 locations) of our customer's retail locations in exchange for a one time payment of $4,100,670 by the financial institution. We will pay to the financial institution 36 monthly lease payments and at the expiration of the equipment lease will pay the greater of the then in place fair market value of the equipment or 10% of the original purchase price.

We also entered into a security agreement with the financial institution pursuant to which we granted a first priority security interest in the equipment, whether now owned or hereafter acquired, and in our customer service agreement and service payments thereunder during the term of the equipment lease. We received a waiver from our 6.25% convertible note holder releasing its security interest in the equipment purchased under our sale lease back financing. See Note 6.

The sale leaseback financing arrangement with the financial institution related to the purchase and deployment of certain digital signage equipment for a new customer.  As a result of this financing, we incurred an obligation to make 36 monthly payments of approximately $144,000 plus applicable sales taxes. The proceeds of the financing are being used to purchase and install the digital signage equipment for our customer and for general working capital purposes.  We have the right to terminate the lease after making 33 payments for a termination fee of approximately $451,000 after which time we would own all of the equipment.  We have accounted for this arrangement as a capital lease.

During the three and nine months ended September 30, 2011, we made lease payments totaling approximately $422,096 and $1,266,287 of which $361,966 and $1,048,491 was applied toward the outstanding lease with $60,130 and $217,796, respectively, included in interest expense.

During the three and nine months ended September 30, 2010, we made lease payments totaling approximately $422,096 and $1,266,287 of which $314,080 and $909,781 was applied toward the outstanding lease with $108,016 and $356,506, respectively, included in interest expense.

Additionally, we recognized amortization of the lease acquisition fee of $12,567 and $37,701 which was included in interest expense for the three and nine months ended September 30, 2011 and 2010, respectively.
XML 20 R15.htm IDEA: XBRL DOCUMENT v2.3.0.15
Interact Devices Inc. (IDI)
9 Months Ended
Sep. 30, 2011
Interact Devices Inc. (IDI) [Abstract] 
Interact Devices Inc. (IDI)
Note 10 - Interact Devices Inc. (IDI)

We began investing in and advancing monies to IDI in 2001. IDI was developing technology which became CodecSys.
 
On October 23, 2003, IDI filed for Chapter 11 Federal Bankruptcy protection. We desired that the underlying patent process proceed and that the development of CodecSys technology continue. Therefore, we participated in IDI's plan of reorganization, whereby we would satisfy the debts of the creditors and obtained certain licensing rights.  On May 18, 2004, the debtor-in-possession's plan of reorganization for IDI was confirmed by the United States Bankruptcy Court. As a result of this confirmation, we issued to the creditors of IDI approximately 111,800 shares of our common stock, and cash of approximately $312,768 in exchange for approximately 50,127,218 shares of the common stock of IDI, which increased our aggregate common share equivalents in IDI to approximately 51,426,719 shares.
 
During the nine months ended September 30, 2011, we acquired 14,571 IDI common share equivalents in exchange for 971 shares of our common stock valued at $903.
 
Since May 18, 2004, we have acquired an aggregate of 4,070,849 additional common share equivalents IDI. As of September 30, 2011, we owned approximately 55,497,568 IDI common share equivalents, representing approximately 94% of the total outstanding IDI share equivalents
 
Since May 18, 2004, we have advanced additional cash to IDI for the payment of operating expenses, which continues development and marketing of the CodecSys technology. As of September 30, 2011 we have advanced an aggregate amount of $3,057,605 pursuant to a promissory note that is secured by assets and technology of IDI.
XML 21 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Fair Value Measurements
9 Months Ended
Sep. 30, 2011
Fair Value Measurements [Abstract] 
Fair Value Measurements
Note 8 - Fair Value Measurements

The Company has certain financial instruments that are measured at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-tier fair value hierarchy has been established which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).  These tiers include:

 
·
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
 
·
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
·
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2011:
               
Significant
       
         
Quoted Prices in
   
Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets
                       
Treasury cash reserves
  $ 414,472     $ 414,472     $ --     $ --  
Total assets measured at fair value
  $ 414,472     $ 414,472     $ --     $ --  
                                 
Liabilities
                               
Derivative valuation (1)
  $ 3,095,900     $ --     $ --     $ 3,095,900  
Total liabilities measured at fair value
  $ 3,095,900     $ --     $ --     $ 3,095,900  
                                 
(1) See Note 6 for additional discussion.
 

The table below presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at September 30, 2011.  We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model.

   
Derivative
 
   
Valuation
 
   
Liability
 
Balance at December 31, 2010
  $ (14,759,300 )
Total gains or losses (realized and unrealized)
       
Included in net loss
    12,257,500  
Valuation adjustment
    --  
Purchases, issuances, and settlements, net
    (594,100 )
Transfers to Level 3
    --  
Balance at September 30, 2011
  $ (3,095,900 )

Money Market Funds and Treasury Securities

The money market funds and treasury cash reserve securities balances are classified as cash and cash equivalents on our condensed consolidated balance sheet.

Fair Value of Other Financial Instruments

The carrying amounts of our accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their immediate or short-term maturities.  The aggregate carrying amount of the notes payable approximates fair value as the individual notes bear interest at market interest rates and there has not been a significant change in our operations and risk profile.
XML 22 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Basis of Presentation
9 Months Ended
Sep. 30, 2011
Basis of Presentation [Abstract] 
Basis of Presentation
Note 1 - Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Broadcast International, Inc. ("we" or the "Company") contain the adjustments, all of which are of a normal recurring nature, necessary to present fairly our financial position at December 31, 2010 and September 30, 2011 and the results of operations for the three and nine months ended September 30, 2010 and 2011, respectively, with the cash flows for each of the nine month periods ended September 30, 2010 and 2011, in conformity with U.S. generally accepted accounting principles.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2010.  Operating results for the three and nine months ended September 30, 2011 are not necessarily indicative of the results that may be expected for the year ended December 31, 2011.
XML 23 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Stock-based Compensation
9 Months Ended
Sep. 30, 2011
Stock-based Compensation [Abstract] 
Stock-based Compensation
Note 4 - Stock-based Compensation

In accordance with ASC Topic 718, stock-based compensation cost is estimated at the grant date, based on the estimated fair value of the awards, and recognized as expense ratably over the requisite service period of the award for awards expected to vest.

Stock Incentive Plans

Under the Broadcast International, Inc. 2004 Long-Term Incentive Plan (the "2004 Plan"), the board of directors may issue incentive stock options to employees and directors and non-qualified stock options to consultants of the company.   Options generally may not be exercised until twelve months after the date granted and expire ten years after being granted. Options granted vest in accordance with the vesting schedule determined by the board of directors, usually ratably over a three-year vesting schedule upon the anniversary date of the grant.  Should an employee terminate before the vesting period is completed, the unvested portion of each grant is forfeited. We have used the Black-Scholes valuation model to estimate fair value of our stock-based awards, which requires various judgmental assumptions including estimated stock price volatility, forfeiture rates, and expected life.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The number of unissued stock options authorized under the 2004 Plan at September 30, 2011 was 2,024,400.

The Broadcast International, Inc. 2008 Equity Incentive Plan (the "2008 Plan") has become our primary plan for providing stock-based incentive compensation to our eligible employees and non-employee directors and consultants of the company. The provisions of the 2008 Plan are similar to the 2004 Plan except that the 2008 Plan allows for the grant of share equivalents such as restricted stock awards, stock bonus awards, performance shares and restricted stock units in addition to non-qualified and incentive stock options. We continue to maintain and grant awards under our 2004 Plan which will remain in effect until it expires by its terms. The number of unissued shares of common stock reserved for issuance under the 2008 Plan was 1,165,000 at September 30, 2011.

Stock Options

We estimate the fair value of stock option awards granted beginning January 1, 2006 using the Black-Scholes option-pricing model. We then amortize the fair value of awards expected to vest on a straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and expected option term.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. The expected option term is derived from an analysis of historical experience of similar awards combined with expected future exercise patterns based on several factors including the strike price in relation to the current and expected stock price, the minimum vest period and the remaining contractual period.

The fair values for the options granted for the nine months ended September 30, 2011 and 2010 were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
 
   
Nine Months Ended
September 30, 2011
   
Nine Months Ended
September 30, 2010
 
Risk free interest rate
    1.96%       3.14%  
Expected life (in years)
    6.28       7.5  
Expected volatility
    81.03%       80.71%  
Expected dividend yield
    0.00%       0.00%  

The weighted average fair value of options granted during the nine months ended September 30, 2011 and 2010 was $0.63 and $0.80, respectively.

Warrants

We estimate the fair value of issued warrants on the date of issuance as determined using a Black-Scholes pricing model. We amortize the fair value of issued warrants using a vesting schedule based on the terms and conditions of each associated underlying contract, as earned. The Black-Scholes valuation model requires various judgmental assumptions including the estimated volatility, risk-free interest rate and warrant expected exercise term.  Our computation of expected volatility is based on a combination of historical and market-based implied volatility.  The risk-free interest rate was based on the yield curve of a zero-coupon U.S. Treasury bond on the date the warrant was issued with a maturity equal to the expected term of the warrant.

The fair values for the warrants issued for the nine months ended September 30, 2011 and 2010 estimated at the date of issuance using the Black-Scholes option-pricing model with the following weighted average assumptions:
 
   
Nine Months Ended
September 30, 2011
   
Nine Months Ended
September 30, 2010
 
Risk free interest rate
    2.04%       1.34%  
Expected life (in years)
    5.00       2.98  
Expected volatility
    85.82%       88.65%  
Expected dividend yield
    0.00%       0.00%  

 
The weighted average fair value of warrants issued during the nine months ended September 30, 2011 and 2010 was $0.79 and $0.53, respectively.
 
Results of operations for the nine months ended September 30, 2011 and 2010 includes $2,072,993 and $879,570, respectively, of non-cash stock-based compensation expense. Restricted stock units and options issued to directors vest immediately. All other restricted stock units, options and warrants are subject to applicable vesting schedules. Expense is recognized proportionally as each award or grant vests.

Included in the $2,072,993 non-cash stock-based compensation expense for the nine months ended September 30, 2011 are (i) $1,544,000 for 1,400,000 restricted stock units issued to all 5 members of the board of directors, (ii) $124,000 for 200,000 restricted stock units issued to one employee, (iii) $263,572 for 600,000 options issued to one individual and one corporation for consulting services, (iv) $51,207 for 874,200 options granted to 38 employees, (v) $4,263 for 8,700 options granted to 15 of our non-employee installation technicians and (vi) $85,951 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2011.

Included in the $879,571 non-cash stock-based compensation expense for the nine months ended September 30, 2010 is (i) $80,000 for 100,000 options granted to one member of the board of directors, (ii) $93,000 for 150,000 warrants issued to three new members of our advisory board, (iii) $44,450 for 460,000 warrants issued to five individuals and two corporations for consulting services, (iv) $568,121 resulting from the vesting of unexpired options and warrants issued prior to January 1, 2010 and (v) $94,000 for 100,000 restricted stock units issued to a member of the board of directors. Additionally, we issued (i) 183,824 warrants to a former member of the board of directors in exchange for the return and cancellation of 125,000 shares of our common stock, (ii) 2,295,075 warrants to investors of our Private Placement Memorandum Offering and (iii) 3,333,333 warrants with the July 2010 amendment to our 6.25% senior secured convertible note.

The impact on our results of operations for recording stock-based compensation for the three and nine months ended September 30, 2011 and 2010 is as follows:
 
   
For the three months ended
September 30,
   
For the nine months ended
September 30,
 
   
2010
   
2011
   
2010
   
2011
 
General and administrative
  $ 96,973     $ 234,185     $ 616,001     $ 1,915,969  
Research and development
    87,593       51,934       263,570       157,024  
                                 
Total
  $ 184,566     $ 286,119     $ 879,571     $ 2,072,993  

Due to unexercised options and warrants outstanding at September 30, 2011, we will recognize an additional aggregate total of $692,344 of compensation expense over the next four years based upon option and warrant award vesting parameters as shown below:

 
2011
  $ 174,037  
2012
    257,857  
2013
    178,090  
2014
    82,360  
Total
  $ 692,344  

The following unaudited tables summarize option and warrant activity during the nine months ended September 30, 2011.
 
   
Options
and
Warrants
Outstanding
   
Weighted
Average
Exercise
Price
 
             
Outstanding at December 31, 2010
    20,442,170     $ 1.13  
Options granted
    1,482,900       0.93  
Warrants issued
    1,275,334       0.68  
Expired
    (201,254 )     3.47  
Forfeited
    (2,319,981 )     1.25  
Exercised
    (455,098 )     0.08  
                 
Outstanding at September 30, 2011
    20,224,071     $ 1.10  

The following table summarizes information about stock options and warrants outstanding at September 30, 2011.
 
   
Outstanding
   
Exercisable
 
         
Weighted
Average
Remaining
   
Weighted
Average
         
Weighted
Average
 
Range of
Exercise Prices
 
Number
Outstanding
   
Contractual
Life (years)
   
Exercise
Price
   
Number
Exercisable
   
Exercise
Price
 
$0.05-0.95     1,901,336       5.12     $ 0.78       1,273,836     $ 0.71  
1.06-6.25
    18,321,135       4.25       1.13       17,916,991       1.13  
9.50-11.50
    1,600       0.42       10.50       1,600       10.50  
$0.05-11.50     20,224,071       4.33     $ 1.10       19,192,427     $ 1.10  

Restricted Stock Units

The value of restricted stock units is determined using the fair value of our common stock on the date of the award and compensation expense is recognized in accordance with the vesting schedule. During the nine months ended September 30, 2011 and 2010, 1,600,000 and 100,000 restricted stock units were awarded, respectively. During the nine months ended September 30, 2010, 35,000 restricted stock units were settled by two individuals through the issuance of 35,000 shares of our common stock.

The following is a summary of restricted stock unit activity for the nine months ended September 30, 2011.

   
Restricted
Stock Units
   
Weighted
Average
Grant
Date Fair
Value
 
             
Outstanding at December 31, 2010
    950,000     $ 1.63  
Awarded at fair value
    1,600,000       1.04  
Canceled/Forfeited
    --       --  
Settled by issuance of stock
    --       --  
Outstanding at September 30, 2011
    2,550,000     $ 1.25  
Vested at September 30, 2011
    2,550,000     $ 1.25  
XML 24 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Significant Accounting Policies
9 Months Ended
Sep. 30, 2011
Significant Accounting Policies [Abstract] 
Significant Accounting Policies
Note 5 - Significant Accounting Policies

Cash and Cash Equivalents

We consider all cash on hand and in banks, and highly liquid investments with maturities of three months or less, to be cash equivalents. At September 30, 2011 and December 31, 2010, we had bank balances of $104,367 and $5,879,632, respectively, in excess of amounts insured by the Federal Deposit Insurance Corporation. We have not experienced any losses in such accounts, and believe we are not exposed to any significant credit risk on cash and cash equivalents.

Current financial market conditions have had the effect of restricting liquidity of cash management investments and have increased the risk of even the most liquid investments and the viability of some financial institutions.  We do not believe, however, that these conditions will materially affect our business or our ability to meet our obligations or pursue our business plans.

Accounts Receivable

Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when collected.

Included in our $1,192,248 and $1,125,055 net accounts receivable for the nine months ended September 30, 2011 and the year ended December 31, 2010, respectively, were (i) $1,150,276 and $1,031,795 for billed trade receivables, respectively; (ii) $86,716 and $143,542 of unbilled trade receivables (iii) $56 and $208 for employee travel advances and other receivables, respectively; less (iv) ($44,800) and ($50,490) for allowance for uncollectible accounts, respectively.

Inventories

Inventories consisting of electrical and computer parts are stated at the lower of cost or market determined using the first-in, first-out method.

Property and Equipment

Property and equipment are stated at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the property, generally from three to five years.  Repairs and maintenance costs are expensed as incurred except when such repairs significantly add to the useful life or productive capacity of the asset, in which case the repairs are capitalized.

Patents and Intangibles

Patents represent initial legal costs incurred to apply for United States and international patents on the CodecSys technology, and are amortized on a straight-line basis over their useful life of approximately 20 years.  We have filed several patents in the United States and foreign countries. As of September 30, 2011, the United States Patent and Trademark Office had approved four patents.  Additionally, eleven foreign countries had approved patent rights.  While we are unsure whether we can develop the technology in order to obtain the full benefits, the patents themselves hold value and could be sold to companies with more resources to complete the development. On-going legal expenses incurred for patent follow-up have been expensed from July 2005 forward.

Amortization expense recognized on all patents totaled $2,538 and $7,613 for the three and nine months ended September 30, 2011, respectively. Amortization expense recognized on all patents totaled $2,591 and $7,466 for the three and nine months and ended September 30, 2010, respectively.

Estimated amortization expense, if all patents were issued at the beginning of 2011, for each of the next five years is as follows:

Year ending
December 31:
     
2011
  $ 12,231  
2012
    11,763  
2013
    11,763  
2014
    11,763  
2015
    11,763  

Long-Lived Assets

We review our long-lived assets, including patents, annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If such assets are considered to be impaired, then the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.  Fair value is determined by using cash flow analyses and other market valuations.

Income Taxes

We account for income taxes in accordance with the asset and liability method of accounting for income taxes prescribed by ASC Topic 740.  Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income in the years in which those temporary differences are expected to be recovered or settled.

Revenue Recognition

We recognize revenue when evidence exists that there is an arrangement between us and our customers, delivery of equipment sold or service has occurred, the selling price to our customers is fixed and determinable with required documentation, and collectability is reasonably assured. We recognize as deferred revenue, payments made in advance by customers for services not yet provided.

When we enter into a multi-year contract with a customer to provide installation, network management, satellite transponder and help desk, or combination of these services, we recognize this revenue as services are performed and as equipment is sold.  These agreements typically provide for additional fees, as needed, to be charged if on-site visits are required by the customer in order to ensure that each customer location is able to receive network communication. As these on-site visits are performed the associated revenue and cost are recognized in the period the work is completed. If we install, for an additional fee, new or replacement equipment to an immaterial number of new customer locations, and the equipment immediately becomes the property of the customer, the associated revenue and cost are recorded in the period in which the work is completed.

In instances where we have entered into license agreements with a third parties to use our technology within their product offering, we recognize any base or prepaid revenues over the term of the agreement and any per occurrence or periodic usage revenues in the period they are earned.

Research and Development

Research and development costs are expensed when incurred.  We expensed $570,197 and $1,793,596 of research and development costs for the three and nine months ended September 30, 2011, respectively. We expensed $588,147 and $2,090,212 of research and development costs for the three and nine months ended September 30, 2010, respectively.

Concentration of Credit Risk

Financial instruments, which potentially subject us to concentration of credit risk, consist primarily of trade accounts receivable. In the normal course of business, we provide credit terms to our customers. Accordingly, we perform ongoing credit evaluations of our customers and maintain allowances for possible losses which, when realized, have been within the range of management's expectations.

For the nine months ended September 30, 2011 and 2010, we had one customer that individually constituted 91% and 87%, respectively of our total revenues.
XML 25 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 26 R18.htm IDEA: XBRL DOCUMENT v2.3.0.15
Subsequent Events
9 Months Ended
Sep. 30, 2011
Subsequent Events [Abstract] 
Subsequent Events
Note 13 - Subsequent Events

During October 2011 we issued 26,640 shares of our common stock to one individual in exchange for 399,601 Interact Device Inc. (IDI) share equivalents.

During October 2011 we issued an aggregate of 77,500 options to one member of our Advisory Board and two employees.
 
During October and November 2011 we entered into an Equipment Sales Agreement under the terms of which a company purchased installation services and equipment to be installed, used and sold to our customers.  The company granted us ninety (90) day terms, which should allow us time to install the equipment, bill our customers, and receive payment to satisfy the outstanding payable to the financing company.  This accommodation will increase the cost of our equipment by approximately 10% if it is paid on time.  The total amount of equipment funding aggregated to $700,000.
 
We evaluated subsequent events pursuant to ASC Topic 855 and have determined that there are no additional events that need to be reported.
XML 27 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Notes Payable
9 Months Ended
Sep. 30, 2011
Notes Payable [Abstract] 
Notes Payable
Note 6 - Notes Payable

The recorded value of our notes payable (net of debt discount) for the nine months ended September 30, 2011 and year ended December 31, 2010 was as follows:

   
December 31, 2010
   
September 30, 2011
 
             
Amended and Restated Senior 6.25% Convertible Note
  $ 6,180,816     $ 6,180,816  
Unsecured Convertible Note
    7,168       257,170  
Pledged A/R Note Payable
    675,000       --  
Short Term Note Payable
    100,000       --  
Total
    6,962,984       6,437,986  
Less Current Portion
    (775,000 )     (171,875 )
Total Long-term
  $ 6,187,984     $ 6,266,111  

Amended and Restated Senior 6.25% Convertible Note

On December 24, 2007, we entered into a securities purchase agreement in which we raised $15,000,000 (less $937,000 of prepaid interest).  We used the proceeds from this financing to support our CodecSys commercialization and development and for general working capital purposes.  Pursuant to the financing, we issued a senior secured convertible note in the principal amount of $15,000,000.  The senior secured convertible note bore interest at 6.25% per annum if paid in cash.  Interest for the first year was prepaid at closing.  Interest-only payments thereafter in the amount of $234,375 were due quarterly and commenced in April 2009.  The original principal of the note was convertible into 2,752,294 shares of our common stock at a conversion price of $5.45 per share, convertible any time during the term of the note.  We granted a first priority security interest in all of our property and assets and of our subsidiaries to secure our obligations under the note and related transaction agreements.

In connection with the 2007 financing, the senior secured convertible note holder received warrants to acquire 1,875,000 shares of our common stock exercisable at $5.00 per share.  We also issued to the convertible note holder 1,000,000 shares of our common stock valued at $3,750,000 and incurred an additional $1,377,000 for commissions, finders fees and other transaction expenses, including the grant of a three-year warrant to purchase 112,500 shares of our common stock to a third party at an exercise price of $3.75 per share, valued at $252,000.  A total of $1,377,000 was included in debt offering costs and was amortized over the term of the note.
 
From March 26, 2010 through October 29, 2010, we entered into a series of amendments to the senior secured convertible note under which we issued to the holder of the senior secured convertible note an additional 3,000,000 shares of our common stock, increased the number of warrants by 3,333,333 shares, and reduced the warrant exercise price to $1.80 per share for all warrants, all as consideration for the amendments.

On December 24, 2010, we closed on the Debt Restructuring (as defined below).  In connection therewith, we (i) issued an Amended and Restated Senior Convertible Note in the principal amount of $5.5 million (the "Amended and Restated Note") to Castlerigg Master Investment Ltd. ("Castlerigg"), (ii) paid $2.5 million in cash to Castlerigg, (iii) cancelled warrants previously issued to Castlerigg that were exercisable for a total of 5,208,333 shares of common stock, (iv) issued 800,000 shares of common stock to Castlerigg in satisfaction of an obligation under a prior loan amendment, (v) entered into a Letter Agreement pursuant to which we paid Castlerigg an additional $2.75 million in cash in lieu of the issuance of $3.5 million in stock and warrants as provided in the loan restructuring agreement under which the Amended and Restated Note and other documents were issued (the "Loan Restructuring Agreement"), and (vi) entered into an Investor Rights Agreement with Castlerigg dated December 23, 2010.  As a result of the foregoing, Castlerigg forgave approximately $7.2 million of principal and accrued but unpaid interest. The Debt Restructuring was considered a troubled-debt restructuring and a gain on debt restructuring of $3,062,457 was recorded during the year ended December 31, 2010, which was the difference between the adjusted carrying value of the original note and the carrying value of the Amended and Restated Note.
 
The Amended and Restated Note, dated December 23, 2010, is a senior, unsecured note that matures in three years from the closing and bears interest at an annual rate of 6.25%, payable semi-annually.  We paid the first year's interest of $350,434 at the closing.  The Amended and Restated Note is convertible into shares of common stock at a conversion price of $1.35 per share, subject to adjustment.  The Amended and Restated Note is convertible in whole or in part at any time upon notice by Castlerigg to us.  The Amended and Restated Note also contains various restrictions, acceleration provisions and other standard and customary terms and conditions.  Two of our consolidated subsidiaries guaranteed our obligations under the Amended and Restated Note.

The Investor Rights Agreement provides Castlerigg with certain registration rights with respect to the Company's securities held by Castlerigg.  These registration rights include an obligation of the Company to issue additional warrants to Castlerigg if certain registration deadlines or conditions are not satisfied.  The agreement also contains full-ratchet anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than the conversion price described above.

As of September 30, 2011 and 2010, we recorded an aggregate derivative liability of $203,700 and $1,000,500 respectively, related to the conversion features of the Amended and Restated Note and the conversion feature and warrants related to the Original Note.  A derivative valuation gain of $2,403,700 and loss of $235,200 was recorded during the nine months ended September 30, 2011 and 2010, to reflect the change in value of the aggregate derivative liability since December 31, 2010 and 2009, respectively. The aggregate derivative liability of $203,700 for the Amended and Restated Note conversion feature was calculated at September 30, 2011 using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate of 0.25%, (ii) expected life (in years) of 2.2; (iii) expected volatility of 68.80% for the conversion feature, (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.

During the nine months ended September 30, 2010, the principal value of the 6.25% senior secured convertible note was increased by $1,131,836 to $17,528,086 (convertible into 9,737,826 common shares), for interest capitalized rather than making a payment in cash.

The original principal value of the note was being accreted over the term of the obligation, for which $1,047,825 and $3,143,475 was included in interest expense for the three and nine months ended September 30, 2010. The note now bears a 6.25% annual interest rate payable quarterly and for the nine months ended September 30, 2010, $27,388 was accrued and included as interest expense.  For the nine months ended September 30, 2010, $1,106,217 ($1,131,836 offset by $25,619 note interest accrued in 2009) was included in interest expense for capitalized interest.

The $6,180,816 value of the note at September 30, 2011 consists of $5,500,000 for the principal due of the note plus $1,031,250 for aggregate future interest less $350,434 for interest withheld at closing for interest due from the initial date of the debt restructuring transaction until December 31, 2011.

Unsecured Convertible Note

On September 29, 2006, we entered into a letter of understanding with Triage Capital Management, or Triage, dated as of September 25, 2006.  The letter of understanding provided that Triage loan $1,000,000 to us in exchange for us entering into, on or prior to October 30, 2006, a convertible note securities agreement.  It was intended that the funding provided by Triage be replaced by a convertible note and accompanying warrants, as described below.  Effective November 2, 2006, we entered into securities a purchase agreement, a 5% convertible note, a registration rights agreement, and four classes of warrants to purchase our common stock, all of which were with an individual note holder, the controlling owner of Triage, who caused our agreement with Triage to be assigned to him, which satisfied our agreement with Triage.

Pursuant to the securities purchase agreement, (i) we sold to the convertible note holder a three-year convertible note in the principal amount of $1,000,000 representing the funding received by us on September 29, 2006; (ii) the convertible note bore an annual interest rate of 5%, payable semi-annually in cash or shares of our common stock; (iii) the convertible note was convertible into shares of our common stock at a conversion price of $1.50 per share subject to full-ratchet anti-dilution price protection provisions ; and (iv) we issued to the convertible note holder four classes of warrants (A Warrants, B Warrants, C Warrants and D Warrants), which give the convertible note holder the right to purchase a total of 5,500,000 shares of our common stock as described below.  The A and B Warrants originally expired one year after the effective date of a registration statement filed under the Securities Act of 1933, as amended (the "Securities Act"), to register the subsequent sale of shares received from exercise of the A and B Warrants. The C Warrants and D Warrants originally expired eighteen months and twenty four months, respectively, after the effective date of a registration statement to be filed under the Securities Act.  The A Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.60 per share, the B Warrants grant the convertible note holder the right to purchase up to 750,000 shares of common stock at an exercise price of $1.75 per share, the C Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $2.10 per share, and the D Warrants grant the convertible note holder the right to purchase up to 2,000,000 shares of common stock at an exercise price of $3.00 per share.

During the year ended December 31, 2007, the convertible note holder exercised 454,000 A Warrants. We entered into an exchange agreement dated October 31, 2007 in which the convertible note holder received 650,000 shares of our common stock in exchange for cancellation of the C and the D Warrants.  The expiration date of the A Warrants and the B Warrants was extended from January 11, 2008 to December 3, 2008. During the year ended December 31, 2008, the convertible note holder exercised 64,400 A Warrants. On December 3, 2008, the remaining 231,600 A Warrants and 750,000 B Warrants expired.

On December 23, 2009 we entered into an amendment with the holder of this unsecured convertible note, which (i) extended the note maturity date to December 22, 2010 and (ii) increased the annual rate of interest from 5% to 8% commencing October 16, 2009. All other terms and conditions of the note remained unchanged.

On December 24, 2010 we closed on a Debt Restructuring as mentioned above. In connection with that Debt Restructuring the Company amended the note with the holder of a $1.0 million unsecured convertible note, pursuant to which the maturity date of the note was extended to December 31, 2013.  We issued 150,000 shares to the holder of this note as consideration to extend the term of the note.

During March 2011, we issued 135,369 shares of common stock to the holder of our unsecured convertible note in satisfaction of $81,221 of accrued interest on the unsecured convertible note.  Also in connection with the satisfaction of the accrued interest we granted to the holder a warrant to acquire up to 221,758 additional shares of our common stock at an exercise price of $0.96 per share.  The warrant is exercisable at any time for a five-year period. For the nine months ended September 30, 2011, the $157,400 value of the warrant was included in interest expense.
 
At September 30, 2011 and 2010 we recorded an aggregate derivative liability of $256,700 and $2,800, respectively, related to the conversion feature of the note. A derivative valuation gain of $1,145,200 and $197,200, respectively, was recorded to reflect the change in value of the aggregate derivative liability since December 31, 2010 and December 31, 2009, respectively.  The aggregate derivative liability of $256,700 for the conversion feature of the note was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.25%, (ii) expected life (in years) of 2.3; (iii) expected volatility of 73.43%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.

In connection with the amendment mentioned above, the principal value of the note will be accreted due to the difference in the value of the conversion feature before and after the amendment.  The accretion for the three and nine months ended September 30, 2011, was $83,334 and $250,002, respectively and was included in interest expense. The note currently bears an 8% annual interest rate payable semi-annually, and for each of the three and nine month periods ended September 30, 2011 and 2010, $20,000 and $60,000, respectively was included in interest expense.

Accounts Receivable Purchase Agreements

During the year ended December 31, 2010 we entered into two Accounts Receivable Purchase Agreements with one individual for an aggregate amount of $775,000. In these agreements, we pledged certain outstanding accounts receivable in exchange for advanced payment and a commitment to remit to the purchaser the amount advanced upon collection from our customer. Terms of the first agreement under which we were advanced $175,000 include a 3% discount with a 3% interest fee for every 30 days the advances remain outstanding. Terms of the second agreement under which we were advanced $500,000 include a 10% discount with a 0.5% interest fee for every 30 days the advances remain outstanding.

During the three months ended March 31, 2011 we converted the remaining $675,000 of principal along with $109,292 of accrued and unpaid interest into 1,307,153 shares of our common stock and warrants to purchase an additional 653,576 shares of our common stock. The warrants contain anti-dilution price protection provisions in the event the Company issues stock or convertible debt with a purchase price or conversion price less than $1.00 per share.

At September 30, 2011 we recorded an aggregate derivative liability of $135,500 related to the warrant reset provision. A derivative valuation gain of $314,600 was recorded to reflect the change in value of the aggregate derivative liability from the time the warrants were issued.  The aggregate derivative liability of $135,500 for the reset provision of the warrants was calculated using the Black-Scholes pricing model with the following assumptions: (i) risk free interest rate 0.83%, (ii) expected life (in years) of 4.5; (iii) expected volatility of 81.42%; (iv) expected dividend yield of 0.00%; and (v) stock trading price of $0.45.

Short Term Note Payable

During the three months ended March 31, 2011 we remitted $100,000 of the principal balance and accrued interest of $8,360 to a company pursuant to a short term note. The note had originated in June 2010 and bore an annual interest rate of 12%. Of the $8,360 of interest paid, $2,327 was related to and included in interest expense for the nine months ended September 30, 2011.
XML 28 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:  
Net income (loss)$ 3,729,513$ (11,649,358)
Adjustments to reconcile net income (loss) to net cash used in operating activities:  
Depreciation and amortization1,117,7031,179,380
Common stock issued for services 399,466
Common stock issued for interest19,634 
Common stock issued for research and development9034,024
Non-cash interest expense upon conversion of convertible notes 802,190
Accretion of discount on convertible notes payable250,0023,251,360
Capitalized interest on convertible note 1,131,836
Stock based compensation2,072,993879,570
Loss on sale of assets362 
Loss on extinguishment of Debt954,033 
Gain on derivative liability valuation(12,257,500)(240,100)
Loss on sale of securities available for sale 49,264
Warrants issued for interest157,400 
Warrants issued for debt extinguishment costs404,000 
Allowance for doubtful accounts1,414(38,904)
Changes in assets and liabilities:  
Decrease (increase) in accounts receivable(68,607)279,020
Decrease (increase) in inventories(54,399)42,295
Decrease in debt offering costs 1,648,620
Decrease in prepaid and other assets126,70420,393
Increase (decrease) in accounts payable and accrued expenses(485,735)259,419
Decrease in deferred revenues(103,629)(10,909)
Net cash used in operating activities(4,135,209)(1,992,434)
Cash flows from investing activities:  
Purchase of equipment(422,978)(190,173)
Proceeds from the sale of auction rate preferred securities 225,000
Proceeds from the sale of assets240 
Net cash provided by investing activities(422,738)34,827
Cash flows from financing activities:  
Proceeds from the sale of common stock 1,335,000
Proceeds from the exercise of options and warrants18,304 
Principal payments on debt(1,151,439)(1,304,658)
Equity issuance costs(24,078) 
Proceeds from notes payable 1,975,000
Net cash provided (used) by financing activities(1,157,213)2,005,342
Net increase (decrease) in cash and cash equivalents(5,715,160)47,735
Cash and cash equivalents, beginning of period6,129,632263,492
Cash and cash equivalents, end of period414,472311,227
Supplemental disclosure of cash flow information:  
Interest paid244,966369,591
Income taxes paid  
XML 29 R7.htm IDEA: XBRL DOCUMENT v2.3.0.15
Reclassifications
9 Months Ended
Sep. 30, 2011
Reclassifications [Abstract] 
Reclassifications
Note 2 - Reclassifications

Certain 2010 financial statement amounts have been reclassified to conform to 2011 presentations.
XML 30 R16.htm IDEA: XBRL DOCUMENT v2.3.0.15
Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2011
Recent Accounting Pronouncements [Abstract] 
Recent Accounting Pronouncements
Note 11 - Recent Accounting Pronouncements

In September 2011, the FASB issued ASU 2011-08, Intangibles - Goodwill and Other (Topic 350)- Testing Goodwill for Impairment. The objective of this Update is to simplify how entities test goodwill for impairment. This Update now allows entities to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step process of (1) comparing the fair value of the reporting unit to its carrying value and (2) test to measure the amount of the impairment loss if the fair value is less than the carrying value.  The more likely than not threshold is defined as having a likelihood of more than 50%.  The option to first assess qualitative factors can be bypassed and an entity can proceed directly to performing the first step of the two-step goodwill impairment test. Some examples of circumstances to consider are 1) macroeconomic conditions, 2) industry and market conditions, 3) cost factors that have a negative impact on earnings, 4) overall financial performance such as negative or declining cash flows 5) other relevant entity specific events and 6) sustained decrease in stock price. The Update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted, including for annual and interim goodwill impairment tests performed as of a date before September 15, 2011 if the financial statements have not been issued.  The Company will evaluate whether or not it will utilize the qualitative assessment option prior to performing the first goodwill impairment test in 2012 and will also determine if it wants to adopt the Update early and utilize the option for its goodwill impairment test.

In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220) - Presentation of Comprehensive Income. This Update eliminates the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity in order to increase the prominence of other comprehensive income items and to facilitate convergence with IFRS. The Update requires that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements (a statement of income and statement of other comprehensive income).  Additionally, adjustments for items reclassified from other comprehensive income to net income must be presented on the face of the financial statements.  This Update should be applied retrospectively. For public entities, the Update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. For nonpublic entities, the Update is effective for fiscal years ending after December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. This will impact how items for Other Comprehensive Income are presented and the Company will plan on following the guidance in the Update as of January 1, 2012.

In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in US GAAP and IFRS. The Amendments in this Update will improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with US GAAP and IFRSs.  The Boards of both organizations worked together to ensure fair value has the same meaning and the measurement and disclosures would be the same other than minor differences in wording. The Amendments explain how to measure fair value and do not require any additional fair value measurements. A few of the more significant changes are; 1) Clarification that quantitative information about unobservable inputs categorized as Level 3 should be disclosed, 2) Specification that premiums and discounts should be applied in the absence of Level 1 input if market participants would do so, but that premiums or discounts related to size/quantity should not be considered, and 3) Additional disclosure requirements for fair value measurements categorized as Level 3, an entity's use of a nonfinancial asset in a way that differs from the asset's highest and best use and the categorization by level for items not measured at fair value in the statement of financial position, but for which fair value disclosure is required. The amendments in this Update are to be applied prospectively. The Update is effective during interim and annual periods beginning after December 15, 2011.  The Company does not expect this guidance to have a significant impact on its financials since the amount of items disclosed at fair value is minimal, but will ensure the guidance is followed for items disclosed at fair value.

The following update was issued in 2010 and became effective on or after January 1, 2011.  Only significant updates that may impact the Company are included herein.

In August 2010, the FASB issued ASU No 2010-22, Accounting for Various Topics. Technical Corrections to SEC Paragraphs- An announcement made by the staff of US Securities and Exchange Commission. This Update makes changes to several of the SEC guidance literature within the Codification.  Some of the changes relate to (1) Oil and Gas Exchange Offers, (2) Accounting for Divestiture of a Subsidiary or Other Business Operations, (3) Replaces "Push Down" basis accounting references with "New" basis of accounting to be used in the acquired companies financial statements, (4) Fees paid to an investment banker in connection with an acquisition or asset purchase, when the investment banker is also providing interim financing or underwriting services must be allocated between the related service and debt issue costs. The amendments in this Update are effective immediately.  The Company does not expect this guidance to have a significant impact on its financials since there are no changes to accounting that were not already being applied by the Company.
XML 31 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 30, 2011
Dec. 31, 2010
Current Assets  
Cash and cash equivalents$ 414,472$ 6,129,632
Trade accounts receivable, net1,192,2481,125,055
Inventory106,57452,175
Prepaid expenses238,043190,877
Total current assets1,951,3377,497,739
Property and equipment, net1,732,1772,419,891
Other Assets, non current  
Patents, net159,797167,410
Deposits and other assets476,156624,598
Total other assets, non current635,953792,008
Total assets4,319,46710,709,638
Current Liabilities  
Accounts payable1,073,9671,552,006
Payroll and related expenses433,169341,255
Other accrued expenses78,526381,015
Unearned revenue35,808139,437
Current notes payable171,875775,000
Other current obligations1,443,0441,426,834
Derivative valuation3,095,90014,759,300
Total current liabilities6,332,28919,374,847
Long-term Liabilities  
Long-term portion of notes payable (net of discount of $992,832 and $742,830, respectively6,266,1116,187,984
Other long-term obligations 1,067,649
Total long-term liabilities6,266,1117,255,633
Total liabilities12,598,40026,630,480
Commitments and contingencies  
STOCKHOLDERS' DEFICIT:  
Preferred stock, no par value, 20,000,000 shares authorized; none issued  
Common stock, $.05 par value, 180,000,000 shares authorized; 74,078,153 and 75,949,016 shares issued as of December 31, 2010 and September 30, 2011, respectively3,797,4513,703,908
Additional paid-in capital96,686,41492,867,561
Accumulated deficit(108,762,798)(112,492,311)
Total stockholders' deficit(8,278,933)(15,920,842)
Total liabilities and stockholders' deficit$ 4,319,467$ 10,709,638
XML 32 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.15 Html 9 115 1 false 0 0 false 3 true false R1.htm 001 - Document - Document and Entity Information Sheet http://www.brin.com/role/DocumentAndEntityInformation Document and Entity Information false false R2.htm 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.brin.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.brin.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.brin.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.brin.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 011 - Disclosure - Basis of Presentation Sheet http://www.brin.com/role/BasisOfPresentation Basis of Presentation false false R7.htm 012 - Disclosure - Reclassifications Sheet http://www.brin.com/role/Reclassifications Reclassifications false false R8.htm 013 - Disclosure - Weighted Average Shares Sheet http://www.brin.com/role/WeightedAverageShares Weighted Average Shares false false R9.htm 014 - Disclosure - Stock-based Compensation Sheet http://www.brin.com/role/StockbasedCompensation Stock-based Compensation false false R10.htm 015 - Disclosure - Significant Accounting Policies Sheet http://www.brin.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R11.htm 016 - Disclosure - Notes Payable Notes http://www.brin.com/role/NotesPayable Notes Payable false false R12.htm 017 - Disclosure - Equity Financing and the Debt Restructuring Sheet http://www.brin.com/role/EquityFinancingAndTheDebtRestructuring Equity Financing and the Debt Restructuring false false R13.htm 018 - Disclosure - Fair Value Measurements Sheet http://www.brin.com/role/FairValueMeasurements Fair Value Measurements false false R14.htm 019 - Disclosure - Equipment Financing Sheet http://www.brin.com/role/EquipmentFinancing Equipment Financing false false R15.htm 020 - Disclosure - Interact Devices Inc. (IDI) Sheet http://www.brin.com/role/InteractDevicesIncIdi Interact Devices Inc. (IDI) false false R16.htm 021 - Disclosure - Recent Accounting Pronouncements Sheet http://www.brin.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements false false R17.htm 022 - Disclosure - Supplemental Cash Flow Information Sheet http://www.brin.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information false false R18.htm 023 - Disclosure - Subsequent Events Sheet http://www.brin.com/role/SubsequentEvents Subsequent Events false false All Reports Book All Reports Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS bcst-20110930.xml bcst-20110930.xsd bcst-20110930_cal.xml bcst-20110930_lab.xml bcst-20110930_pre.xml true true EXCEL 33 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V,3A?.#%C,%\S8F5A M,#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E=E:6=H=&5D7T%V97)A9V5?4VAA#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I7;W)K#I3='EL97-H965T($A2 M968],T0B5V]R:W-H965T3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V,3A?.#%C,%\S M8F5A,#'0O:'1M;#L@8VAA2!);F9O2!296=I'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,3QS M<&%N/CPO'0^43,\2!&:6QE3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A8CDU M,S-A.5]B,3DW7S0V,3A?.#%C,%\S8F5A,#'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E2!A;F0@97%U:7!M96YT+"!N M970\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7)O;&P@86YD(')E;&%T960@97AP96YS97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A M8CDU,S-A.5]B,3DW7S0V,3A?.#%C,%\S8F5A,#'0O:'1M;#L@8VAAF5D(&1I6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ.#`L,#`P+#`P,#QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V,3A?.#%C,%\S8F5A,#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'!E;G-E'!E;G-E'!E;G-E*3H\+W-T2!I'1I;F=U:7-H;65N="!O M9B!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPP,#`\ M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A8CDU,S-A.5]B,3DW7S0V,3A?.#%C,%\S8F5A,#'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^)FYB'0^)FYB'0^)FYB'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!I;G9E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)FYB&5R8VES92!O9B!O<'1I;VYS(&%N9"!W M87)R86YT'0^ M)FYB2!I'0^)FYB'0^)FYB3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V M,3A?.#%C,%\S8F5A,#'0O:'1M M;#L@8VAA'0^/"$M+41/0U194$4@:'1M M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R M86=M96YT+2T^(#QD:78@6EN9R!U;F%U9&ET960@8V]N9&5N M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX@/"]D:78^(#QD:78@65A7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@,B`M(%)E M8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@,R`M(%=E:6=H=&5D M($%V97)A9V4@4VAA65A&5R8VES92!O9B!S M=&]C:R!O<'1I;VYS+"!W87)R86YT'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@9F]L;&]W:6YG('1A8FQE('-E=',@ M9F]R=&@@=&AE(&-O;7!U=&%T:6]N(&]F(&)A6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!C;VQS<&%N/3-$-B!N;W=R87`],T1N;W=R87`^(#QD:78@'0M86QI9VXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,#PO9&EV/B`\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("9N8G-P.R9N8G-P.TYE="!I;F-O;64@*&QO6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B9N8G-P.R0\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS+#"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^-#,L,#DX+#@P,#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^-S4L,C0P+#,Q,SPO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+2T\+W1D/B`\=&0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M(#!P="<^("9N8G-P.R9N8G-P.U)E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3XM+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3XR+#4U,"PP,#`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@1&EL=71E9"!W96EG:'1E9"!A=F5R86=E M('-H87)E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S@L-#$T+#0U,SPO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@ M-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#LF;F)S<#M. M970@:6YC;VUE("AL;W-S*2!P97(@8V]M;6]N('-H87)E/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP-3PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XF;F)S<#LD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,"XP-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`F;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#M$:6QU=&5D/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP-3PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF M;F)S<#LD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M,"XP-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!0;W1E;G1I86QL>2!D:6QU=&EV92!S96-U&-L=61E9"!F3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V,3A?.#%C,%\S M8F5A,#'0O:'1M;#L@8VAA'0^/"$M+41/0U194$4@:'1M M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R M86=M96YT+2T^(#QD:78@'!E;G-E(')A=&%B;'D@;W9E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^56YD97(@=&AE($)R;V%D M8V%S="!);G1E2!I&5R8VES960@=6YT:6P@='=E;'9E(&UO;G1H'!I2!O=F5R(&$@=&AR964M>65A M2P@9F]R9F5I='5R92!R871E2!);F-E;G1I=F4@4&QA;B`H=&AE("(R,#`X M(%!L86XB*2!H87,@8F5C;VUE(&]U6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M5&AE(')I6EE;&0@8W5R=F4@;V8@82!Z97)O+6-O=7!O;B!5+E,N)FYB2!E<75A;"!T;R!T:&4@97AP96-T M960@=&5R;2!O9B!T:&4@&5R8VES92!P871T97)N6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@9F%I6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3,E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$R)3XS+C$T)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!%>'!E8W1E9"!L:69E("AI;B!Y96%R6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!E8W1E9"!V;VQA=&EL M:71Y/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\ M+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XF M;F)S<#L\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$R)3XP+C`P)3PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^)FYB2X\+V1I=CX@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!787)R86YT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!792`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/F5S=&EM871E('1H92!F86ER('9A;'5E(&]F M(&ES6EN M9R!C;VYT'!E M8W1E9"!E>&5R8VES92!T97)M+B9N8G-P.R9N8G-P.T]U'!E8W1E9"!V;VQA=&EL:71Y(&ES(&)A2XF;F)S<#LF;F)S<#L\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/E1H92!R:7-K+69R964@:6YT97)EF5R;RUC;W5P;VX@52Y3+B!4 M2!B;VYD(&]N('1H92!D871E('1H92!W87)R86YT('=A'!E8W1E9"!T97)M M(&]F('1H92!W87)R86YT+CPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE(&9A:7(@=F%L=65S(&9O'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R M.R!415A4+4E.1$5.5#H@,'!T)SX@4V5P=&5M8F5R(#,P+"`R,#$Q/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!2:7-K(&9R964@:6YT97)E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$R)3XR+C`T)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AP96-T960@ M;&EF92`H:6X@>65A6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!C96YT97(G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$R)3XR+CDX/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#XF;F)S<#L\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$R)3XX."XV-24\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AP96-T960@9&EV:61E M;F0@>6EE;&0\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XF;F)S M<#L\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE('=E:6=H=&5D(&%V97)A9V4@9F%I6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^ M("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5S=6QT'!E;G-E+B!297-T2!A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!);F-L M=61E9"!I;B!T:&4@)FYB65E'!I2!B;V%R9"P@*&EI M:2D@)FYB6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!4:&4@:6UP86-T(&]N(&]U6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@ M"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,3AP="<^($9O M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4 M+4E.1$5.5#H@,'!T)SX@1F]R('1H92!N:6YE(&UO;G1H6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4V5P=&5M M8F5R(#,P+#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D'0M M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M,C`Q,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S M<#LD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C,T M+#$X-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M4F5S96%R8V@@86YD(&1E=F5L;W!M96YT/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3XX-RPU.3,\+W1D/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,C@V+#$Q.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$=64@=&\@=6YE>&5R8VES960@;W!T M:6]N65A6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C$W-"PP,S<\ M+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C(U-RPX-3<\ M+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M,C`Q,SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-#PO9&EV/B`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4;W1A M;#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,34E/C8Y,BPS-#0\+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@5&AE(&9O;&QO=VEN9R!U;F%U9&ET960@=&%B;&5S('-U M;6UA6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E(&-O;'-P M86X],T0R/B`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`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4')I8V4\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!/=71S=&%N9&EN9R!A="!$96-E;6)E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@3W!T:6]N M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!787)R86YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/C$L,C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!%>'!I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!&;W)F96ET960\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/B@R+#,Q.2PY.#$\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/C$N,C4\+W1D/B`\ M=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#EP="<^($5X97)C:7-E9#PO9&EV/B`\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,B4^,"XP.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!796EG:'1E9#PO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!!=F5R86=E/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,34E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!. M=6UB97(\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,34E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!#;VYT M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,:69E("AY96%R6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,34E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!% M>&5R8VES93PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!06QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!%>&5R8VES86)L93PO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E/C$L.3`Q+#,S-CPO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,30E/C$L,C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,30E/C$X+#,R,2PQ,S4\+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,30E/C$W+#DQ-BPY.3$\+W1D/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,30E(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M.2XU,"TQ,2XU,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q! M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q-"4^,2PV,#`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4^,3`N-3`\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`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`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4^ M,C`L,C(T+#`W,3PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`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`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`R<'@@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@=F%L=64@;V8@F5D M(&EN(&%C8V]R9&%N8V4@=VET:"!T:&4@=F5S=&EN9R!S8VAE9'5L92X@1'5R M:6YG('1H92!N:6YE(&UO;G1H2!F;W(@=&AE M(&YI;F4@;6]N=&AS(&5N9&5D(%-E<'1E;6)E6QE/3-$)TU!4D=)3BU,1494.B`V M,W!T.R!T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-S`E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@5V5I9VAT960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`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`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!/=71S=&%N9&EN9R!A="!$96-E;6)E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@.7!T)SX@07=A6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Y<'0G/B!#86YC96QE9"]& M;W)F96ET960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/BTM M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E/BTM/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`Y<'0G/B!3971T;&5D(&)Y(&ES6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^+2T\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!/=71S=&%N9&EN9R!A="!397!T96UB97(@ M,S`L(#(P,3$\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E/C(L-34P+#`P,#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5F5S=&5D(&%T(%-E<'1E;6)E M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!.;W1E(#4@+2!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S M/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@5V4@8V]N2P@:6X@ M97AC97-S(&]F(&%M;W5N=',@:6YS=7)E9"!B>2!T:&4@1F5D97)A;"!$97!O M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@06-C;W5N=',@4F5C96EV86)L93PO9&EV/B`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!46QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M26YC;'5D960@:6X@;W5R("9N8G-P.R0Q+#$Y,BPR-#@@86YD("9N8G-P.R0Q M+#$R-2PP-34@;F5T(&%C8V]U;G1S(')E8V5I=F%B;&4@9F]R('1H92!N:6YE M(&UO;G1H6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!);G9E;G1O6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!);G9E;G1O6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!02!A;F0@ M17%U:7!M96YT/"]D:78^(#QD:78@'!E;G-E9"!A&-E<'0@=VAE;B!S=6-H M(')E<&%I2!A9&0@=&\@=&AE('5S969U;"!L:69E M(&]R('!R;V1U8W1I=F4@8V%P86-I='D@;V8@=&AE(&%S6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@4&%T96YT6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4&%T M96YT2!F;W(@56YI=&5D(%-T871E'!E M;G-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06UOF%T:6]N(&5X<&5N MF5D(&]N(&%L;"!P871E M;G1S('1O=&%L960@)FYB6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!%F%T:6]N(&5X M<&5N'0@9FEV92!Y96%R M6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@ M6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B`R,#$R/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q-B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E M/C$Q+#'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C$Q+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE2!OF5D(&ES(&UE87-U7-E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!792!A8V-O M=6YT(&9O2!!4T,@5&]P:6,@-S0P+B9N8G-P M.R9N8G-P.U5N9&5R('1H92!A"!R871E'!E M8W1E9"!T;R!A<'!L>2!T;R!T:&4@=&%X86)L92!I;F-O;64@:6X@=&AE('EE M87)S(&EN('=H:6-H('1H;W-E('1E;7!O2!D:69F97)E;F-E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5V4@&ES=',@=&AA="!T:&5R M92!I2!O9B!E<75I<&UE;G0@6UE;G1S(&UA9&4@:6X@861V86YC92!B>2!C=7-T;VUE2!PF5D(&EN('1H M92!P97)I;V0@=&AE('=O6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26X@:6YS=&%N8V5S M('=H97)E('=E(&AA=F4@96YT97)E9"!I;G1O(&QI8V5N2!A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!297-E87)C M:"!A;F0@1&5V96QO<&UE;G0\+V1I=CX@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO9&EV/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-O'!E;G-E9"!W:&5N(&EN8W5R2X@5V4@97AP96YS960@)FYB6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!#;VYC96YT2!O9B!TF5D+"!H879E(&)E96X@=VET:&EN('1H92!R86YG M92!O9B!M86YA9V5M96YT)B,S.3MS(&5X<&5C=&%T:6]N6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R('1H92!N:6YE(&UO M;G1H2!O9B!O=7(@=&]T86P@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@6T%B'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#8@+2!.;W1E6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1B;W1T M;VT@8V]L6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!$96-E;6)E"<@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!;65N9&5D(&%N9"!297-T871E9"!3 M96YI;W(@-BXR-24@0V]N=F5R=&EB;&4@3F]T93PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BPQ.#`L M.#$V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@56YS96-U6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-RPQ-C@\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+2T\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%-H;W)T M(%1E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3XQ,#`L,#`P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@3&5S6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3XH,3#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P@ M3&]N9RUT97)M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^-BPR-C8L,3$Q/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6UE;G1S('1H M97)E869T97(@:6X@=&AE(&%M;W5N="!O9B`F;F)S<#LD,C,T+#,W-2!W97)E M(&1U92!Q=6%R=&5R;'D@86YD(&-O;6UE;F-E9"!I;B!!<')I;"`R,#`Y+B9N M8G-P.R9N8G-P.U1H92!O2!T:6UE(&1U2!A;F0@87-S971S(&%N9"!O9B!O=7(@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26X@8V]N;F5C=&EO;B!W:71H M('1H92`R,#`W(&9I;F%N8VEN9RP@=&AE('-E;FEO65A2!A="!A;B!E>&5R8VES92!P'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M3VX@1&5C96UB97(@,C0L(#(P,3`L('=E(&-L;W-E9"!O;B!T:&4@1&5B="!2 M97-T&5R8VES86)L92!F;W(@82!T;W1A M;"!O9B`U+#(P."PS,S,@2`F;F)S<#LD M-RXR(&UI;&QI;VX@;V8@<')I;F-I<&%L(&%N9"!A8V-R=65D(&)U="!U;G!A M:60@:6YT97)E6EN9R!V86QU92!O9B!T:&4@06UE;F1E9"!A;F0@4F5S M=&%T960@3F]T92X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&IU2!T M:6UE('5P;VX@;F]T:6-E(&)Y($-A6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/E1H92!);G9E28C,SD[2!T;R!I6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M07,@;V8@4V5P=&5M8F5R(#,P+"`R,#$Q(&%N9"`R,#$P+"!W92!R96-O2X@5&AE(&%G9W)E9V%T92!D97)I=F%T:79E(&QI86)I;&ET>2!O9B`F M;F)S<#LD,C`S+#'!E;G-E(&9O'!E;G-E+B9N8G-P.R9N8G-P.T9O M6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!5;G-E8W5R960@0V]N=F5R=&EB;&4@3F]T93PO9&EV/B`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!397!T96UB97(@ M,CDL(#(P,#8L('=E(&5N=&5R960@:6YT;R!A(&QE='1E&-H86YG M92!F;W(@=7,@96YT97)I;F<@:6YT;RP@;VX@;W(@<')I;W(@=&\@3V-T;V)E M2!A(&-O M;G9E6EN9R!W87)R86YT2P@869T97(@=&AE(&5F9F5C=&EV92!D871E(&]F(&$@&5R8VES92!P&5R8VES92!P65A'!I6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!$96-E;6)E6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!$96-E;6)E&5R8VES92!P'0M86QI9VXZ(&IU2!O9B`F M;F)S<#LD,C4V+#'!E;G-E+CPO9&EV/B`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@070@4V5P=&5M8F5R(#,P+"`R,#$Q M('=E(')E8V]R9&5D(&%N(&%G9W)E9V%T92!D97)I=F%T:79E(&QI86)I;&ET M>2!O9B`F;F)S<#LD,3,U+#4P,"!R96QA=&5D('1O('1H92!W87)R86YT(')E M2!F'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!3:&]R="!4 M97)M($YO=&4@4&%Y86)L93PO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!$=7)I;F<@=&AE('1H2!P=7)S=6%N="!T;R!A('-H;W)T('1E M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!&:6YA;F-I;F<@86YD M('1H92!$96)T(%)E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#<@+2!%<75I M='D@1FEN86YC:6YG(&%N9"!T:&4@1&5B="!297-T'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!/;B!$96-E;6)E2!F:6YA;F-I;F<@*'1H92`B17%U:71Y($9I;F%N8VEN9R(I(&%S('=E;&P@ M87,@82!R97-T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!792!E;G1E2!A9W)E960@=&\@<&%Y(%!"0R!A(&-O;6UI'!E;G-E2`F;F)S<#LD M,3@P+#`P,"!U<&]N('1H92!C;&]S:6YG(&]F('1H92!%<75I='D@1FEN86YC M:6YG(&%N9"!T:&4@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.970@<')O8V5E9',@ M9G)O;2!T:&4@17%U:71Y($9I;F%N8VEN9RP@869T97(@9&5D=6-T:6YG('1H M92!C;VUM:7-S:6]N&EM871E;'D@)FYB2!D;W=N M(&1E8G0@86YD('1H92!R96UA:6YD97(@:7,@8F5I;F<@=7-E9"!F;W(@=V]R M:VEN9R!C87!I=&%L+CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B!/;B!.;W9E;6)E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26X@8V]N;F5C M=&EO;B!W:71H('1H92!%<75I='D@1FEN86YC:6YG(&%N9"!U;F1E2!A9W)E960@=&\@<')E<&%R92!A;F0@9FEL92P@86YD(&1I9"!F:6QE M+"!W:71H:6X@-C`@9&%Y2`F;F)S<#LD-RXR(&UI;&QI;VX@;V8@<')I;F-I<&%L M(&%N9"!A8V-R=65D(&)U="!U;G!A:60@:6YT97)E2!T:6UE('5P;VX@;F]T:6-E(&)Y($-A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/E1H92!);G9E28C,SD[2!T;R!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@ M,S$L(#(P,3$L('=E(&ES2!I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!) M;B!C;VYN96-T:6]N('=I=&@@=&AE($1E8G0@4F5S=')U8W1U'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!.;W1E(#@@+2!&86ER(%9A;'5E($UE87-U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@0V]M<&%N>2!H M87,@8V5R=&%I;B!F:6YA;F-I86P@:6YS=')U;65N=',@=&AA="!A2!I;B!A;B!O2!G:79E M2!T;R!U;F%D:G5S=&5D('%U;W1E9"!P M2!T;R!U;F]B6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB3H@4WEM8F]L M+"!S97)I9CL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P="<^("9M:61D;W0[/"]D:78^(#PO=&0^(#QT M9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1( M.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y M;6)O;"P@'0M M86QI9VXZ(&QE9G0G/B!,979E;"`S+"!D969I;F5D(&%S('5N;V)S97)V86)L M92!I;G!U=',@:6X@=VAI8V@@;&ET=&QE(&]R(&YO(&UA6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!792!M96%S=7)E(&-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@4VEG;FEF:6-A;G0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@475O=&5D(%!R:6-E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M3W1H97(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(%-I9VYI9FEC86YT/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@06-T:79E($UA6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^($ED96YT:6-A;"!!6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^($EN<'5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@26YP=71S/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$"<@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1) M3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!42!C87-H(')E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B9N8G-P.R0\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4;W1A M;"!A"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XF;F)S<#LD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^-#$T+#0W,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!,:6%B:6QI=&EE6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE#L@4$%$1$E.1RU,1494.B`S M)2<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^($1E"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P.R0\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P.R0\+W1D M/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3XS+#`Y-2PY,#`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1O=&%L(&QI86)I;&ET:65S(&UE87-U6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE('1A8FQE(&)E;&]W('!R97-E;G1S(&]U M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX@/"]D:78^(#QD:78@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^($1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(%9A;'5A=&EO M;CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!686QU871I;VX@861J=7-T M;65N=#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R M8VAA6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.#(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1R86YS9F5R M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q-24^+2T\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@0F%L86YC92!A="!397!T96UB97(@,S`L(#(P,3$\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@2!396-U2!M87)K970@9G5N9',@86YD('1R96%S=7)Y(&-A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@1F%I6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M(&-A6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,@87!P M3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V,3A?.#%C M,%\S8F5A,#'0O:'1M;#L@8VAA M'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO M+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD M:78@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!/;B!!=6=UF5D M(&)E;&]W+CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!792!E;G1E2!L96%S92!P87EM96YT2!T:&4@9W)E871E6UE;G1S('1H M97)E=6YD97(@9'5R:6YG('1H92!T97)M(&]F('1H92!E<75I<&UE;G0@;&5A M6UE;G1S(&]F(&%P<')O>&EM871E;'D@)FYB M&5S+B!4:&4@ M<')O8V5E9',@;V8@=&AE(&9I;F%N8VEN9R!A&EM871E;'D@ M)FYB6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$=7)I M;F<@=&AE('1H2`F;F)S<#LD-#(R+#`Y-B!A;F0@)FYB2P@:6YC;'5D960@:6X@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG('1H92!T:')E M92!A;F0@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$P+"!W M92!M861E(&QE87-E('!A>6UE;G1S('1O=&%L:6YG(&%P<')O>&EM871E;'D@ M)FYB2P@:6YC;'5D M960@:6X@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@061D:71I;VYA;&QY+"!W92!R96-O9VYI>F5D M(&%M;W)T:7IA=&EO;B!O9B!T:&4@;&5A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;W1E(#$P M("T@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5V4@8F5G M86X@:6YV97-T:6YG(&EN(&%N9"!A9'9A;F-I;F<@;6]N:65S('1O($E$22!I M;B`R,#`Q+B!)1$D@=V%S(&1E=F5L;W!I;F<@=&5C:&YO;&]G>2!W:&EC:"!B M96-A;64@0V]D96-3>7,N/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!/8W1O8F5R(#(S+"`R,#`S+"!) M1$D@9FEL960@9F]R($-H87!T97(@,3$@1F5D97)A;"!"86YK6EN9R!P871E M;G0@<')O8V5S2!W92!W;W5L9"!S871I2!#;W5R="X@07,@82!R97-U;'0@;V8@=&AI&EM871E;'D@)FYB&EM871E;'D@-3`L,3(W+#(Q."!S:&%R97,@;V8@ M=&AE(&-O;6UO;B!S=&]C:R!O9B!)1$DL('=H:6-H(&EN8W)E87-E9"!O=7(@ M86=G2`U,2PT,C8L-S$Y('-H87)E'0M86QI9VXZ(&IU&-H86YG92!F;W(@.33L@5$585"U)3D1%3E0Z(#!P M="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4VEN8V4@36%Y(#$X M+"`R,#`T+"!W92!H879E(&%C<75I&EM M871E;'D@-34L-#DW+#4V."!)1$D@8V]M;6]N('-H87)E(&5Q=6EV86QE;G1S M+"!R97!R97-E;G1I;F<@87!P2`Y-"4@;V8@=&AE('1O=&%L M(&]U='-T86YD:6YG($E$22!S:&%R92!E<75I=F%L96YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4VEN M8V4@36%Y(#$X+"`R,#`T+"!W92!H879E(&%D=F%N8V5D(&%D9&ET:6]N86P@ M8V%S:"!T;R!)1$D@9F]R('1H92!P87EM96YT(&]F(&]P97)A=&EN9R!E>'!E M;G-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!);B!397!T96UB97(@,C`Q,2P@=&AE M($9!4T(@:7-S=65D($%352`R,#$Q+3`X+"`\9F]N="!S='EL93TS1"=&3TY4 M+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^26YT86YG:6)L97,@ M+2!';V]D=VEL;"!A;F0@3W1H97(@*%1O<&EC(#,U,"DM(%1E2!T;R!P M97)F;W)M('1H92!T=V\M6EN9R!V86QU92!A;F0@*#(I('1E6EN9R!V86QU92XF;F)S<#LF;F)S<#M4 M:&4@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AR97-H;VQD(&ES(&1E9FEN960@ M87,@:&%V:6YG(&$@;&EK96QI:&]O9"!O9B!M;W)E('1H86X@-3`E+B9N8G-P M.R9N8G-P.U1H92!O<'1I;VX@=&\@9FER2!S<&5C:69I M8R!E=F5N=',@86YD(#8I('-UF4@=&AE('%U86QI M=&%T:79E(&%SF4@=&AE(&]P=&EO;B!F;W(@:71S M(&=O;V1W:6QL(&EM<&%I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@26X@2G5N92`R,#$Q+"!T:&4@1D%30B!I M6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;VUP65A65A2!W:6QL('!L86X@;VX@9F]L;&]W:6YG M('1H92!G=6ED86YC92!I;B!T:&4@57!D871E(&%S(&]F($IA;G5A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M26X@36%Y(#(P,3$L('1H92!&05-"(&ESF%T:6]N2!A9&1I=&EO;F%L(&9A:7(@=F%L=64@;65AF5D M(&%S($QE=F5L(#,@2X@5&AE(%5P M9&%T92!I2!D;V5S(&YO="!E>'!E8W0@=&AI2!S:6=N:69I8V%N="!U<&1A=&5S('1H870@ M;6%Y(&EM<&%C="!T:&4@0V]M<&%N>2!A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!);B!!=6=U M&-H86YG M92!/9F9E2XF;F)S<#LF M;F)S<#M4:&4@0V]M<&%N>2!D;V5S(&YO="!E>'!E8W0@=&AI'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^($YO=&4@,3(@+2!3=7!P;&5M96YT86P@0V%S:"!&;&]W($EN9F]R;6%T M:6]N/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`R,#$Q/"]D:78^(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!-87)C M:"`R,2P@,C`Q,2P@=&AE($-O;7!A;GDL(&-O;G9E&5R8VES92!P65A28C,SD[2!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@26X@36%R8V@@,C`Q,2P@=V4@9W)A;G1E9"!T;R!T:&4@:&]L M9&5R(&]F(&]U&5R8VES92!P&5R8VES960@=&AE6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R M('1H92!N:6YE(&UO;G1H6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@1F]R('1H92!N:6YE(&UO;G1H'!E;G-E(&9R M;VT@=&AE(&9O;&QO=VEN9SH@*&DI("9N8G-P.R0U.3DL.34R(')E;&%T960@ M=&\@8V]S="!O9B!S86QE6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#(P,3`\+V1I=CX@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^/&)R("\^(#PO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG('1H92!N:6YE(&UO;G1HF4@:70@87,@<&%R="!O9B!C;W-T(&]F('-A;&5S+CPO9&EV M/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$=7)I;F<@=&AE M(&YI;F4@;6]N=&AS(&5N9&5D(%-E<'1E;6)EF4@:70@ M;W9E6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!&;W(@=&AE(&YI;F4@;6]N=&AS(&5N9&5D(%-E<'1E;6)EF%T:6]N(&5X<&5N2!B>2!O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG('1H92!N:6YE(&UO;G1H MF5D M(&YO=&4@9&ES8V]U;G1S(&%N9"!A8V-R=65D(&EN=&5R97-T+CPO9&EV/B`\ M(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V,3A? M.#%C,%\S8F5A,#'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@ M&-H86YG92!F;W(@,SDY+#8P,2!);G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG($]C=&]B97(@,C`Q,2!W92!I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SXF;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($1U2XF;F)S<#LF;F)S<#M4:&ES(&%C8V]M;6]D871I;VX@=VEL;"!I;F-R M96%S92!T:&4@8V]S="!O9B!O=7(@97%U:7!M96YT(&)Y(&%P<')O>&EM871E M;'D@,3`E(&EF(&ET(&ES('!A:60@;VX@=&EM92XF;F)S<#LF;F)S<#M4:&4@ M=&]T86P@86UO=6YT(&]F(&5Q=6EP;65N="!F=6YD:6YG(&%G9W)E9V%T960@ M=&\@)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!792!E=F%L=6%T960@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC&UL/@T*+2TM+2TM/5].97AT4&%R=%]A8CDU,S-A.5]B,3DW7S0V 8,3A?.#%C,%\S8F5A,#